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PREFACE

When we are struck with wonder, our minds are suddenly cleared of the clutter of
everyday concerns that otherwise constantly occupy us. We are confronted by the thing, the
phenomenon in all of its strangeness and uniqueness. The wonder of that thing takes us in, and
renders us momentarily speechless as.
Van Manen, 2002
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FOREWORD
The dissertation set forth consists of five chapters. The first chapter (Chapter 1) sets the
stage for the dissertation research and consists of the following eight (8) sections which set the
stage for the rest of the inquiry: 1) Experiential context, 2) Assumptions, biases, intuitions, and
perceptions, 3) The phenomenon, 4) Background, 5) Justification for studying the phenomenon,
6) Phenomenon discussed within a specific context, 7) Selective qualitative research methods
and justification for its potential, and 8) Significance to nursing. In order to facilitate inquiries
into the research methods, journal entries, procedures, and participant responses are followed by:
(Audit trail). The second chapter (Chapter 2) presents the evolution of the study from a historical
context, and presents a synthesis of the literature in several aspects, including: 1) Health care
practices among patients with heart failure and advanced heart failure, 2) Quality of life among
patients with left-ventricular assist devices (LVADs) as a bridge to transplant (BTT), 3) LVADs
as a destination therapy (DT), 4) Caregiver support in situations similar to LVADs as DT, 5)
Caregiving in the heart failure population, 6) Caregiving in patients with a BTT, 7) Caregivers of
patients with advanced heart failure: a palliative care and end of life care perspective, 8)
Caregiving in patients with life-sustaining devices, 9) Ethical dilemmas, and ends with the
statement of the problem. The third chapter (Chapter 3) defines and discusses phenomenology, a
brief historical review of phenomenology as a philosophy and methodology, and discusses van
Manen’ (1990) phenomenological method of inquiry as the guide for the inquiry. The research
activities are outlined, including strategies for ensuring methodological rigor, human subject
considerations, and conclude with the strengths and limitations of the method of inquiry. A view
into the incorporation of humanities, the living arts, and photography is provided to illustrate the
creativity used in interpreting participants’ voices. The fourth chapter (Chapter 4) presents the
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findings from patients’ and caregivers’ voices in biographical format, using themes and subthemes to illustrate the lived experience. Finally, the fifth chapter (Chapter 5) attempts to
explicate the essence of the lived experience of DT using the extant literature and Roy’s
Adaptation Model as a theoretical framework. Conclusions and implications preface the need for
future research and building a sustainable program of research dedicated to meet the palliative
care and end of life care needs for patients with life-sustaining devices and their family
caregivers.
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CHAPTER 1: INTRODUCTION
AIM OF THE STUDY
“This device is the only therapy we have left for your husband....he is not eligible for a
heart transplant....he will have this device for the rest of his life — ma’am....if he doesn’t get this
LVAD, he will die.” These words just echoed unmercifully in her head as the surgeon’s words
became a muffled, buzzing sound. She became dizzy and weak, clutching the side rail for
support while sinking down in the chair. As her eyes turned towards her husband hooked up to
every line, tube and machine possible – she could only hear those words, “he will die....” over,
and over again. She sat very still in her chair. “It seemed like only yesterday,” her eyes filling
with tears, as she recalled the conversation with the transplant surgeon only three month ago.
She had never heard of such a device – a mechanical heart that will make him live? Can that be
so? The memories of her husband laying almost life-less in bed, ineligible for a heart transplant,
and how she had to make the decision for a surgical implantation of a mechanical heart seemed
liked yesterday. She was torn with this decision – should we get this LVAD? Can we handle
such a high-tech machine? Yet, her husband remembered the day quite vividly. He recalled
hearing a voice in the background. He turned his head towards this voice and saw flickering
lights. Much to his shock and disbelief, a picture of Jesus Christ surrounded in brilliant pink and
White lights covered the TV screen. He could not believe his eyes. It was as if Jesus was right
there calling out to him and supporting him in his time of need. He recalled that at that precise
moment, he knew that it was his destiny to receive the mechanical heart. As he heard his wife
talk to the doctor about this LVAD, he reached over to her, touched her hand, and said, “I want
to live – I want this mechanical heart.” And so it was. The couple was faced with a life-anddeath decision but through what the patient felt as divine intervention, wanted to take the risk
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for another chance at life.
This vignette provides an example of the initial uncertainties and experiences patients in
the final stages of heart failure and their caregivers face as they make the decision for a surgical
implantation of an LVAD. The patient in this vignette received an LVAD as a DT — the final
therapeutic option for patients ineligible for a heart transplant. This vignette, however, prefaces
a world unknown to those who are not recipients of this life-sustaining device —what is life like
with this life-sustaining device for these patients and their caregivers once they are released from
the hospital? This phenomenological inquiry aims to explore the experience of living with DT
from patients’ and caregivers’ perspective. My interest into this phenomenon stemmed from
many years of caring for patients with chronic and terminal illnesses, who have palliative care
and end of life care needs.
Experiential Context
For the past 25 years, I provided the palliative and end of life needs for patients in various
settings, such as maternal child health, critical care, and case management. Given this
knowledge, I wanted to become part of a research team dedicated to advancing the science in this
field, including the health and well-being of caregivers. In January 2009, I was invited to
participate in a qualitative study exploring self-concept and life-style modification of patients
with implantable LVADs. That summer, I commenced my first interview with a BTT patient. In
subsequent interviews, I met a patient with DT. As I listened to this patient, he described how
lucky he was to have this life-sustaining device and that if he was given the chance to do it all
over again, he would so in an instant. Another interview with a patient with DT revealed a
similar story. It appeared that for any LVAD indication, they were grateful to receive the device
and perceived this opportunity as a second chance at life. Yet, it was the story of a caregiver
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for a DT patient that aroused my interest in researching both patients with an LVAD as DT and
their caregivers.
As I listened to her story and the stories of other participants in my inquiry, I couldn’t
help think of how similar these perspectives where in my own field experiences with palliative
care and end of life care. On August 8, 2010, I commenced my first research as primary
investigator to explore the lifestyle adjustments of caregivers of patients with LVADs. It was the
particular story of a woman caring for her husband with DT that specifically aroused my interest.
She described for me a conversation that occurred with another caregiver of a patient with a DT.
It appeared that that particular patient experienced multiple strokes, blood clots, and died at
about 7 months. This weighed heavily on my participant’s mind. Subsequently, she was afraid
to leave him alone, even for an hour, because she was “concerned that something serious will
happen and nobody will be there to help him.”
Assumptions, Biases, Intuitions, and Perceptions
It is important to understand and make explicit my assumptions related to palliative and
end of life care and DT in order to give voice to the experience and meaning of living with such
a life-sustaining device. Let me share with you my knowledge about palliative care and end of
life care.
Palliative care, end of life care, and end-stage heart failure.
Palliative care is defined as a holistic approach to improve the quality of life of persons
afflicted with life-limiting illnesses and their caregivers (National Consensus Project for quality
Palliative Care [NCPQP], 2004; World Health Organization [WHO], 2010). Nurses and other
health care providers are part of this holistic, palliative care approach, including timely
discussions of palliative and end of life options (Hunt et al., 2005). End of life discussions,
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however, may not occur until these patients are nearing death (Goodlin, 2009; Hupcey, Penrod,
& Fogg, 2009; Rizzieri, Verheijde, Rady, & McGregor, 2005).

These discussions occur

infrequently due to the unpredictable nature of heart failure, even provider and patient barriers
such as lack of knowledge and fear (Aldred et al., 2005; Exley, Field, Jones & Stokes, 2005;
Selman et al., 2007). Improving communication, timely discussions, and education about
diagnosis, symptoms and disease trajectory are warranted among this expanding population.
Therefore, nurses must continually assess educational and palliative care needs, including timely
preparation for end of life for this emerging population (Goodlin, 2009; Hupcey et al., 2009;
Quaglietti et al., 2005; Rizzieri et al., 2005).
As I reflect upon my assumptions and prior knowledge, I strove to remain unbiased and
open to my phenomenon. There is always a possibility that one’s values and beliefs may be
challenged by their personal perceptions and knowledge (Munhall, 2008).

By identifying

assumptions and biases prior to engaging in research, van Manen (1990) posited that one can
hold them at bay, possibly even turning the knowledge against itself. I assumed that patients
with DT and their caregivers want to talk about their experiences so they can help other patients,
even health care providers. Furthermore, study participants understand that having an LVAD as
a DT is the last therapy available to alleviate the incapacitating symptoms from end-stage heart
failure. I understand that participants may not even talk about this experience as a final therapy
and I must remain open to these responses. My assumption is that when the patient will share
their experience about living with such a life-sustaining device, I will not know what they are
going to say. Although my assumptions are based on conjectures as I reviewed the literature on
end of life and caregiving at the end of life, these patients may view the LVAD as a second
chance at life, not even thinking about it as the beginning to the end of life.
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In my own practice, I provided the inpatient care, discharge preparation, and resources
necessary for patients and their caregivers to continue with palliative and/or end of life care at
home. I noticed that many times, when nurses speak to patients and their caregivers individually,
they often talk about their needs and issues differently. Both patients and caregivers are grateful
for the care received, yet caregivers tend to “pull-aside” nurses or other health care providers to
relay more in-depth information. This information usually included concerns for the patient,
self, uncertainties related to delivering palliative and end of life care. It was the paucity of
literature on the inside perspective of DT, and the vacillating concerns between both patients and
their caregivers, that stimulated my interest to explore the experience of living with a DT from a
patient and caregiver perspective.
Until I explore this phenomenon, we may never know what it’s like for these individuals
to be living with such a life-sustaining device. I believe it is necessary for this population to tell
us what this experience means to them so we can provide holistic care that is sensitive to the
complex realities of living with and caring for someone with a DT. Therefore, the focus of my
research was to explore patients’ and caregivers’ inside perspective of living with an LVAD as a
DT.
The Phenomenon
The phenomenon explored in this inquiry is the experience of living with a mechanical
heart from patients’ and caregivers’ perspectives. The context of this inquiry is destination
therapy. As we see an increasing number of patients in the community with these long-term
devices, the number of persons serving as caregivers will also rise. The following questions will
guide this inquiry:
1) What is the experience and meaning of living with an LVAD as DT from patients’
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perspectives?
2) What is the experience and meaning of caring for a patient with an LVAD as DT?
The following discussion provides the background for an inquiry into my phenomenon of
interest.
Background
Heart failure is a major public health concern affecting almost 6 million persons in the
United States (AHA, 2010). Despite improvements in diagnosis and medical management, there
are over 650,000 new cases diagnosed yearly, with almost 300,000 deaths reported annually
(AHA, 2010). Heart failure remains the leading cause of hospital admissions in older adults
(e.g., ≥ 65 years old) (i.e., over 1 million with a primary diagnosis of heart failure) with high readmission rates (50% within six months of discharge) (AHA, 2010; Fang et al., 2008). The
incidence of heart failure effects almost 10 per 1,000 in the ≥ 65 age group, with the annual rate
doubling every 10 years as older adults progress in age (Roger et al., 2012), and is often
preceded by hypertension and diabetes (AHA, 2010a; Roger et al., 2012). Moreover, heart
failure disproportionately affects racial and ethnic minorities, specifically Blacks compared to
Whites —a 50% higher incidence than in the general heart failure population (Crowder, Irons,
Meyerrose, & Seifert, 2010; Gordon, Nowlin, Maynard, Berbaum, & Deswal, 2010). Blacks
develop heart failure symptoms earlier than Whites (e.g., ≤ 65 years old) due to the higher
prevalence of risk factors, such as hypertension, diabetes, and have higher mortality rates
compared to Whites (AHA, 2010; Crowder et al.; Gordon et al., 2010). Since there is no cure
for heart failure, the progressive and debilitating nature of this disease poses significant societal
burdens and is estimated to cost the health care system over $39 million in 2011 (AHA, 2010).
This trend is expected to escalate due to an aging population, better prevention of sudden cardiac
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death, and improved survival after myocardial infarction (Fang et al., 2008; Gheorghiade &
Pang, 2009; Hugli, 2005). In order to grasp an understanding of heart failure, it is necessary to
discuss the characteristics, signs, symptoms, and therapies used to treat heart failure.
Characteristics of heart failure.
Heart failure is a chronic, progressive syndrome characterized by impaired cardiac
functioning and altered systemic perfusion (AHA, 2010b; Hunt et al., 2009). Subsequently,
patients with heart failure are at high risk for several disease-related outcomes, such atrial
fibrillation with rapid ventricular response, pulmonary edema, hypertensive crisis, hypotension,
low-output syndrome, and acute or chronic renal failure, all which contribute to frequent
hospitalizations, high re-admission, and mortality rates (Fonarow, Gawlinski, Moughrabi, &
Tillisch, 2001; Gheorghiade & Pang, 2009). Heart failure can be systolic (e.g., reduced cardiac
contractility) or diastolic (e.g., altered cardiac relaxation and abnormal ventricular filling) (AHA,
2010b). Left ventricular systolic dysfunction is most common and affects nearly 60% of patients
afflicted with heart failure (AHA, 2010b; Hunt et al., 2009). Studies report that persons have a
greater risk for developing heart failure if they have certain risk factors, such as coronary artery
disease (CAD), diabetes, hypertension, coronary artery disease (CAD), obesity, family history of
heart disease or cardiotoxin exposure (AHA, 2010b). Despite the incidence and prevalence of
this disease, there remains no cure for heart failure. It is the progressive, yet unpredictable nature
of this disease that continues to mystify, even frustrate, health-care providers, patients and their
caregivers alike. Decades of research into treatment has culminated in improvements in
diagnosis, preventative measures, and optimal medical management to improve overall quality of
life for many patients and their caregivers.
Stages, symptoms, and medical management.
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In order to determine the best treatment for patients with heart failure, health care
providers determine the stage and functional class of heart failure. As shown in Table A2, this
classification system subjectively determines the degree of functional limitation from Class I
(e.g., patient experiences no dyspnea or undue fatigue with ordinary physical activity) to Class
IV (e.g., dyspnea at rest or with very little exertion) (AHA, 2010b).

More recently, the

ACC/AHA has identified the stages of heart failure. These stages complement the NHYA
classification, by objectively identifying patients along the heart failure continuum, and linking
them to recommended medical management at each stage of the disease (Francis et al., 2010;
Hunt et al., 2009).
Stages of heart failure. Stage A is the first stage of heart failure. Patients in this stage
have risks for heart failure but do not exhibit heart disease —prevention is stressed at this stage
(Francis et al., 2010; Hunt et al., 2009). In stage B, patients have been diagnosed with heart
failure but no clear symptoms are reported (Francis et al., 2010; Hunt et al., 2009). Physicians
may prescribe ACEIs, beta blockers and closely monitor blood pressure along with other
symptoms. The goal is prevention of left-ventricular remodeling (e.g., progressive ventricular
dilatation) which may lead to HF (Francis, 2010; Hunt et al., 2005). In stage C, patients have
structural heart disease and usually experience dyspnea, fatigue, and exercise intolerance.
Medical management includes the addition of diuretics, digoxin, aldosterone antagonists, or
possibly cardiac resynchronization therapy, which is a specialized pacemaker designed to recoordinate actions of the right and left ventricles) (Francis, 2010; Hunt et al., 2009). Despite
these advances and the progressive nature of the disease, many patients will progress to Stage D,
which is advanced or end-stage heart failure. This is the final stage many patients endure prior to
transplant or mechanical circulatory support.

Patients in this trajectory of heart failure
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experience profound shortness of breath at rest, profound fatigue, and marked physical
limitations, with sudden onset and/or recurrence of symptoms despite maximal management
(Francis et al., 2010; Hunt et al., 2009). These patients must be referred for specialized
treatments, including continuous positive inotropic infusions, heart transplant or LVADs (Hunt
et al., 2009).
Medical management for advanced or end-stage heart failure.
Almost a century of research has culminated in significant advancements aimed at
improving the quality of life of those afflicted with heart failure. These significant advances, or
optimal medical management, includes pharmacologic, surgical, and technological therapies
aimed at improving the function of the failing heart, such as: 1) diuretics, 2) beta-blockers, 3)
angiotensin II receptor blockers (ARBs), 4) angiotensin-converting enzyme inhibitors (ACEIs),
5) implantable cardioverter defibrillators, 6) cardiac resynchronization, 7) cardiomyoplasty, and
8) left ventriculectomy, aimed at improving the function of the failing heart (Krishnamani,
DeNofrio, & Konstam, 2010). There are also specialized treatments for patients with advanced
heart failure whose symptoms continue to progress despite optimal medical management, which
may include: 1) intravenous positive inotropic infusions, 2) heart transplant, and 3) mechanical
circulatory support, such as an LVAD (Hunt et al., 2005).
Intravenous positive inotropic therapy. If patients exhibit volume overload, continue to
deteriorate, and progress towards cardiogenic shock (inadequate tissue perfusion resulting from
cardiac dysfunction), they are usually admitted for intravenous infusions including positive
inotropic agents (e.g., milrinone) and vasodilators, such as nitroprusside (Hunt et al., 2009). If
patients are eligible for a heart transplant or even mechanical circulatory support, they may
remain on these infusions while waiting for a donor heart or even a mechanical circulatory
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support device (Francis, 2010). However, if patients are not eligible for either a transplant or
LVAD, inotropic infusions are utilized as a palliative and end of life care strategy (Felker &
O’Connor, 2001; Francis et al., 2010; Hauptman et al., 2006; Hershberger et al., 2003). Patients
who meet the transplant eligibility criteria (Table A3), however, are placed on a waiting list.
Heart transplant. To date, heart transplant is the best treatment for advanced or endstage heart failure. It is estimated that almost 5,000 heart transplants are performed worldwide,
with over 2,000 performed in the United States alone (Stehlik et al., 2010). Yet, not everyone on
the transplant list, however, receives a donor heart. For example, in 2010, there were 3160
patients on the heart transplant list, but only 2211 donor hearts were implanted in the United
States in 2010 (Organ Procurement & Transplant Network [OPTN] and Scientific Registry of
Transplant Recipients [SRTR] (OPTN/SRTR, 2011). As a result, thousands of patients on the
transplant list must wait almost one year for a donor heart (i.e., 302 days in 2011), continue to
experience a poor quality of life, or may even die without a transplant (OPTN/SRTR, 2011).
Estimates show that little more than half patients on the waiting list receive a donor heart, while
the rest face a mortality rate of 21% at 6 months and 47% at 10 months respectively (Lietz et al.,
2005). However, when patients received a heart transplant, mortality rates significantly improve.
For example, the median survival post-transplant is 10 years, with a median survival rate of 13
years during the first year (Stehlik et al., 2010). In addition, the number of older adults ≥ 65
years old receiving a heart transplant is on the rise, with estimates reaching almost 12% amongst
a predominantly White male population (75%) (Stehlik et al., 2010). Given the increasing
number of older adults with advanced heart failure and a limited pool of donor organs,
mechanical circulatory support provides increased survivability and improved quality of life
while waiting for a transplant, or as a DT, if ineligible for transplant (Francis et al., 2010; Rose et
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al., 2001).
Despite these advances, recent estimates show over 100,000 patients progressed to endstage (Stage D) heart failure (American College of Cardiology/American Heart Association
[ACC/AHA]), and exhibited class III or IV symptoms as described by the New York Heart
Association (NYHA) (Tables A1 and A2). Patients with this most advanced stage of heart failure
have end-organ damage as a result of poor organ perfusion and consequently experience a poor
quality of life. Symptoms resulting from organ dysfunction include marked shortness of breath
at rest or with minimal exertion, profound fatigue, and debilitating physical limitations (Hunt et
al., 2005; Hunt et al., 2009). Prognosis is grim, as the 1 year mortality rate reaches almost 50%
if a heart transplant or a mechanical circulatory support device is not performed (Krishnamami &
DeNofrio, 2010). These specialized treatments, specifically heart transplant and LVADs, are
final options for a chance at improved quality of life (Hunt et al., 2009). Yet many patients are
ineligible for heart transplant due to strict transplant criteria, such as malignancies, various comorbidities, and advanced age (e.g., ≥72 years old), as shown in Table A3 (Jessup et al., 2009;
Milano et al., 2006; Park et al., 2005).

Innovative technological advances dedicated to

improving the quality of life among for these patients culminated in the development of an
alternative to transplant, better known as DT.
Mechanical circulatory support. Mechanical circulatory support technologies, such as
LVADs, (Figure B1), provide mechanical assistance to the failing heart. These devices are
mostly utilized as a BTT, and/or bridge to myocardial recovery, to sustain the function of the
failing heart and improve overall quality of life while waiting for transplant. Distinct from total
artificial hearts which permanently replaces the heart, an LVAD supports the failing heart but
does not replace it. Most current models of LVADs are implanted in the upper abdomen, have a
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percutaneous lead (e.g., driveline) protruding from the abdomen, and connected to tubes from
which blood is drawn from either the right or left ventricle, and empties into the pump. An
extracorporeal controller initiates pumping and blood is propelled into the circulatory system
(Figure B1). These devices primarily assist the left ventricle, the ventricle most often affected in
heart failure (Maher, Butler, Poirier, & Gernes, 2002). LVADs are mostly indicated for viral,
ischemic, or peripartum cardiomyopathy, recurrent and/or refractory arrhythmias, acute
myocardial infarction, post-cardiotomy failure, and other types of heart failure (Hunt et al., 2009;
Rose et al., 2001). For patients ineligible for transplant, LVADs are implanted as a permanent
alternative to transplant, or DT. These patients must be classified as NYHA class IV heart
failure, and meet the following criteria, as shown in Table A3: 1) received optimal medical
management 60 out of the last 90 days, 2) left-ventricular function ˂ 25%; 3) life expectancy ˂
two years, and 4) ineligible for heart transplant (Hunt et al., 2009).
Evolution of mechanical circulatory support.
In the last several decades, almost 7000 mechanical circulatory devices were implanted
in the United States to support the failing heart and improve overall quality of life for patients
with advanced heart failure (Interagency Registry for Mechanically Assisted Circulatory Support
[INTERMACS, 2011], Kirklin et al., 2011). The increased utilization of LVADs is reflected in
the number of patients bridged to transplant — over 20% of recipients have an LVAD and 3%
have a right ventricular assist device at the time of transplant (Stehlik et al., 2010). The design
and application of the first mechanical circulatory support device can be traced back to the works
of several pioneers in Europe and in the United States. In 1937, a 21-year old Russian medical
student, Vladimir Demikhov, partially implanted a para-corporeal (pump outside the body)
mechanical assist device into the thorax of a dog, which sustained the function of the heart for
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almost 5 ½ hours (Schumaker, 1994).
With the advent of open heart surgery as an acceptable treatment for heart disease and
heart failure in the 1950s, cardiopulmonary bypass was developed to mechanically support
circulation during surgery (Cohn, 2003). However, failure to wean from cardiopulmonary bypass
necessitated extended mechanical support for myocardial recovery (Delgado, Rao, Ross, Verma,
& Smedira, 2002). It was at this time that the first artificial heart program began through the
direction of the National Heart, Lung, and Blood Institute (NHLBI) in 1964, with the intent to
develop both long and short-term mechanical circulatory support systems, as well as the total
artificial heart (Hogness & VanAntwerp, 1991; Stevenson et al., 1999).

Despite initial

advancements in total artificial hearts, mechanical problems, high mortality rates, and the
growing number of patients dying while waiting for heart transplant fueled the impetus to
develop implantable, electrically powered mechanical circulatory support devices which allowed
better patient mobility (Stevenson et al., 1999).
The first LVAD was developed in 1962 by Domingo Liotta (Liotta et al., 1963). In 1966,
DeBakey implanted the first pneumatically driven LVAD (an air-powered push plates) in a
woman after complicated cardiac surgery which supported her for 10 days (DeBakey, 1971).
With the advent of clinical trials of LVADs as a BTT in 1975 (Hogness & VanAntwerp, 1991),
Phillip Oyer performed the first BTT with an electrically powered LVAD in 1984 (Portner,
1985).

Continued developments and refinement of mechanical circulatory technology

culminated in electrically driven pneumatic and vented LVADs (i.e., volume displacement
pumps). Eventually, these devices were approved by the U. S. Food and Drug Administration
(FDA) as a BTT in 1994 (pneumatic) and 1998 (vented) (Maher, Butler, Poirier, & Gernes,
2001). These devices were mobile and patients were discharged home while waiting for
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transplant. Also, with an LVAD, the patient keeps the natural heart, so it can receive signals
from the brain to slow or speed up the heart rate as needed. The development of pneumatically
and electrically driven LVADs marked the era of first generation LVADs.
First generation LVADs While these first generation pumps mimic the pulsating heart,
referred to as pulsatile flow LVADs, (i.e., pulsatile), second generation pumps provide
continuous, or non-pulsatile flows) (Figure B1). In most first generation devices, the blood
enters the LVAD via an inflow device attached at the top of the left ventricle.

Blood fills the

left ventricle, enters the pump, and an external controller signals the pump to start pumping. The
blood-filled chamber becomes pressurized by the push plate, forces a pliable diaphragm upward
and blood is propelled through an outflow channel to the aorta. Check valves located on both
sides of the LVADs pumping chamber keeps blood flowing in a single direction. This pusher
plate is free floating, allowing for fluctuations in blood supply (Maher, Butler, Poirier, & Gernes,
2001). However, there are several drawbacks related to first generation LVADs which include:
(a) the large size of the device, or the device pocket [which required extensive surgical
dissection, especially in small statured patients]; (b) poor mechanical durability related to longterm use (e.g., bearing and/or bioprosthetic valve wear and tear; and (c) infection, bleeding, or
concurrent bi-ventricular support. In addition, these devices were uncomfortable for patients
because they weight three pounds and were very noisy. Several design alterations to these first
generation devices had led to the development of second generation, non-pulsatile, continuous
flow LVADs, which show promising long-term durability and less adverse events.
Second generation LVADs. Second generation LVADs are continuous flow devices
which weigh less than their first generation predecessors (12 ounces compared to three pounds ),
more durable, and last longer than pulsatile flow LVADs (Pagani, Long, Dembitsky, Joyce, &
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Miller, 2006; Pagani et al., 2009). As shown in Figure B1, most second generation pumps weigh
only 12 ounces while previous devices weighed 3 pounds (Stahovich, Chillcott & Dembitsky,
2007). Termed continuous flow LVADs (or non-pulsatile LVADs), these devices house either a
centrifugal or axial flow pumps. Pump housings are comprised of a rotor with magnets. As
electric run through the coils, forces are applied to the magnets and the rotors start to spin.
LVADs with centrifugal pumps have rotors shaped to accelerate the blood circumferentially
towards the outer edge of the pump (Maher, Butler, Poirier, & Gernes, 2001). In contrast, the
axial pumps have cylindrical rotors with helical blades, which make the blood accelerate towards
the rotor’s axis. These pumps produce a steady pressure by a continuously rotating impeller,
housed within blood lubricated bearings (Figure B2) (Maher et al., 2001). The interior of the
pump has two surfaces: a textured, bead-like surface made out of titanium (a metal used often in
medical devices), and the other side is a textured polyurethane diaphragm. These textured
surfaces form a lining inside the LVAD which mimics the internal surfaces of the blood vessels.
Since second-generation devices have only one single moving part, there is less device wear,
improved longevity, and reduction in pump-pocket and driveline infections (Pagani et al., 2006;
Pagani et al., 2009). However, increased thrombogenicity in second generation devices requires
anticoagulation, rendering some patients high-risk for gastrointestinal bleeding (Crow et al.,
2008; Grasso, Fenkel, Sorensen, & Felier, 2007). Subsequently, third generation devices were
designed to address issues with first and second generation devices such as thrombogenicity,
device durability, and long-term outcomes.
Third generation LVADs. Advancements in mechanical circulatory support focused on
noncontact bearing designs, such as magnetic or hydrodynamic levitation (Maher et al., 2001).
Similar to their second generation predecessors, these devices are continuous flow and utilize
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either centrifugal or axial flow pumps. What is distinct between second and third generation
LVADs is the design use to suspend the rotor. As shown in Figure B2, most second generation
designs used solid bearings (e.g. a ball-shaped device used to reduce friction between stationary
and moving parts).

These newer, third generation pumps use either hydrodynamic or

electromagnetic suspension, contain only one moving part, and have an impeller that is
hydrodynamically or magnetically levitated, as shown in Figure B3. (Krishnamani, DeNofrio,
Konstam, 2010). This was designed to improve device durability with the elimination of bearings
utilized in first and second generation models (Krishnamani et al., 2010). Compared to second
generation LVADs, third generation devices have the potential for greater efficiency and less
device wear (Maher et al., 2001). Other technology, such as trans-cutaneous induction power to
control the LVAD rather than percutaneous cables, are currently being evaluated for clinical
effectiveness (Francis et al., 2010; Krishnamani et al., 2010; Nguyen & Thourani, 2010). Despite
these innovative technological advancements, the overall mortality rate due to the progressive
nature of this disease remains high and patients continue to die while waiting for a transplant
(Rose et al., 2001; Hunt et al., 2009). While over 4 decades of research into mechanical
circulatory support devices focused on survivability and quality of life for this patient population,
the shift in focus from a BTT to long-term support was motivated by the increasing prevalence
and grim prognosis of this disease (Rose et al., 2001).
Justification for Studying the Phenomenon
There are almost 7000 registered patients in 140 centers nationwide who have
received an LVAD while waiting for a donor heart, as DT, or as bridge to recovery (e.g., used to
recover the myocardium due to cardio-toxins, etc.) — a 50% increase since 2006 (Kirklin, 2011).
Most patients received an LVAD as a BTT (36.3%), followed by likely to be eligible (26.2%),
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then DT (20%) (Kirklin et al., 2011). Patients were mostly White (70.5%) males (78.6%), 40-59
(45.2%) years old, followed by the 60-79 year-old age group (39.2%) (Kirklin et al., 2011). The
main indications for an LVAD included overall progressive decline in cardiac functioning
(42.1%) followed by patients who are stable, but inotrope dependent (21%) (Kirklin et al., 2011).
Despite the expanded indications, current data demonstrate that the utilization of LVADs as DT
has more than doubled in just one year (120%) compared to a 65% increase in BTT/possible
BTT indications (Kirklin et al., 2011). Moreover, older adults (e.g., 72 years and older) are
currently the second largest group requiring LVADs and most frequently referred for DT since
they are not eligible for a heart transplant (Kirklin et al., 2011) Krishnamani, DeNofrio, &
Konstam, 2010). Since the number of persons 65 years or older is projected to increase from 35
million today to 72 million by 2030 (Administration on Aging [AOA], 2010; Older Adults,
2010), this trend will continue, especially in view of FDA approval and Medicare/Medicaid
reimbursement of LVADs (Kirklin et al., 2011). Moreover, advancements in LVAD design have
made the transition from hospital to home more feasible with smaller, durable, and more mobile
devices. As these patients transition from hospital to home, it is imperative to explore what life
is like living with such a life-sustaining device in order to better assist them with their long-term
needs.
Patients with DT and their caregivers have needs, issues, and concerns which have not
been explored. Nurses and other healthcare professionals provide the education for living with
such a life-sustaining device, yet, may lack the knowledge of these needs, issues, and concerns
while living with an LVAD. My inquiry seeks to shed light on the experience of living with an
LVAD as DT from patients’ and caregivers’ perspective. This inquiry will not only uncover
what it is like to live with this device, but also has practice and research implications. The
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knowledge obtained will enhance the understanding of what the experience is like from a patient
and caregiver perspective and assist nurses and other health care workers to provide a holistic
approach to care.
Phenomenon Discussed Within a Specific Context
I sought to explore the experience of patients with LVADs and their caregivers. The
context of this inquiry is DT—the only option left for patients ineligible for heart transplant, and
those who care for them.
Destination therapy.
Decades of clinical research have culminated in technological advancement aimed at
developing such a long-term device with improved morbidity and mortality. However, it was the
landmark study, the Randomized Evaluation of Mechanical Assistance for the Treatment of
Congestive Heart Failure (REMATCH) trial, which revealed these technological achievements.
Findings of the REMATCH trial demonstrated a 48% reduction in mortality in patients who
received an LVAD versus optimal medical management (P = 0.001) (Rose et al., 2001). In this
study, (N = 129) patients who did not quality for heart transplant and had evidence of NYHA
class IV symptoms and were randomized into two groups, those who received a HeartMate VE
LVAD as DT (n = 68); or those who received optimal medical management (n = 61). There was
a significant improvement in one year survival compared to two-years (52% and 25%
respectively), in patients with a HeartMate VE LVAD versus 25% and 8% (1 and 2-year
intervals, respectively), in patients on optimal medical management only (Rose et al., 2001).
Subsequently insurance coverage of LVAD implantation for began for Medicare beneficiaries
beginning Oct. 1, 2003. Continued improvements in LVAD and clinical management since the
REMATCH trial have illustrated a sustained increase in overall quality of life, improved survival
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rates, reduced adverse effects, and device durability in long-term DT patients (Lietz et al., 2007;
Long et al., 2008). Despite increased longevity and better quality of life outcomes, living with a
mechanical circulatory support device may cause severe complications and sometimes lifethreatening conditions, including infections, thrombosis and device failure. For example, almost
90% of patients may experience some type of adverse event during LVAD support (Genovese et
al., 2009; Holman et al., 2009). Most occur during the first 30-60 days after implantation
(Esmore et al., 2008; John et al., 2008), and primarily includes bleeding, infection (Schaffer et
al., 2010), cardiac arrhythmias, and more surgical interventions (Genovese, 2009; Holman et al.,
2009). Despite these negative outcomes, most adverse events were related to utilization of firstgeneration devices. However, technological improvements in second-, even third generation
devices have reduced the number of adverse events in patients with LVADs as DT.
Nevertheless, as the limited availability of donor hearts and long-waits for transplants continues
to rise, the number of LVAD implantations has increased dramatically in recent years (Kirklin et
al., 2011). As we begin to see an increasing the number of patients in the community with these
long-term devices, the number of persons serving as caregivers will also rise.
Caregivers of patients with LVAD as DT.
Designated caregivers are vital to the promotion and maintenance of health and wellbeing among patients with DT. Patients with LVADs of any indication are required to have a
designated caregiver to assist with daily dressing changes, device maintenance, and the ability to
respond to and carry-out the emergency protocol (Casida, 2005). A designated caregiver for a
patient with DT is usually a family member, or a significant other. Intensive training begins the
day after patients receive an LVAD and continues as both patients and caregivers transition from
hospital to home.
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Although LVAD nurses are available around the clock when discharged home, caregivers
of LVAD patients face the reality of caring for a loved one with complex technology all by
themselves. Feeling overwhelmed was expressed in a recently completed study exploring
lifestyle adaption among LVAD caregivers (Marcuccilli & Casida, 2011). Coping strategies
such as positive thinking, fatalism and religiosity, and acceptance, helped caregivers adapt to
their new roles (Marcuccilli & Casida, 2011). Consequently, these participants accepted and
eventually adapted to their new caregiving roles (Marcuccilli & Casida, 2011). Despite the
intensive training for device maintenance and patient care, most caregivers of LVAD patients in
other studies reported an overall positive experience while caring for patients with LVADs —yet
continued to express concerns related to patient safety, uncertain future, even death (Dew et
al.,2000; Dew et al., 2004; Baker et al., 2009; Casida , 2005; Kaan et al., 2010). However, much
of this research is based on the perspective of BTT patients awaiting heart transplant and their
caregivers (Casida, 2005; Dew et al., 2004; Baker et al., 2010; Kaan et al., 2010).

The

experience and meaning of living with DT may be much different than someone awaiting a heart
transplant (Baker et al., 2010).

Utilizing focus group methodology to explore the LVAD

caregiving experience of (N =13) participants caring for BTT recipients, Kaan and colleagues
(2010) discovered that the burden and stress in caregiving for BTT patients are diminished once
they received a donor heart. Such an outcome may not be the same as in caregivers for LVAD
DT patients. For example, in a small, qualitative study, one DT caregiver described the constant
fear, uncertainty, and anxiety she lived with on a daily basis knowing that her husband, the
LVAD recipient, could die or have a stroke at anytime (Marcuccilli & Casida, 2011). Despite
these fears, the realization remains that DT is the final option for many of these patients. Yet, no
literature explored theses issues among the DT population at this time. This gap in knowledge
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may result in overall poorer health outcomes and reduced quality of life among this growing
population. This knowledge is vital for health care professionals to provide the knowledge,
resources, and support for optimal health, well-being and quality of life, including palliative care
options and preparation for the end of life. Given the unpredictable nature of heart failure and
the growing number of patients with DT and their caregivers, research is needed now to explore
the experience of living with DT from a patient and caregiver perspective.
Selected Qualitative Research Method
Qualitative research is appropriate for exploring research problems when little is
known about the phenomenon of study and more must be learned from persons experienced
with the proposed phenomenon (Creswell, 2005). The research questions, “What are the lived
experiences of DT patients and their caregivers?” lends itself to phenomenology, which is an
inquiry into the lived experience (van Manen, 1990). Phenomenology guides understanding of
the meaning of the research phenomena from the insiders’ perspectives through description,
reflection, and interpretation of the lived experience (Morse & Richards, 2002). The research
questions necessitate a qualitative inquiry, specifically phenomenology, to explore the essence of
the phenomenon of DT. Since no published research has been done to address these questions,
phenomenology is best suited to engage in a dialogue with patients and caregivers who have
lived with an LVAD as DT and can give voice to their experiences.
Significance to Nursing
To date, 20% of patients registered in the INTERMACS registry have an LVAD as
a DT (Kirklin et al., 2011). However, many patients with a BTT have a moderate to unlikely
chance at receiving a transplant (Kirklin et al., 2011). Given the number of patients who will
never receive a donor heart, many of these patients will eventually transition to a DT. These
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patients will live with a mechanical device attached to their bodies for the rest of their lives and
face the end of life with uncertainty, even fear. Although most studies examined survivability,
quality of life, and improved outcomes while living with such a device, patients’ and caregivers’
inside perspectives of living with DT were not explored. Since the population of DT patients
and caregivers is predicted to rise, the chance for optimal quality of life, palliative and end of life
care is dependent upon an understanding of this experience.
This investigation is significant because as one the first known inquiry to uncover these
inside perspectives, findings have the potential to enhance the understanding of living with DT.
Findings could also assist nurses and other health care workers to provide a holistic approach to
care. Additionally, this inquiry will provide the foundation for a program of research aimed to
developing evidence-based practice guidelines, specifically for the ACC/AHA and other
professional societies. Currently, the ACC/AHA recommendations for palliative care and end of
life care utilize “Class C” evidence (e.g., expert consensus, case studies, etc.), thereby denoting
an area of much needed research in palliative and end of life care within this population (Hunt et
al., 2005; Hunt et al., 2009). Since patient preferences and values are incorporated into the
decision-making process about the type of care provided (Melynk & Fineout-Overholt, 2004),
findings from this inquiry can be used to inform evidence-based practice for patients with DT
and their caregivers. Finally, initial findings will begin to bridge the gap and advance the science
of palliative and end of life care for patients with life-limiting illnesses, and life-sustaining
technologies, and thus promoting quality of life for them and their caregivers.
Summary
Chapter 1 described the aims of my study, the phenomenon of interest, the background
and context of the research, the justification, and its significance to nursing. The context is the
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experience of living with DT from patients’ and caregivers’ perspectives. The specific context
of DT, caregiving, and the palliative care and end of life concerns where described. This
phenomenon merits recognition for investigation, as it will advance the science of palliative and
end of life care for patients with life-limiting illnesses, life-sustaining technologies, and
promoting quality of life for this expanding population.
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CHAPTER II
LITERATURE REVIEW: EVOLUTION OF THE STUDY
Historical Context of the Study
The following review of the literature is divided into 9 sections: 1) Palliative care and end
of life care among heart failure patients, 2) Palliative care and end of life care among patients
with DT; 3) quality of life among patients with LVADs as BTT, 4) Left ventricular assist devices
as DT, 5) Caregiving in the heart failure population, 6) Caregiving in patients with LVADs, 7)
Caregiving in advanced heart failure population, 8) Caregiving in patients with other lifesustaining technology, and 9) Ethical dilemmas related to LVAD therapy. Since DT is the final
treatment option for end-stage heart failure, the palliative care and end of life concerns of this
population may mirror the concerns, issues, and experiences of advanced heart failure patients
without mechanical circulatory support or those with other life-sustaining devices. Therefore,
the review is supplemented with this literature. Chapter two ends with an identification of the
gaps in the literature, statement of the problem, purpose, study aim, and a preface to Chapter 3,
Methods.
Health care practices among patients with heart failure and advanced heart failure.
DT is not only the last treatment option for patients ineligible for transplant, but also a
chance for improved quality of life at the end-stage of an unpredictable, yet progressive clinical
syndrome. Since this is the last therapeutic option for these patients, palliative care and end of
life issues/concerns described by these patients and their caregivers may mirror those with
advanced heart failure without mechanical circulatory support. Therefore, the review is
supplemented with this literature. An integral part of this review includes a description of
palliative care and end of life care as distinct, yet complimentary entities, including the barriers
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to providing and implementing these vital services.
Palliative care and end of life care—the distinction. Palliative care is defined as a
multi-disciplinary and holistic approach aimed at improving the quality of life of patients with
life-limiting illnesses and their caregivers, regardless of the stage of the disease or the need for
concurrent therapies (National Consensus Project for Quality Palliative Care [NCPQP], 2004).
Palliative care is designed to meet the bio-psycho-socio-spiritual needs of patients and their
caregivers by optimizing quality of life by assessing, treating, and preventing pain and suffering,
and promotes autonomy through informed decision-making (National Hospice and Palliative
Care Organization [NHPCO], 2008). Conversely, end of life care is comprised of resources to
support patients and their caregivers during and at the end of life (NCPQP, 2004). Despite the
similarities among resources and supportive care, palliative care focuses on the reduction of
symptom burden and improving quality of life before the final stages of life (Curtis, 2008;
NCPQP, 2004; NHPCO, 2008). Patients with heart disease experience significant symptom
burden throughout the disease trajectory, especially at the end of life (Goodlin, 2009). Early
referrals to palliative care, including timely end of life discussions could improve symptom
burden and provide much needed resources for both patients and their caregivers (Goodlin, 2009;
Rizzieri et al., 2008). Yet many patients do not receive these services until death is imminent
due to patient, caregiver, provider, and communication barriers (Goodlin, 2009; Hupcey, Penrod,
& Fogg, 2009; Quaglietti, Pham, & Froelicher, 2005; Rizzieri, Verheijde, Rady, & McGregor,
2005).
Barriers in physician-patient communication. Effective, collaborative physician-patient
communication is necessary for all patients (von Guten, 2000; von Guten, Ferris, & Emanuel,
2000), but especially for those experiencing terminal illnesses, such as cancer (Bernard, de
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Roten, Despland, & Stiefel, 2009; Fallowfield & Jenkins, 2004). Engaging in discussions for
end of life care preferences (Tierney, Dexter, Grameispacher, Perkins, Zhour & Wolinsky,
2001), including advanced care planning (Saraiya, Bodnar, Leventhal & Leventhal, 2007),
ensures death with dignity for all patients with life-limiting illnesses (NHPCO, 2009). However,
promoting quality end of life care requires a range of skills, including mutual decision-making
with family members, timely communication, and personal psychosocial factors impacting end
of life care (von Gunten, Ferris, & Emmanuel, 2000). Barriers to effective communication at the
end of life, such as communication difficulties, anxiety about patients’ reactions to end of life
discussions, time constraints, and limited end of life conversations have been ignored in the
literature (Teno et al., 2007; Saraiya, et al., 2007). Challenges examined in the literature include
when to initiate discussions and referrals to end of life care, especially when prognostication is
uncertain among non-malignant diseases, such as advanced heart failure (Goodlin, 2009;
Hupcey, Penrod, & Fogg, 2009; Quaglietti, Pham, & Froelicher, 2005; Rizzieri, Verheijde, Rady,
& McGregor, 2005).
Communication barriers are also seen in palliative care referrals. For example, the
literature reports that patients with cancer diagnoses are usually referred to palliative care
services more frequently (Cosgriff et al., 2007; Crawford, 2010; Murray, Boyd, & Kendall,
2002; Rogers et al., 2000) than those with advanced heart failure (Goodlin, 2009; Hupcey,
Penrod, & Fogg, 2009; Quaglietti et al., 2005; Rizzieri et al., 2005). Yet, patients with heart
failure also have palliative care needs. As patients’ symptoms progress to more advanced stages,
discussions about therapeutic options for palliative care, even end of life care, is necessary in
order to facilitate timely and highly quality care (Goodlin, 2009; Hunt et al., 2009; Hupcey et al.,
2009; Rizzieri et al., 2005). Many of these patients, however, are referred only when they are
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near death (Goodlin, 2009; Quaglietti et al., 2005; Rizzieri et al., 2005). Although preferences
for early referrals to palliative care and continued life support were reported (Aldred et al., 2005;
Selman et al., 2007), patients with heart failure and their family caregivers continue to report a
lack of communication about palliative and end of life choices (Aldred et al., 2005; Levenson,
McCarthy, Lynn, Davis, & Phillips, 2000; McCarthy et al., 2008; Selman et al., 2007).
Communication is vital to convey preferences for palliative care and end of life care to ensure a
good quality of life and death with dignity. Following is a summary of palliative care and end of
life care preferences among patients’ with advanced heart failure.
Preferences for palliative care and end of life care. Patients afflicted with advanced
heart failure expressed some end of life preferences and arrangements (Levenson et al., 2000;
McCarthy et al., 2008). For example, of the surviving participants (N = 220) of the original
cohort of the Framingham Heart Study, most had a designated health care proxy (75%), a living
will (55%), or both (41%) (McCarthy et al., 2008). With regards to end of life care preferences,
McCarthy and colleagues (2008) reported that the majority of the sample (69%) discussed end of
life care preferences with another person other than a health care provider. Over 2/3’s of the
cohort (80%) preferred comfort care over life-extending care, and would rather die than receive
long-term life-prolonging interventions, such as mechanical ventilation (63%), or tube feedings
(64%) (McCarthy et al., 2008). Similarly, patients with heart failure in other studies reported an
overall preference for improved quality of life using comfort measures only during the end of life
(Levenson et al., 2000; McIver et al., 2008). Levenson and colleagues (2000) found that many
participants were willing to tolerate some stressful health conditions, yet 46% preferred to die
than live the rest of their lives with a lot of pain (46%) or be in a confused and/or forgetful state
of mind (45%). As patients approached the end of life, however, patients’ preferences remained
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consistent for comfort measures only (Levenson et al., 2000; MacIver et al., 2008).
Comfort measures only at the end of life. Levenson and colleagues (2000)
examined end of life preferences among (N = 539) patients entering the last 6 months of life.
Patients reported a preference for a Do No Resuscitate (DNR) status as death approached
(Levenson et al., 2000). These preferences significantly rose from 33% at 6 months to 47% one
month and up to 3 days before death (p ˂ 0.05). These results are consistent with a study
reported by MacIver and colleagues (2008) which described the end of life treatment preferences
of 91 patients with either NYHA II (n = 48) or NYHA IV (n = 43) heart failure. Given the
limited functional capacity or symptom severity, 55% chose oral inotropes over medical
management (including LVADs) preferring a significantly shorter life (i.e.,182 days) with
improved symptoms, whereas 45% chose medical management and longer life with worsening
symptoms of heart failure, compared to a shorter survival time with fewer symptoms (MacIver et
al., 2008). This population not only preferred for comfort measures only at the end of life, but
also wanted to know about their prognosis.
Lack of communication in prognostication. Patients’ and caregivers’ reported a lack of
communication about prognostication for advanced heart failure throughout the literature. For
example, in a cross-sectional qualitative study exploring palliative and end of life preferences
and communication among advanced heart failure patients (n = 20), caregivers (n = 11),
palliative (n = 6) and cardiologists (n = 6), both patients and caregivers described a lack of
understanding of congestive heart failure and its symptoms (Exley et al., 2005). Whether it was
prognostication, palliative or end of life care, evidence illustrates that a lack of communication
remained a major concern for these patients’ and their family caregivers. Despite the desire for
improved communication at the outset of their diagnosis, many of these patients continue to
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experience unnecessary symptom burden and distress as they progress along the illness
trajectory. Since palliative care can be initiated regardless of any disease or the need for
concurrent therapies, DT represents an innovative component of a holistic, palliative care
approach.

Many patients, however, will continue to deteriorate due to the unpredictable,

progressive nature of heart failure, including device-related events. These patients may
eventually experience adverse events (i.e., sepsis, stroke) related to device therapy, device
failure, and/or become ineligible for LVAD re-implantation (Hunt et al., 2009). Deteriorating
quality of life, knowledge of impending death, and the difficult decision for patients and/or their
caregivers to deactivate this life-sustaining device may further contribute to fear, anxiety, and
depression for this expanding population (Rizzieri et al., 2008). Early referrals to palliative care,
including timely end of life discussions, therefore, could improve symptom burden, provide
much needed resources, including preparation for a peaceful death (Byram, 2012; Goodlin, 2009;
Rizzieri et al., 2008; Swetz, 2011). Clearly, palliative care and end of life issues are unavoidable
for patients with advanced heart failure. How best to approach these issues remain understudied.
Meeting these sensitive, yet vital issues among this growing population is needed now to ensure
death with dignity.
Palliative and end of life care among patients with and LVAD as DT.
Currently, recommendations are in place for initiating palliative care and end of life care
discussions along the advanced heart failure trajectory (Hunt et al., 2005). With the increase in
utilization of LVADs as DT and improving technology, there will be an increase in LVADs as
DT for longer periods of time, and more patients and their family caregivers will be confronted
with necessity for ongoing palliative care and end of life preparation. To date, limited literature
identifies the need for pre-implantation palliative medicine consultations and end of life
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discussions among the expanding population of DT patients (Brush et al., 2010; Byram, 2012;
Swetz et al., 2011a; Swetz et al., 2011b). Only two studies provided empirical evidence for
initiating palliative care consultations and establishing end of life care goals among patients with
DT and their caregivers (Brush et al., 2010; Swetz et al., 2011a). For example, Swetz and
colleagues (2011) examined the implementation of palliative medicine consultation aimed at
identification of goals for care and quality of life preferences prior to implantation. Palliative
care consultation ranged from 5 days before to 16 days after implantation (Median = 1 day
before implantation). Thirteen (68%) out of 19 patients were consulted about palliative care and
subsequently completed advance directives. Both the implant team and family caregivers
reported that palliative care discussions prior to implantation made postoperative care clearer and
that complications were dealt with more efficiently. Findings indicated that proactive palliative
care planning improved completion of advanced directives and contributed to overall improved
care.

Studies exploring end-of-life among DT were scant, however. However, 1 study was

found on the end-of-life decision making amongst patients with DT.

Brush and colleagues

(2011) retrospectively examined end-of-life decision making among (N = 20) patients who died
with DT and qualitative inquiries with their surviving (N = 20) caregivers. Findings indicated
that decreases in quality of life as a result of new and/or decline in current comorbidities
prompted end of life discussions.
Despite anecdotal assumptions in the literature and studies presented thus far, no known
published research explored the palliative care and end of life issues and concerns among
patients who were still alive with DT. Furthermore, several issues, concerns, quality of life, or
other experiences related to living with a DT remain unknown. Thus, I began to wonder, “How
do advanced heart failure patients with LVADs as DT describe their palliative and end-of-life
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needs?” Section II of this literature review continues with the limited evidence examining shortand long-term quality of life outcomes in patients with BTT.
Quality of life among patients with an LVAD as BTT.
Previous research illustrates an overall improvement of quality of life of patients with
BTT (Dew et al., 1999; Dew et al., 2000; Grady et al., 2001; 2002; 2003; 2004; Moskowitz,
Weinberg, Mehmet & Williams, 1997). One of the first studies examining quality of life among
bridge-transplant patients elicited the preferences of patients (N = 29) via standard gamble (i.e.,
responses obtained by participants after the introduction of a hypothetical scenario) prior to
LVAD implant (n = 14), while on LVAD support (n = 20), and after heart transplant (n = 11).
Mortality risk scores before LVAD implantation were worse and participants were willing to risk
a 45% chance of death in exchange for a return to health (Moskowitz et al., 1997). Scores on
participants’ willingness to take on a death risk to improve overall health reduced significantly
after LVAD implant and after heart transplant (19.1% and 3.6% respectively) (Moskowitz et al.,
1997). The findings suggest that LVAD recipients reported better quality of life than those
treated with medical management only, but not as good as heart transplant (Moskowitz et al.,
1997).

Consequently, results of this study lead to an acceptance of long-term utilization of

LVADs in the healthcare community.
However, few studies have explored the experience of living with an LVAD from
patients’ perspectives. For example, a phenomenological study by Savage and Canody (1999)
explored the lived experiences of 6 hospitalized LVAD patients. Five overarching themes were
constructed by the researchers which illustrated bio-psychosocial issues, concerns with
performing ADLs, quality of life, and coping strategies.

Religiosity and participation in

diversional activities were other coping strategies described by patients hospitalized with

32

LVADs (Savage & Canody, 1999). However, inpatients and out-patients with LVADs stressed
the importance of good family support as they strove to cope with their new device, which are
consistent with the findings in other studies (Dew et al., 1999; Grady et al., 2001; 2002; 2003).
In contrast to LVAD inpatients, those discharged home reported overall improved quality of life
(Dew et al., 1999; Grady et al., 2001). For example, Dew and colleagues (1999) assessed quality
of life among both inpatient (n = 25) and outpatient (n = 10) LVAD patients one month after
implantation. Second interviews were performed to assess quality of life on patients discharged
to outpatient settings. Those discharged to an outpatient setting were interviewed again after
discharge to evaluate their quality of life. Quality of life for outpatients with LVADs was
significantly different (p = 0.05) compared to inpatients, with the majority of improvements in
emotional and physical and social functionality (Dew et al., 1999). Similarly, several studies
conducted by Grady and colleagues continued to support improved quality of life among
discharged LVAD patients (Grady et al., 2001; 2002; 2003). Grady and colleagues (2001)
reported improved quality of life (i.e., lower symptom distress, improved functionality, and an
overall perception of good health) among a convenience sample of 81 patients 1-2 weeks precompared to 1-2 weeks post-LVAD implantation. Since these studies examined quality of life
from a short-term perspective, more studies were needed to reveal quality of life from a longterm perspective (Grady et al., 2001). One study examined the relationships between physical,
psychosocial, clinical variables, and quality of life (Grady et al., 2002). The researchers found
that psychological factors, such as satisfaction with health care providers, good emotional
support, and having significant others were the strongest predictors of satisfaction with quality of
life, accounting for 46% of variance in quality of life. Similar long-term quality of life
improvements following LVAD implantation were reported in one of the largest, prospective,
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multi-site studies of patients with BTT (N = 62). Despite fairly good quality of life outcomes
and improved health status of inpatients and outpatients, significant differences were reported in
functional disability related to self-care disability (p = 0.001), and a reduction in overall physical
disability (p = 0.006) in patients discharged with LVADs. However, quality of life outcomes
were mostly measured in patients bridged to transplant in the immediate and 6-week postoperative recovery period. Since many of these patients must wait almost one year for a donor
heart, examining quality of life beyond 6 weeks, therefore, was necessary. In a prospective,
longitudinal study, Grady and colleagues (2004) examined quality of life among patients (N =
78) with an LVAD as a BTT from 1 month to 1 year post implantation (Grady et al., 2004).
These patients perceived their health status as quite good, with moderate stress levels, coped
fairly well, and experienced improved social and relationships from 1 month to 1 year post
LVAD implantation (Grady et al., 2004).

Similarly, findings from few qualitative studies

reported overall improved quality of life from both physical and psychosocial dimensions. For
example, an interpretive phenomenological study of based on the methods of van Manen (1990)
explored sex and intimacy among patients (N = 9) who had an LVAD from 3 months to 2 ½
years (Marcuccilli & Casida, 2011). The researchers reported that as overall improved health,
their intimate and sexual relationships improved as well (Marcuccilli & Casida, 2011). In a
related hermeneutic phenomenological inquiry, one overarching theme elucidated by several
sub-themes constructed from the data illustrated the process of lifestyle adjustments required by
patients with LVADs (Casida, Marcuccilli, & Peters, 2011).

Phases of adjustment and

acceptance were delineated into an early and late adjustment phases, in which participants
learned to live with the LVAD as part of their bodies and lives. Overall improved quality of life
from a psychosocial perspective was noted in a more recent hermeneutic phenomenological
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study exploring self-concept among patients (N = 9) with LVADs (Marcuccilli, Casida, & Peters,
2012). Two themes were constructed from the data, “Having an LVAD means living,” and “A
desire to be ‘normal’ in public.” Participants accepted the LVAD as necessary to live making it
easier for them to modify their self-concept and accept the changes to their bodies and daily
lives.

Finally, attaining a sense of normalcy was more difficulty in public and required

additional lifestyle modifications. Despite these findings, some participants in other studies
continued to report some type of functional disability related to work, care of the home, sleeping
and rest, social interaction, self-care ability, and physical disability up to 1 year into the study
(Grady et al., 2004). Moreover, patients reported across all time periods (e.g., one month to one
year) negative emotions, such as anxiety, sadness, feelings of helplessness, even depression
(Grady et al., 2004). It is important to point out, however, that the participants used in these
studies represented the population of patients with a BTT. Patients who will be on LVADs, such
as in DT, may also experience these negative quality of life outcomes warranting further
research. With the increasing number of patients ineligible for heart transplant or may never
receive a donor heart, LVADs as DT represent the final palliative care option for the relief of
progressive and debilitating symptoms of the final stages of heart failure. Thus, I began to
wonder, “How do patients describe their quality of life (inclusively considering the wide range of
issues expected in the literature) as advanced heart failure patients with LVADs as DT?”
Adaptation among patients with left-ventricular assist devices.
Although some other studies exploring quality of life have addressed the bio-psychosocial aspects of living with the LVAD (Dew et al., 1999; Grady et al., 2003; Grady et al.,
2003b; Savage 2003), no published studies to date have addressed how patients adapt to an
LVAD. In a related phenomenological inquiry exploring lifestyle adjustments among 9 adults
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with LVADs, one overarching theme, “Adjustments take time,” were elucidated by 2 subthemes, “Early phase: Changes in the basics of everyday life,” and “Late phase: New way of
living,” constructed from the data.

Themes illustrated the process of lifestyle adjustments

required by patients with LVADs (Casida, Marcuccilli, & Peters, 2011). Phases of adjustment
and acceptance were delineated into an early and late adjustment phases, in which participants
learned to live with the LVAD as part of their bodies and lives. Themes constructed from the
data illustrated that participants were able to overcome physical, emotional, and psychosocial
issues as they learned to incorporate a mechanical heart into their lives.
Left-ventricular devices as a DT.
Several studies have emerged illustrating the clinical benefits of receiving an LVAD as a
DT (Long et al., 2008; Park et al., 2005; Rose et al., 2001; Slaughter, 2009). In the landmark
study of the REMATCH trial, Rose and colleagues (2001) reported that patients implanted with
the HeartMate VE, a first generation pulsatile LVAD. Patients demonstrated an improvement in
survival, functional status, and overall quality of life when compared to patients receiving
maximal medical management. As a result of this study, LVADs were approved for use of DT
in 2002, and subsequently approved for Medicare and Medicaid in2003. A 2-year follow-up,
post-hoc analysis by Park and colleagues (2005) demonstrated that two-year survival rates for
LVAD patients post REMATCH trial more than doubled compared to patients receiving optimal
medical management (52% to 28% and 29% to 13%, 1 and 2 years respectively). Patients
participating in the second part of the study compared with the first part also demonstrated a
significant improvement in survival (Park et al., 2005).
Continued improvements in LVAD technology since the REMATCH trial have showed a
sustained increase in overall quality of life and survival rate outcomes in patients supported with
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HeartMate XVE as a DT (Long et al., 2005; Long et al., 2008). Similar results were also found
in a prospective, nationwide study of 4 high-volume LVAD institutions and demonstrated that
patients implanted with the new Heart Mate XVE LVAD as a DT had improved morbidity and
mortality rates. Patients implanted with DT had a 40% reduction in mortality and were less
likely to experience long-term complications, such as sepsis or stroke (Long et al., 2005).
Improved survival rates were reported at 30-day and 1-year intervals among patients with DT
compared to the REMATCH cohort (i.e., 30 days = 90% to 81% respectively; 1 year = 61% and
53% respectively). Subsequent studies following the REMATCH trial continued to demonstrate
a reduction in mortality and adverse events, as described previously (Long et al., 2008).

Yet,

more research on second generation devices was necessary to evaluate long-term outcomes. This
prompted the investigation of the newer, second generation devices for use in the destination
therapy population.
In a random control trial of 200 participants from 38 centers, 46% of 134 patients
implanted with a second-generation, nonpulsatile pump, were still alive two years postimplantation with no reported adverse events such as stroke or need for LVAD re-implantation
compared to 11% of 66 patients in the control group with pulsatile LVADs (Slaughter et al.,
2009). Based on these data, HeartMate II© was approved by the FDA 2010 as a DT for patients
ineligible for heart transplant or unresponsive to optimal medical management. Although these
studies provide for us evidence of improved morbidity and mortality rates among patients with
long-term LVADs, I began to wonder about what life is like living with such a life-sustaining
device, specifically, “What do advanced heart failure patients with LVADs as DT suggest
healthcare providers need to know based on patients’ lived experiences? Moreover, I began to
wonder, “With respect to healthcare practices, how do patients describe their lived experiences
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as people with advanced heart failure, and with LVADs as a DT?”
The second part of the literature review examining the evidence on patients with LVADs
comes to a close. I now turn my focus to the caregiving literature within the context of LVADs,
advanced heart failure, palliative and end of life caregiving, life-sustaining technologies, and
ethical considerations.
Caregiver support in situations similar to LVADs as DT.
As the numbers of patients with DT continues to rise, so will their caregivers. Yet we
know little about the caregiving experience of this population. Due to the long-term care
required for DT patients, these caregivers may exhibit burden, stress, even an overall poor
quality of life, as experienced by caregivers of heart failure patients (Alfred, Gott, & Gariballa,
2005; Pressler et al., 2009; Saunders, 2010).

Since it is possible that the DT caregiving

experience may be comparable to chronic heart failure caregiving [and the heart failure
caregiving literature is more substantial than the LVAD caregiving literature], this evidence was
used to compliment the LVAD caregiving literature.
Caregiving in the heart failure population.
Over two decades of research on caregiving have been dedicated to heart failure
caregiving. Since most patients with heart failure are over 75 years of age, they will experience
progressive functional decline and require frequent hospitalizations (AHA, 2010c) and a
caregiver, often provides care and support at home (Artinian, Artinian, & Saunders, 2004).
Caregivers are essential to the overall health and well-being of heart failure patients (Aldred,
Gott & Gariballa, 2005; Bakas, Pressler, Johnson, Nauser, & Shaneyfelt, 2006; Clark & Dunbar,
2003; Saunders, 2008; 2009; 2010). Caregiving responsibilities and tasks include assisting with
and promoting self-care, monitoring compliance, recognizing worsening signs and symptoms of
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heart failure (Pattenden, Roberts & Lewin, 2007), and continuing to manage household tasks and
finances (Saunders, 2009; Saunders, 2010). In view of the responsibilities and tasks required for
heart failure caregiving, these caregivers must adapt current lifestyles, even balance caregiving
roles. However, adapting to this new role can be an overwhelming experience (Martensson,
Dracup, & Fridlund, 2001; Murray et al., 2002; Scott, 2000).

Consequently, heart failure

caregivers are at risk for negative health outcomes such as depression (Luttik, Blaauwbroek,
Dijker, & Jaarsma, 2007a; Luttik, Jaarsma, Veeger, & van Vledhuisen, 2005; Mahoney, 2001;
Molloy, Johnston, & Whitham, 2005; Murray et al., 2002), caregiver burden (Karmilovich, 1994;
Saunders 2008; 2009), worsening overall health (Luttik et al., 2007a; Luttik et al., 2005; Pressler
et al., 2009), and poor health-related quality of life (Luttik et al., 2007b; Pressler, 2009). Since
caregivers’ must make lifestyle changes due to the progressive and debilitating nature of heart
failure, the following review illustrates the most commonly cited bio-psycho-social outcomes in
the literature.
Depression and anxiety. Negative emotional health, such as depression and anxiety, has
been studied extensively in the general caregiving literature. Caregiving has been associated with
negative emotional health (Dew et al., 2004; Molloy et al., 2005; Yee & Schulz, 2000), including
increased anxiety or depression with greater caregiving burden (Dew et al., 2004). Several
studies have illustrated this emotional burden in the literature. For example, a review of 30
studies of caregivers and psychiatric morbidity found higher depression, including clinical, or
major depression, among women (Yee & Schulz, 2000). Similarly, a meta-analytic review by
Molloy and colleagues (2005) found that informal caregiving contributes to poor psychiatric and
physical health among caregivers. Several studies have also reported moderate to severe levels
of depression in the heart failure caregiving literature (Molloy et al., 2006; Pattenden et al., 2007;
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Schwarz & Dunphy, 2003; Schwartz & Elman, 2003). Although previous research showed that
heart failure caregivers experience depression, emerging studies continue to illustrate other
outcomes related to the negative effects of burden on heart failure caregivers.
Caregiver burden.

Negative outcomes reported in the caregiving literature include

physical and health-related morbidity due to increased caregiver burden. While caregiver burden
has been documented in other illnesses such as stroke (Bakas, Austin, Jessup, Williams, &
Oberst, 2004; Foster & Chaboyer, 2003) and heart failure (Bennett & Sauve, 2003; Gure,
Kabeto, Blaum, & Langa, 2008), factors influencing heart failure caregiver burden have been
occasionally described and poorly understood (Dunbar, Clark, Quinn, Gary, & Kaslow, 2008).
Several studies have examined both objective and subjective factors related to health-related
quality of life in caregiving (Ågren, Evangelista, & Strömberg, 2010; Alfred et al., 2005; Pihl,
Jacobsson, Fridlund, Stromberg, & Martensson, 2005; Luttik et al., 2005; Pressler et al., 2009;
Saunders, 2009). Caregiver burden has both objective (e.g., degree of interruption to the one’s
life) and subjective (one’s perceptions and feelings about caregiving) components (Braithwaite,
1992; Foster & Chaboyer, 2003). For example, subjective and objective variables in healthrelated quality of life were examined in relation to caregiver burden. Saunders (2009) examined
health-related quality of life among 50, mostly White female caregivers of older heart failure
patients. In this study, an increase in caregiver burden explained 62% of the variance in healthrelated quality of life (adjusted R2 = 0.58, p ˂0.01). Predictors of caregiver burden included
poorer patient functionality (Ågren, Evangelista, & Strömberg, 2010; Saunders, 2008). Ågren
and colleagues (2010) used the Caregiver Burden Scale to determine predictors of caregiver
burden on a sample of mostly female caregivers (N = 135). The researchers found that a higher
degree of caregiver burden was associated with poorer physical function of the patient, similar to
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findings in Saunders (2008). Other studies also reported higher caregiver burden with poorer
patient functionality and mental health problems (Alfred et al., 2005; Luttik et al., 2005; Pihl,
Jacobsson, Fridlund, Stromberg, & Martensson, 2005). Another negative outcome reported in
the caregiving literature is a reduction in socialization or personal interests.
Limited socialization. Negative outcomes related to social well-being are illustrated in
the heart failure caregiving literature (Gott et al., 2006; Pattenden et al., 2007; Pressler et al.,
2009). For example, few qualitative studies reported that participants felt socially isolated as a
caregiver for patients with heart failure (Aldred et al., 2005; Murray et al., 2002). Other studies
continue to report limited opportunities for socialization for these caregivers (Bakas et al., 2006;
Karmilovich, 1994; Pressler et al., 2009). In a prospective study utilizing 63 patients and 63
caregivers, Pressler and colleagues (2009) reported 43% of caregivers had limited socialization.
A descriptive, correlational study by Bakas and colleagues (2006) reported less time for
socialization among (N = 21) White female heart failure caregivers. The results of these studies
supported further exploration of the demographic variables, gender and lifestyle changes.
Differences in gender-related caregiving outcomes.

Although the majority of the

studies focused on the experience of White, spousal female caregivers, gender differences have
been reported among the caregiving experience (Karmilovich, 1994; Lutzky & Knight, 1994;
Rohrbaugh et al., 2002). Generally, female caregivers of patients with chronic illnesses were
found to be more distressed (Karmilovich, 1994; Lutzkey, 1994; Lutzik & Knight, 1994;
Pinquart & Sorensen, 2003; Pinquart & Sorensen, 2006; Rohrbaugh et al., 2002), and
experienced overall worse well-being and health (Pinquart & Sorensen, 2006; Rohrbaugh et al.,
2002) than males. Notably, females have reported more distress in the heart failure caregiving
literature.

Karmilovich (1994) was first to report gender differences in the heart failure
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caregiving population. Karmilovich found that (50%) of female spouses felt helpless and had
difficulty watching male spouses, and (40%) had concerns about the future and their ability to
care for their spouses. In addition, (36%) of the sample. reported higher role alterations than
male caregivers, and the inability to share concerns with spouses while male caregivers
experienced less distress than female caregivers (Karmilovich, 1994; Evangelista et al., 2002),
gender differences were also explicated on an intimacy level. Male caregivers reported concerns
over less time for intimacy compared to females (Karmilovich, 1994). Given the variety of
negative outcomes caregivers of patients with heart failure can experience, the following section
describes the evidence related to lifestyle modifications required for caring for these patients.
Lifestyle changes. Previous studies have documented worsening lifestyle changes among
caregivers, such as stroke patients (Bakas et al., 2004; Bakas, Champion, Perkins, Farran, &
Williams, 2006). However, few studies have specifically examined lifestyle changes in the heart
failure caregiving population. Lifestyle changes reported by heart failure caregivers include
providing care (Brostrom, Stromberg, Dahlstrom, & Firdlund, 2003; Martensson et al., 2003;
Scott, 2000), lack of sleep and increased worry over patients (Brostrom et al., 2003), financial
worries (Bakas et al., 2006; Pressler, 2009; Saunders, 2008; Saunders, 2010), and limited
socialization. However, significant life changes for heart failure caregivers include an overall
worsening of life. Caregivers have reported that their lives have changed for the worse (Bakas et
al., 2006; Pressler, 2009). For example, over 48% of heart failure family caregivers rated future
outlook, finances, energy level, and time for social activities as changed for the worse, while
57% of heart failure caregivers rated their emotional well-being as changed for the worse (Bakas
et al., 2006). Similarly, Pressler and colleagues (2009) found that caregivers reported a change
in their lives for the worst after 4 months (p = 0.03), while symptoms of depression predicted
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emotional health-related quality of life both at 4 and 8 months intervals (p ˂ 0.001, and p = 0.001
respectively). Since these caregivers have experienced depression, burden, limited socialization,
and more difficult lifestyle changes, clearly, it is imperative to support patients and caregivers to
improve overall quality of life (Dracup et al., 2004; Pressler, 2009; Saunders, 2008; Saunders,
2010).
Despite decades of heart failure caregiving research illustrating the negative outcomes
of caregiving, caring for patients with chronic illnesses can be a positive, even a rewarding
experience (Kramer, 1997; Rees, O’Boyle, & MacDonagh, 2001). For example, caregiving has
been related to enhanced self-esteem, gratification, pride, even closer personal relationships in
patients with chronic illnesses (Chappell & Reid, 2002; Kramer, 1997; Rees, O’Boyle, &
MacDonagh, 2001). Kramer (1997) reported that some caregivers experienced pride in
caregiving challenges, enhanced self-esteem, deeper meanings and overall pleasure in their new
roles and relationships. Similarly, Chappell and Reid (2002) reported overall satisfaction and
quality of life among caregivers (N = 234) of dementia and non-dementia patients, despite
caregiver burden. However, empirical research limits the personal experience of many of these
chronic caregivers. As a result, personal meanings associated with caregiving among patients
with chronic illnesses, such as heart failure, may never be known. Therefore, researchers argued
that qualitative research is necessary to explore the caregiving experience of heart failure
caregivers (Karmilovich, 1994; Luttik et al., 2007a).
A qualitative study by Aldred and colleagues (2005) utilizing focused interviews among
patient/caregiver dyads which uncovered four overarching themes reflecting the impact of heart
failure on the lives of both patients and caregivers: 1) Impact of heart failure on life, 2)
relationships, 3) professional support, and 4) concerns for the future. Similar to other studies
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(Gott et al., 2006; Karmilovich, 1994; Luttik et al., 2007a; Pressler et al., 2009), patients and
caregivers alike reported about how heart failure affected their overall life, including limited
social activities [even staying indoors]. Moreover, respondents in Aldred and colleagues’ study
partially blamed health care providers for not addressing their needs and concerns. Concern for
caregiver ‘burden’ was expressed by heart failure patients, although caregivers did not perceive
caregiving as a burden. Collectively, respondents reported the need for more information about
prognosis and condition, in spite of the understanding that heart failure was a life-limiting illness.
Given the limitations inherent in qualitative studies, the value of providing an inside
perspective of the heart failure caregiving experience is noteworthy. Understanding the inside
perspective of heart failure caregiving provides a holistic approach to care. Since heart failure is
a chronic, incurable condition, patients and caregivers alike may continue to experience negative
outcomes with little opportunity for a good quality of life. Although evidence suggests that
LVADs enhance quality of life for many patients as previously indicated, researchers have
projected that the overall caregiving experience can increase burden for LVAD caregivers
(Pressler et al., 2009; Rizzieri, Verheijde, Rady, & McGregor, 2005). However, the integral
role of the LVAD caregiver has only recently begun to emerge.
Caregiving in patients with LVADs as BTT.
Despite overall improvements in quality of life with LVADs as a BTT, some negative
patient outcomes and general anxiety was expressed among LVAD caregivers. In a descriptive,
correlational study by Dew and colleagues (2000), caregivers (N = 20) expressed overall positive
experiences with caregiving but reported several worries and concerns related to possible
infection (52%), device malfunction (40%), and device noise (32%). Open-ended responses
about living with an LVAD illustrated an overall improved quality of life from a caregiver
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perspective, including: “It allows [my spouse] to live until a transplant is available,” “[My
spouse] feels better physically,” even concern related to the overall well-being of the LVAD
recipient: “the risk of infection,” and “the uncertainty of how long [my spouse] will be on the
device” (Dew et al., 2000). Although physical and psychosocial variables were measured among
LVAD patients, these variables were not examined among LVAD caregivers. Examining biopsycho-social variables such as functionality, depression, burden, and lifestyle adjustments,
would shed light on the caregiving needs and health related and overall quality of life among
LVAD caregivers, and provide the direction for future research studies.
More recently, four qualitative studies illustrated the experience of LVAD caregiving. A
phenomenological study based on the philosophy and methodology of van Manen (1990) was
utilized to explore and uncover the lived experience among female spouses of LVAD patients
awaiting heart transplant (Casida, 2005). Despite the sample size (N = 3), three main themes
were identified (i.e., emotional distress, determination, and optimism: a new lease on life),
which were further explained by 8 subthemes: guilt and realization of severity of illness, fear
and anxiety, caregiver’s role: an overwhelming experience and a burden, coping, living with
hope, realization of a loving relationships, adaptation to a new life, and joyful feeling (Casida,
2005). Themes and sub-themes reflected participant’s personal experiences from the initial
realization of needing an LVAD up to time of transplantation (Casida, 2005). Casida noted that
it was during this time that LVAD caregivers became “more resilient” and felt better prepared
for future caregiving responsibilities.

Casida’s study provided the foundation for the

development of future studies aimed at exploring caregiving experiences and examining factors
associated with LVAD caregiving. Although Casida utilized in-depth interviews to explore the
lived experience of LVAD caregiving, utilizing various perspectives of the human experience
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(e.g., personal life stories, favorite quotes, photography, etc.) would assist the researcher to arrive
at a deeper meaning of phenomenon being researched (van Manen, 1990). van Manen argued
that conducting an existential investigation from many perspectives of human experience,
including the phenomenological literature, is necessary to fully capture the essence of the true
lived experience.
Another qualitative study by Baker, Flattery, Salyer, Haugh, and Maltby (2009) described
the experience of one male and five women caregivers of BTT patients awaiting heart
transplant.

One overarching theme, commitment, was further explicated by two subthemes:

sacrifice and moving beyond. The theme suggested that the role of caregiving required many
lifestyle changes, including personal, health-related, even financial sacrifices as participants
strived to cope with LVAD caregiving (Baker et al., 2009). Participants described sacrificing
relationships with family, social relationships, health, even jobs, and peace of mind to care for
the LVAD recipient was necessary (Baker et al., 2009). Although scant studies have illustrated
LVAD caregiving experiences, similar themes were reported in two studies. Casida (2005)
identified the theme “caregiver’s role: overwhelming, difficult, and to some extent a burden”
which explicates the unwavering acceptance of roles amidst the “burdens” and responsibilities of
LVAD caregiving (p. 149).

One participant described interference with sleep and work

schedules, while another participant described LVAD caregiving as “...one of the hardest things I
had to deal with...” (p. 149). Concerns with infections, device malfunction, rose as patients had
the LVAD. Similarly, Dew and colleagues (2000) reported that caregiver burden was described
mostly as worries about infection and device malfunctions. In the second sub-theme, Baker and
colleagues (2009) described “moving beyond” as the ability of the LVAD caregiver to adapt to
the role of LVAD caregiver, even in the face of adversity. Resiliency was suggested as an
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attribute, or even process, utilized by LVAD caregivers to positively cope in an otherwise
overwhelming or difficult situation. However, Baker and colleagues argued that the caregiving
experiences of LVAD patients who are not awaiting transplant, such as DT patients, could be
very different.
The latest qualitative study employed a focus-group and grounded theory methodology to
explore the lived experiences of 13 caregivers caring for LVAD patients at home (Kaan, Young,
Cockell, & Mackay, 2010). Supporting the majority of findings in other qualitative studies
(Casida, 2005; Dew et al., 2000; Baker, Flattery, Salyer, Haugh, & Maltby, 2009), the authors
described four themes: fear and anxiety, loss, burden, and coping, elucidated by several subthemes. Although the majority of these studies utilized in-depth interviews to explore the
experiences of LVAD caregiving, again, incorporating various perspectives of this lived
experience, such as personal life stories, favorite quotes, and photography would assist the
researcher to arrive at a deeper meaning of the phenomenon being researched to further
understand the LVAD caregiving phenomenon (van Manen, 1990). Using the hermeneuticphenomenological approach by van Manen (1990), Marcuccilli and Casida (2011) explored and
described the lifestyle adjustments involving 5 caregivers. Themes found were caregiving: a
“24/7” responsibility, coping strategies, and satisfaction, where elucidated by thirteen subthemes describing the process of how participants adjusted to caring for an LVAD patients. The
researchers concluded that lifestyle adjustments with caregiving may become easier over time,
and with effective use of coping strategies, caregivers accepted their new caregiving role as part
of life.
Clearly, the limited literature to date has portrayed the critical need to continue to
examine LVAD caregiving in view of this expanding LVAD patient population. However, most
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studies explored the experience of LVAD caregiving among mostly White, female spouses of
BTT LVAD patients, limiting the responses and experiences from more diverse
sociodemographic participants. Since the majority of caregivers are White females and reflect
the current national data (NFCA, 2009), this proportion may soon reflect an older and even more
racially and ethnically diverse population in the next decade (Aging Statistics, 2010; Older
Americans, 2010). Future studies addressing caregiver variables (e.g., burden, health-related
quality of life, and quality of life ) and more qualitative studies in an older and culturally diverse
population may shed light on important areas in need for developing nursing intervention. Since
this population is predicted to rise (Krishnamani, DeNofrio, & Konstam, 2010), more research is
needed to better assist nurses and other health care professionals to improve overall quality of
life. Therefore, I began to wonder, “with respect to healthcare practices, how to caregivers of
heart failure patients with LVADs as DT talk about and explain their lived experiences: a) with
heart failure (or advanced heart failure) and b) with LVADs as DT? Also, “how do caregivers of
heart failure patients with LVADs as DT describe their quality of life? (inclusively considering
the wide range of issues expected in the literature).
Because DT is utilized for as the last therapeutic option available for patients with endstage heart failure, experiences may be parallel with the knowledge of caregivers of patients
living with chronic, advanced heart failure patients near the end of life.
Caregiving at the end of life.
Caregivers of advanced heart failure patients with palliative care and end of life needs
encounter a number of caregiving stressors. Responsibilities include learning how to perform
complex nursing care at home, care coordination, and patient advocacy (e.g., making medical
and financial decisions for patient) (American Cancer Society, 2009). Caregiving burden and
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strain mirrors psychosocial and physical morbidities of caregivers in chronic illnesses previously
described, including emotional distress (e.g., depression, anxiety, fatigue, and sleep problems)
health concerns, unemployment, financial difficulties, and limited socialization (Braun et al.,
2007; Clark et l., 2006; Fang et al., 2001; Given et al., 2004; Harding, Higginson, & Donaldson,
2003; Herbert, Arnold &Schulz, 2007; Kozachik et al., 2001). Despite this evidence, caregivers
of patients with heart failure, COPD, even cancer, and have expressed the need for more
assistance with caregiving tasks (Garlo, O’Leary, Van Ness, & Fried, 2010; Gysels & Higginson,
2009), better support, knowledge, and resources on how to care for these patients (Fried &
O’Leary, 2008; Gysels & Higginson, 2009). Garlo and colleagues (2010) examined caregiver
burden over 12 months among caregivers of patients with terminal cancer, heart failure, or
COPD (N = 179). High caregiver burden was related with the need for more assistance with
activities of daily living (odds ratio = 23.13, 95% CI) and the desire for more communication
with the care recipient (odds ratio = 2.54, CI = 1.16-5.53) (Garlo et al., 2010). Similarly,
communication difficulties with care recipients were described in a cross-sectional investigation
of caregivers of patients in the community with advanced cancer, COPD, or heart failure (N =
64) (Fried & O’Leary, 2008). Communication difficulties stemmed from differing preferences
for advanced care planning, including place of death (Fried & O’Leary, 2008).

Despite this

evidence, results generally indicated that caregivers reported a lack of knowledge on how to
provide the best care for symptom reduction, including a lack of support for caregiver
psychosocial needs (Fried & O’Leary, 2008; Garlo et al., 2010; Gysels & Higgins, 2008).
While studies report the need for ongoing psychosocial and educational needs among
palliative and end of life caregivers, limited evidence demonstrated effective interventions for
meeting their needs (Bee, Barnes, & Luker, 2008; Harding & Higginson, 2003; Lorenz et al.,
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2008). A meta-analysis by Lorenz and colleagues (2008) evaluated evidence about interventions
designed to improve palliative care and end of life care. Among other results, there was weak
evidence found for interventions to improve burden in cancer caregiving, and no evidence of
interventions aimed at improving advanced heart failure caregiver burden (Lorenz et al., 2008).
Notably, there was no citation of caregiving interventions for patients with COPD. These
findings were confirmed by Caress and colleagues (2009) reporting a lack of interventions for
ongoing education and support for caregivers of COPD patients.

Despite two decades of

intervention studies aimed at supportive services for caregivers, and the growing number of
patients with palliative and end of life care needs, much more intervention research must be done
to address caregivers’ needs (Harding & Higginson, 2003; Hudson, Remedios, & Thomas, 2010;
Lorenz et al., 2008). Addressing these gaps in caregiver research is crucial because of the
increasing role of caregivers for an expanding number of patients with life-limiting illnesses
requiring palliative care and end of life care (Lorenz et al., 2008). Therefore, I began to wonder,
“How do caregivers of heart failure patients with LVADs as DT describe their experiences with
palliative and end-of-life needs?”
Caregiving in patients with life-sustaining devices.
With the projected increase of older patients in the next decade (i.e., ≥ 65 years) (Aging
Statistics, 2010), we are expecting to see an increase of chronic illnesses [including LVADs]
among this population, including their caregivers.

As these patient and caregiver groups

continue to expand, bio-medical advancements will continue to evolve permitting long-term care
in the home. However, limited evidence illustrates the caregiving experience of individuals and
families caring for patients with other implantable, life-sustaining devices, such as long-term
mechanical ventilation, peritoneal dialysis, and intracardioverter defibrillators.
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Caregiving and mechanical ventilation. Limited research has explored caregiving
among patients with long-term mechanical ventilation (e.g., a machine used to take over
breathing) (Douglass & Daly, 2003; Im, Belle, Schulz, Mendelsohn, & Chelluri, 2004). The
majority of caregivers in these studies were White women (76.5%) caring for their husbands
(52.2%) (M = 52.9 years old, SD, 14.2). Although 33 of the caregivers (28.7%) were working,
30% had to reduce work hours in order to care for the patient (Im et al., 2004). Similar caregiver
outcomes of other chronic caregiving populations, such as depression, burden, and decreased
emotional and physical health, where reported in caregivers of long-term mechanical ventilation
(Douglass & Daly, 2004). A prospective descriptive longitudinal study of (N =135) caregivers of
patients receiving long-term mechanical ventilation reported that perceptions of physical health
and overload (p = 0.025, and p = 0.006, respectively), were significant explanations for
depression among caregivers (Douglass & Daly, 2004).

The researchers concluded that

caregivers of long-term mechanical ventilation in institutions reported higher levels of
depression compared to other chronic caregiving populations, including heart failure and COPD
(Douglass & Daly, 2004). However, patients with implantable, life-sustaining devices also
report negative outcomes.
Caregiving and percutaneous implants for peritoneal dialysis.

By 2020, almost

800,000 people aged 65-years and older people will be afflicted with end-stage renal disease
(ESRD) (Buemi et al., 2008; Stengel et al., 2003; United States Renal Data System Annual Data
Report [USRDS], 2010). Out of the 368,544 patients who received hemodialysis, almost 27,000
patients received peritoneal dialysis (PD) in an ambulatory or home-care setting (USRDS, 2010;
Lin-sun Fan, Sathick, McKitty, & Punzalan, 2008). Despite this prediction, limited evidence
describes caregiver characteristics, including quality of life, while assisting with PD.
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Patients on PD rely on caregivers to perform the daily exchanges of continuous PD
or to connect, disconnect, and troubleshoot problem with the peritoneal dialysis machine (Linsun Fan, et al., 2008). Although caring for an LVAD patient may be more cognitively difficulty,
caregivers of patients with PD share similar tasks at home, such as assisting with or performing
fluid balance, assessment, and adjustments — even the home environment must be adapted to
accommodate the supplies required to care for a PD patient (Lin-sun Fan, et al., 2008). A
descriptive exploratory study of caregivers of elderly patients on hemodialysis (n = 84), PD (n =
40), and caregivers of non-elderly patients with heart failure found that 32% of caregivers of
older PD patients experienced depression, significant burden, and negative effects on their
quality of life (Belasco et al., 2006). Like caregiving in other chronic illnesses discussed
previously, stress, anxiety, fatigue, social isolation, and decline in personal and familial
relationships may occur among caregivers of home dialysis for children or adults (Belasco, 2002;
Belasco et al., 2006).
Caregiving and implantable cardioverter defibrillators. Caregivers of patients with
implantable cardioverter defibrillators (ICDs) experience significant changes in the psychosocial
dimensions of quality of life within the first year of implantation (Dougherty & Thompson,
2009; Jenkins et al., 2007; Sears, Todaro, Lewis, Sotile, & Conti, 1999; Sowell, Sears, Walker,
Kuhl, & Conti, 2007). Most caregiver/partners were employed, White females, with an average
age of 60.96 ± 12.8 (Jenkins et al., 2007). Similar to caregivers of patients with heart failure,
studies reported a decline with mental and physical health (Dougherty & Thompson, 2009;
Jenkins et al., 2007), even limited family support (Dougherty & Thompson, 2009) during the
first 12 months after implantation especially if the ICD patient was elderly or had more disease
burden (Dougherty & Thompson, 2009; Jenkins et al., 2007). Yet, as caregivers of ICD patients
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became adjusted to their changes new role 12 -30 months after implant, they reported overall
enjoyment and satisfaction with life, and reduced uncertainties about patient death (Jenkins et al.,
2007). Sowell and colleagues (2007) reported similar findings as patient and partner dyads
adjusted to the ICD. Measurements of anxiety and marital adjustments within 30 months of ICD
placement showed no statistical differences between these dyads. Satisfaction with caregiving
was also reported amongst caregivers of patients with LVADs (Marcuccilli & Casida, 2011).
These caregivers eventually adapted to caring for an LVAD patient and expressed satisfaction
with their new roles. Although declining physical and mental health remain significant burdens
for caregivers of other chronic illnesses, limited literature suggests that both LVAD and ICD
caregivers face similar challenges while caring for a patient with an implantable device, but they
eventually adjusted lifestyles and caregiving roles.
As patients with these and other life-sustaining technology transition from hospital to
home, caregivers will be required to learn new skills and adapt lifestyles to care for these
vulnerable patients. Since the population of patients with life-sustaining devices and their
caregivers is expected to increase, it is imperative for nurses and other healthcare providers to
have the knowledge and understanding of their preferences and needs in order to better care for
them. Since caregiving is recognized as a national priority (NCA, 2009) and a forefront for
nursing research (National Institute of Nursing Research [NINIR], 2006), future studies must
include caregivers in order to develop priority interventions on how to maintain health, promote
socialization, and prevent caregiver burden in this increasingly vulnerable population. Given the
need for more caregiving research, no evidence demonstrates the experience of DT caregivers.
Therefore, I began to wonder, “How do caregivers of heart failure patients with LVADs as DT
describe their experiences with caring for someone with an implantable device? Despite the
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limited evidence, there are several ethical dilemmas both health care providers and this
expanding population may face.
Ethical dilemmas and decision-making within the context of palliative care and end
of life care.
Ethical issues raised in the LVAD literature relate to several ethical principles, including
the principle of justice, and respect for persons.
Principle of justice. In the principle of justice, location of donor hearts, and
current transplant eligibility targeting younger patients and those with less comorbidities,
remains an ongoing area of debate, especially with the predicted increase in the older population
(Brush, 2010; Dudzinski, 2006). Secondly, the principle of respect for persons, and the patientprovider discussions of risks and benefits of LVAD therapy (e.g., increased risk for stroke,
infection), including the unpredictable nature of advanced heart failure and device therapy (e.g.,
gradual decline in quality of life and functionality, device malfunction and failure; not being a
candidate for device exchange out due to increased morbidities or chance of death). However,
withdrawal of the LVAD poses practice and ethical boundaries which is projected to increase as
more patients receive this device.
Discontinuing the LVAD. Decreasing quality of life, worsening and/or new comorbidities
are issues this population must face while living with this device (Hunt et al., 2009).
Eventually, a natural death for an LVAD patient may occur by device deactivation, device
failure, progressive cognitive or functional decline, or progression of HF (Bramsted et al., 2001;
Dudzsinski, 2006; Kirkpatrick, Fedson, & Verdino, 2007; MacIver & Ross, 2005; Weigand, &
Kalowes, 2007). However, concerns related to the ethical permissibility of discontinuing the
LVAD are the pinnacle of discussions (Bramsted et al., 2001; Dudzinski, 2006; MacIver & Ross,
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2005; Rizzieri, Verheijde, & Rady, 2008; Simon & Fischbach, 2008). For example, when a
device is deactivated, blood backflows and pooling may cause thrombosis and disrupt
contractility of the heart (Bramsted & Wenger, 2001; Rizzieri et al., 2008; Dudzinski, 2006).
Arguments about the cause of patient death surrounds the process of actual device deactivation
as cause of death or the underlying disease (advanced heart failure) (Bramstedt & Wenger, 2001;
Dudzinski, 2006; MacIver & Ross, 2005; Rizzieri et al., 2008).

Despite these justifiable

concerns, patients (and their caregivers as surrogate decision-makers) are autonomous human
beings and have the right to self-determination.
Respect for persons. The principle of respect for persons mandates that patients and their
families have right to refuse or withdraw medical treatment at anytime (ANA, 2001; Patient selfdetermination act, 1992). Since the LVAD is a medical treatment, patients and their caregivers
have a right to deactivate and/or disconnect the LVAD, especially if quality of life is
deteriorating and the risks of the device outweigh the benefits. Therefore, it is imperative for
nurses and other health care providers to engage in timely end of life discussions, and advanced
directives.
Communication about end of life care and advanced directives. Although it
recommended that all patients diagnosed with heart failure receive palliative care and timely end
of life consultations, with or without the need for LVADs, (Francis et al., 2010; Jessup et al.,
2009; Waterworth & Gott, 2010), the unpredictable nature of heart failure represents an
additional hurdle for health care providers on when to best initiate these sensitive discussions
(Dudzinski, 2006; Goodlin, 2009; Levenson, McCarthy, Lynn, Davis, & Phillips, 2000). First,
device implantation and the hopes of receiving a donor heart may dissuade or prevent or suspend
important conversations between LVAD patients, their caregivers, and mechanical heart health
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care providers (Dudzinski, 2006; Goodlin, 2009; Goodlin et al., 2004). Second, the shift from a
life-saving focus to the end of life can certainly be a source of great anxiety for everyone
involved, and further repress discussions about palliative and end of life care among this
population. Despite these issues, the literature recommends these discussions to commence prior
to LVAD implantation (Francis et al., 2010; Goodlin, 2009; Hupcey, Penrod, & Fogg, 2009).
However, barriers to effective communication in end of life care have been documented and
reported previously, including physicians’ anxiety that patients might react negatively to these
discussions (Saraiya, Deren, Leventhal, & Leventhal, 2008; Teno, Gruneir, Schwartz, Nanda, &
Wetle, 2007). Yet, evidence illustrates that generally, physicians are more willing to have end of
life discussions with patients who have cancer compared to those with heart failure, because
prognosis and expected decline are more predictable with cancer (Carter et al., 2006). This
conclusion parallels with argument that physicians assert the moral imperative to treat patients
(beneficence vs. nonmaleficence) (Cockerham, 2010), hence, the development and advancement
of mechanical circulatory support. That is, even at the end of life, medical emergencies and donot-resuscitate orders maybe largely ignored because physicians have an obligation to treat
patients (Hippocratic Oath, 2002). Yet, the principle of respect for persons mandates that
patients and their families are informed of all treatment options, including palliative and end of
life options (ANA, 2001; Patient self-determination act, 1992). Since there is no cure for
advanced heart failure, respect for persons mandates that preparation for palliative care and end
of life care should commence at the initial diagnosis of heart failure (ANA, 2001; Patient selfdetermination act, 1992. However, effective doctor-patient relationships are necessary for these
timely discussions (Tierney et al., 2001; Goodlin, 2009), including advanced care planning and
the appointment of a surrogate decision-maker (Francis et al., 2010; Goodlin, 2009; Goodlin et

56

al., 2004; Hupcey, Penrod, & Fogg, 2009). Given these arguments, nurses have an integral role
in preserving the autonomy of patients with DT and their caregivers, which includes effective
communication and shared decision-making (ANA, 2001).

Although these principles have

molded nursing care, practice, and research for decades, the advent of health care reform and the
timely report on the future of nursing (Institute of Medicine [IOM], 2010), has acknowledged the
integral role nurses play in the health and welfare of patients, families, communities, and society.
Therefore, nurses must continually take the lead in all levels of the health care system, research,
and policy development, and advocate for timely palliative and end of life discussions for this
emerging population not only prior to device implantation, but at the onset of heart failure
(Francis et al., 2010; Goodlin, 2009; Hupcey et al., 2009). Therefore, I began to wonder, “What
do caregivers of advanced heart failure patients with LVADs as DT suggest healthcare providers
need to know based on caregivers’ lived experiences?
Statement of the problem
Patients with heart failure have limited access to palliative care resources, understand less
about their illness, and have poor quality or limited communication with their health care
providers about end of life care. Despite preferences for improved communication at the outset
of their diagnosis, many of these patients continue to experience unnecessary symptom burden
and distress as they progress along the illness trajectory. Since palliative care can be initiated
regardless of any disease or the need for concurrent therapies, mechanical circulatory support
represents an innovative component of a holistic, palliative care approach. Yet despite this
innovative technology, many patients will continue to deteriorate while they wait for a transplant
or even as a DT, due to the unpredictable, progressive nature of heart failure. Eventually, they
will experience adverse events (e.g., sepsis, stroke) related to device therapy, device failure,
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and/or become ineligible for device exchange (Hunt et al., 2009). With the projected increase of
older patients in the next decade (NPP, 2008), chronic illnesses, such as advanced heart failure
will necessitate long-term, life-sustaining devices, such as LVADs, As these patient and
caregiver groups continue to expand, technological advancements will continue to evolve
requiring more sophisticated, complex, long-term care in the home. Caregivers will be vital in
promoting the health and well-being of patients on life-sustaining devices.

However, limited

studies described patients’ and caregiver’s issues and concerns about living with an LVAD as a
BTT, leaving out the perspectives of living with DT. Patients with DT and their caregivers have
needs, issues, and concerns which have not been explored.

Nurses and other healthcare

professionals provide the education for living with this device, however, may lack the knowledge
of these needs and day-to-day challenges experienced while living with an LVAD.

It is

imperative to explore what life is like living with such a life-sustaining device in order to better
assist them with their long-term needs. The purpose of this inquiry, therefore, is to explore and
describe the experience of DT from patients’ and caregivers’ perspectives. This study aims,
through a phenomenological inquiry, to understand the meaning of the DT experience from
patients’ and caregivers’ perspectives.
Summary
This chapter described the evolution of the study from the historical and experiential
contexts. The historical context described the extant literature describing the evolution of studies
from several perspectives, including: 1) palliative care and end of life perspective, 2) BTT, 3)
DT, 4) caregiving, and 5) ethical issues. This provided the context for the development of the
research questions and justification for the method of inquiry. The chapter concludes with the
purpose and aims. Chapter three, Methods, describes the phenomenological method of inquiry,
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general, and applied, for this study.
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CHAPTER III
METHODS
The Method of Inquiry: General
This study aimed to understand patients’ and caregivers’ inside perspective of DT. A
qualitative design, specifically van Manen’s methods, guided this inquiry. Chapter 3 begins with
a brief discussion of phenomenology, describes van Manen’s philosophy and methodology, and
ends with the applied phenomenological method of inquiry (procedures and research activities)
chosen to explore the inside perspective of patients’ and caregivers’ living with DT.
The Merriam Webster dictionary defines phenomenology as the study of “phenomena” observable facts, events, objects, or aspects known through the senses rather than by thought or
intuition, including the meanings attributed to them. As both a philosophy and methodology,
phenomenology assumes that there is a formal structure of the objects of awareness (human
consciousness), or all human experience, which culminates to the experience as lived by human
beings (Smith, 2011, Thorne, Kirkham, & MacDonald-Emes, 1997). Thus, phenomenology is
focused on exploring the experience of a phenomenon as perceived through human awareness.
The essential structures of phenomenology includes: 1) lifeworld – lived experience, 2) first
person perspective, 3) intentionality, and 4) consciousness.
Lifeworld – lived experience.
The lifeworld is the world in which one lives —the world of experience—a world
complete with relationships, experiences, and the lifeworld in which the person has lived the
experience (van Manen, 1990). The lifeworld for participants in this inquiry represents the
culmination of their experiences and how they live their life with a DT. Through a
phenomenological method of inquiry, I explored the lifeworld of patients with an LVAD and
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their caregivers from the context of living with a DT.
First-person perspective.
Edmund Husserl (1859-1938) believed that the meaning of the lived experience can only
be obtained from the first person perspective. The lived experience represents the totality of life
as lived; it is already present and is part of our awareness, or consciousness (van Manen, 1990).
The meaning of living with an LVAD as a DT, however, can only be described from those who
live with such a device. My method of inquiry sought participants who gave voice, or recounted
a first-hand experience, of living with such a device. Although the LVAD is already implanted
in the patient and has a designated caregiver, this life-sustaining device is a visible, tangible part
of their awareness. It is an awareness that living with an LVAD will create experiences in the
lifeworld only known to those who live with and care for someone with this life-sustaining
device. The first person perspective is an integral component of the structure of the lived
experience. Yet, it is this realization, this self-awareness, which represents the third structure of
phenomenology, that is, consciousness.
Consciousness.
van Manen (1990) described that by being conscious, “we are already related to the
world” (p. 9). In other words, we are connected – aware of our presence and our surroundings.
The structure of consciousness has both phenomenological (what the experience is like) and
ontological (the experience of being) qualities (Smith, 2011). To be conscious of an experience
means that one must have experienced the phenomenon. Within the context of this study,
consciousness means that patients with DT have lived with this life-sustaining device, and their
designated caregivers have experienced the caregiving context as well. However, van Manen
asserted that it is not possible to view an experience introspectively (to search within onself), but
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retrospectively (inward reflections of the past). Reflection on lived experience, therefore, is a
recollection or reflection on past lived experience (van Manen, 1990). Given these premises, the
essential structure of an experience is its intentionality, or mental representation of a
phenomenon.
Intentionality.
Intentionality represents the features of several mental states, such as beliefs, hopes,
judgments, intentions, love, and hatred (Smith, 2011). It is intersection of these mental states
and events of the lifeworld (intentional or non-intentional, perceived or not-perceived), which
represent the experiences of life (Husserl 1926/1971). van Manen (1990) concurs, describing
intentionality as “the inseparable connectedness of the human being to the world” (p. 181). Van
Manen (1990) affirmed, however, that “we are not reflexively conscious of our intentional
relation to the world....intentionality is only available to consciousness upon retrospective
reflection” (p. 181).

In other words, a persons’ orientation to intentionality is not always

conscious but a reflection on the lived experience (van Manen, 1990). Intentionality, therefore,
is key to deeper reflections and meaning of the lived experience.
In order to explicate these experiences, it was important for me as researcher to set aside
any assumptions about the phenomenon in order to “hear” the intersection of my participants’
experiences.

This was accomplished through bracketing, or phenomenological reduction.

Bracketing my assumptions, biases, and beliefs assisted me to remain objective about the
experience of living with a DT from a patient and caregiver perspective, and to uncover the
essence of this phenomenon.
Historical Perspective
Drawing from the works of Husserl, Heidegger, Merleau-Ponty (1945) proposed that
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phenomenology aims to search for the meanings or essences of the lived experience through
returning to the things themselves (e.g., rediscovery).

Since human understanding stems

predominantly from the experience of the world as perceived, humans cannot conceive what is
not perceived or perceptible (Merleau-Ponty, 1945). By returning to the things themselves, such
a re-discovery of the phenomenon leads one to find meaning and understanding in life through
descriptions of the lived experiences of human beings in their world. According to MerleauPonty, the researcher’s interaction with the study participant and the interpretation of the
description of the phenomenon of interest constitutes the hermeneutic (e.g., interpretive)
approach to the phenomenological method of inquiry. This interconnectedness is the central
tenet of hermeneutic phenomenology, the methodological foundation for van Manen’s
phenomenological approach, and the method of inquiry for my research.
Method of Inquiry: Applied
The following section introduces van Manen’s phenomenological approach. The
application of van Manen’s approach to the phenomenon of the inside perspective of patients and
caregivers living with DT is discussed.
van Manen’s phenomenological method of inquiry.
van Manen believed that the phenomenological inquiry starts with the lived experience.
van Manen’s methods incorporate description and interpretation of the phenomenon to elicit the
meaning of the lived experience. This approach incorporates a more reflective approach to
uncover the meaning of lived experiences. van Manen described his human science approach as
the way one orients to the experience as lived. This is accomplished through interpretation, or
hermeneutics, which describes how the researcher interprets participants’ lived experiences. In
this inquiry, the experience of DT was explored through the collective language of those who
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have experienced this phenomenon. Although personal experiences of living with and caring for
someone with such a life-sustaining device may remain private, some of these personal
experiences can be revealed through this method of inquiry. It is the intersection of participants’
descriptions of their private experiences and the researchers’ ability to interpret the verbal and
non-verbal language of these words (e.g., semiotics), which further illuminates the meaning of
living and caring for someone with such a life-sustaining device. This form of hermeneutic, or
interpretive phenomenology, uncovers the hidden meaning of the lived experience from insiders’
perspective (van Manen, 1990).
The essence or nature of the lived experience, as described by van Manen (1990), has
been uncovered through writing if the phenomenological story illuminates the significance of the
lived experience in a most profound manner. In order to assist my interpretation of the meaning
of my phenomenon, van Manen discussed incorporating many types and sources of meaning to
aid in the interpretation of the lived experience (van Manen, 2002). These sources include
poetry, artwork, everyday life experiences, language, social science, historical, cultural, literary,
and phenomenological literature sources. A description of these sources is provided in the data
analysis section. The final product of my research is a phenomenological story uncovering the
meaning and significance of the experience of DT as lived.
Rationale for selection of the phenomenological method.
Since the research method should be guided by the research question (Creswell, 1998),
van manen’s phenomenological method of inquiry was best suited to answer the research
questions, which aimed to uncover the meaning of living with DT.

van Manen’s (1990)

phenomenological method of inquiry has hermeneutic underpinnings that enabled me to uncover
the experiences and meaning of living with and caring for someone with a DT as described by
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participants. Although van Manen’s phenomenology of practice stems from an educational and
pedagogical perspective, it can also be used to guide nursing research. Recently, several studies
used this philosophy and method of inquiry to advance the science and discipline of nursing
(Cashin, Small, & Solberg, 2008; Marcuccilli & Casida, 2011a; Marcuccilli & Casida, 2011b;
Moene, Bergbom, & Skott, 2006). Finding will provide an understanding of how patients and
caregivers live with and adapt to such a life-sustaining device. Additionally, findings can aide
in knowledge development for nursing practice. By articulating this knowledge, we can explore
additional possibilities and use them as a basis for new research.
As I continue to develop my phenomenological inquiry, an interpretation of van Manen’s
research methods and activities are presented. The interpretation is followed by an integration of
the methods and research activities within the procedures of my research.
Research Activities and Procedures
van manen’s (1990) method involves a variety of empirical and reflective research
activities designed for performing a phenomenological inquiry. The empirical activities are
designed to explore experiential material about phenomenon, while the reflective activities are
performed to interpret meaning associated with the phenomenon (van Manen, 2010).

The

empirical and reflective activities are incorporated into six methodological themes, or research
activities, which guided my study:

1) Turning to the lived experience, 2) Exploring the

experience, 3) Reflection on essential themes, 4) Capturing the essence through writing and
rewriting, 5) Remain focused and oriented, and 6) Balancing the inquiry through parts and
wholes (van Manen 1990). van Manen (1990), however, cautioned against using these activities
in a mechanistic way, but rather to “animate inventiveness and stimulate insight” while exploring
the phenomenon (p. 31). The six research activities interfaced with one another and were used to
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explore the experience of living with an LVAD as DT from patients’ and caregivers’
perspectives.
Turning to the lived experience.
The first research activity required a commitment to the phenomenon of interest and
formulating the phenomenological question. According to van Manen, turning to a phenomenon
of interest requires the researcher to become full of thought, to “recognize our lot minding the
whole – that which renders fullness or wholeness to life” (p. 31). This inquiry began with an
exploration of my interests and research activities. These included my own interest in palliative
and end of life care, the qualitative studies and interviews I performed as part of my doctoral
studies, and how it has led me to inquire about patients’ and caregivers’ lived experience of DT.
By turning to my phenomenon of interest, no published literature was found exploring this
experience as lived. As I focused on my research question and the method of inquiry, this
research activity continued with an inquiry into the experience of living with DT by formulating
a phenomenological question suitable for inquiry into the experience as lived, “What is the
experience and meaning of living with a DT from a patient and caregiver perspective?” I
remained true to the phenomenological question by selecting participants who gave voice to the
experience and meaning of living with DT. Since I am committed to promoting quality of life
among patients with chronic and terminal illnesses, life-sustaining devices, and their caregivers,
choosing such a sample provided a beginning understanding of living with and caring for
someone with this device.

Despite not having clinical expertise with this population, the

mentored research experience helped develop a program of research that may not be exclusive to
LVADs, but for similar conditions or other life-limiting illnesses.
Exploring the experience.
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The second research activity commenced with the strategies to investigate the experience
as lived. To investigate the experience of DT as lived means that I must become filled with the
world of the experience of living with such a life-sustaining device. This is necessary in order to
gain a deeper understanding of this phenomenon. To actualize this activity, I engaged in several
activities to explore my phenomenon of interest. The first activity was a vignette written in my
reflective journal to illustrate my own personal experience of caregiving. van Manen (1990)
recommended using one’s own personal experience as a foundation to begin to understand the
experience of others because we may share common experiences.

Although I have not

personally experienced a life-threatening situation such as LVAD patient, both patients and
caregivers have been plunged into an unknown world. I can share the personal, experiential
account of being a caregiver plunged into this unknown world from the perspective of caring for
my dying father. As I wrote and reflected on this experiential primer, my voice remained private
until I explicated my personal story of caregiving for a dying person. The voices of those
experiencing DT patients and their caregivers, for example, may remain private as well. The
interaction with participants in this study and my interpretation of the descriptions and meaning
of living with DT co-created an understanding of living with and caring for someone with such a
life-sustaining device.
Secondly, my experience with palliative and end of life care, experience with developing
phenomenological inquiries, and performing qualitative interviews, has provided me with the
background to explore participants’ experiences as lived and described. As the investigation of
the phenomenon continued, I explored phenomenological literature by reading Heidegger (1962,
1968, 1971), Husserl (1970) and van Manen (1990, 1997), including several phenomenological
studies performed in the literature (Esdaile, 2009; Maxton, 2008; Cashin, Small, & Solberg,
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2008; Eggenberger & Nelms, 2007; Cangelosi, 2007; Moene, Bergbom, & Skott, 2006;
Gasquoine, 2005). I also observed photographs, videos, and stories of patients with LVADs on a
support website for patients with mechanical circulatory support devices and their caregivers to
understand the experience of living with such a life-sustaining device. Next, I gathered
information from participant interviews as part of my research inquiry from the Center for
Mechanical Circulatory Support (CMCS) at The University of Michigan Systems (U of M).
These participants are required to have an LVAD as a DT, or served as a designated caregiver. In
the inquiry, participants were encouraged to describe their experiences in a face-to-face, taperecorded conversation (i.e., interview).

van Manen (1990) discussed that by engaging in

conversations with participants, meanings are uncovered.

Next, van Manen discussed the

importance of the researcher becoming a participant observer by recounting living phrases of
participants. While engaging in conversations with my participants, I gathered interview notes
which included “living phrases” and key events that brought to life participants’ experiences to
life. These interview notes illustrated the setting of conversations, body language, and feelings
and perceptions I had during these conversations. The culmination of this data provided the
essence, or meaning of the lived experience. According to van Manen (1990), these data
obtained from these interviews are the human experiences.
Reflection on essential themes.
The third research activity involved thoughtful reflection to understand the meaning
about a specific phenomenon. van Manen (1990) described that this research activity uncovers
the essence of the phenomenon by reflecting upon participants lived experiences. I reflected on
all data gathered during conversations and incorporated the four existentials of the lifeworld as a
guide for reflection throughout thematic analysis: 1) Spatiality, or lived space, 2) Corporeality,
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or lived body, 3) Temporality, or lived time, and 4) Relationality, or lived other (van Manen,
1990).
Lived space. Lived space is the physical and emotional world known to and described
by participants in my inquiry. Here, participants described how their lives were before the
LVAD and the emotions surrounding that experience. Descriptions of their physical world
included things that they liked to do which were, in some ways, limited due to their new lives
with the LVAD. Emotions ranged from being scared, overwhelmed to feelings of happiness,
gratitude, even uncertainty as they continue to live with this life-sustaining device.
Lived body.

Lived body is an awareness of the presence of the physical and

metaphorical body towards one another, both revealing and concealing aspects of this awareness.
As my participants and I engage in conversation, we may both reveal and conceal something
about ourselves. There were many times that the context of conversations took an emotional toll
on both me and my participants. Asking participants to describe the feelings that surrounded a
particular situation usually ended up in both of us reaching for tissue to wipe away our tears.
Yet, we both seemed comfortable in revealing aspects of our deep emotions, and, in some
unusual way, found comfort in one another’s presence as participant descriptions continued. I
remain amazed that these participants felt comfortable enough to talk to me about their
experiences.
Lived time. van Manen (1990) describes lived time as “subjective time” instead of
“clock time or objective time” (p. 104) with temporal components of being in the world, such as
childhood or young adulthood. Participants may describe the temporal dimensions of past,
present, and future as they reflect upon their experiences as lived. During their interviews,
participants’ expressed emotions from the time before patients had heart failure, how they
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improved with the device, and how they watched and cared for their loved ones living with DT.
Descriptions included the times they spent in the hospital, time for recovery and rehabilitation at
home, feeling comfortable with living with the device, and how grateful they were for being
given more time to live.
Lived other. Lived other is the acknowledgement of others within our space, such as
researcher and participant (van Manen, 1990). Participants acknowledged the instrumental role
caregivers, family, and the team at U of M played in giving them more time
Capturing the essence through writing and rewriting.
The fourth research activity entails the process of ongoing writing to capture the meaning
of the lived experience. While reflecting on participants’ descriptions, I continued to write and
rewrite phrases of participants’ descriptions that suggested themes.

By writing, rewriting and

reflecting, I engaged in deeper reflection upon my interpretations to capture the essence of living
with and caring for someone with a DT. van Manen (1990) concluded that the themes
constructed through this process illustrates the meanings ascribed to the human experience. A
phenomenological story illustrating the experience and meaning of living with DT was
constructed with overarching themes and sub-themes uncovering the essence of the experience of
living with a DT (Chapter 4, Results).
Remain focused and oriented.
This activity calls for the researcher to have a focused orientation towards the
phenomenon of interest, the research questions, and the phenomenological inquiry. I remained
focused on the research questions and methods through interviews with participants and
maintained close observation.

While focused, I remained open to the words of the lived

experience from participants’ descriptions and not my own. This was achieved by listening to
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descriptions and formulating probing questions as conversations unfolded. An excerpt from a
section of my ongoing journal, Living and Finding Meaning Through Arts, illustrates how I
strove to remain true and oriented to my inquiry:
These participants openly talked about their experiences with me, a stranger, who
asked to enter their private world of living with DT. As I examined how and why these
participants recounted their personal experiences with me, I realized that I became a
participant observer. van Manen discussed the importance of the researcher becoming a
participant observer by recounting living phrases of participants. But it was not only
gathering “living phrases” that captured participants’ experiences, but my ability as
researcher to elicit experiences as lived through open dialogue, encouraging deep,
reflective thoughts, without influencing thoughts during conversations. Examples include
my research skills to promote an open, comfortable environment for my

participants,

such as using open-ended questions, positioning and utilizing my body language to make
participants feel comfortable. The feelings of comfort felt in the room, the amazing,
heart-felt stories, the fears and detailed descriptions of very personal experiences, led me
`

to conclude that I was capable of putting aside my own thoughts, biases, and assumptions
in order for participants to reveal their lived experiences.
Finally, I closely examined the data that was relevant in order to maintain my

commitment to the phenomenon and the research question. This process enabled me to reflect on
the experiential descriptions of participants’ stories to deeply understand and therefore, interpret
the essence of living with and caring for someone with a DT.
Balancing the inquiry by considering parts and whole.
The final research activity focuses on balancing the phenomenological inquiry by taking
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into account the whole design compared to the parts.

In this activity, I questioned the overall

design, or whole of the study (e.g., phenomenological method of inquiry), against the parts, (e.g.,
tape recorded interviews, transcribed texts, ongoing reflective journals, constructed themes, etc.).
This final research activity enabled me to describe the experience of living with a DT, and their
interplay in the development of the final phenomenological story. I continuously questioned my
reflections and interpretations by stepping back and looking at the whole to see if my
phenomenological story explicated the meaning of living with a DT. This circular movement
from the parts to the whole, stepping back, and reflecting on my interpretations, constitutes the
hermeneutic circle. I provided an illustration of this process in Figure B4. This process not only
broadened my thinking to deeper levels, but also helped to confirm participants’ descriptions and
interpretation of their meanings. Part of the process of interpreting the experience as lived is the
ability of the researcher to put aside any pre-understandings, assumptions, or any scientific
knowledge about the phenomenon of concern which could influence interpretation of results (van
Manen, 1990).
Hermeneutic reduction: Bracketing.
Within van manen’s methods, reductions in thinking, or openly disclosing perceptions,
assumptions, and biases about a phenomenon of concern, begins prior to data collection and
throughout the interpretive process.

Reductions in thinking facilitate reflection on the

phenomenon in the lived world — the researcher needs to be cognitively and deliberately aware
of holding prior knowledge and assumptions at bay, continually questioning those assumptions
and “turning the knowledge against itself” (van Manen, 1990, p. 47). By suspending prior
knowledge of the phenomenon, the researcher remains open to the descriptions of the
phenomenon and allows the meaning to be revealed by the participants (van Manen, 1990). In
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other words, I strove as a researcher to hear my participants’ voices — rather than allowing my
own beliefs and biases to superimpose the meaning of living with a DT. Bracketing (e.g.,
suspending), or keeping at bay these preconceived ideas, is the technique used in
phenomenology.

Bracketing was accomplished through maintaining an ongoing reflective

journal to record my professional and personal feelings about my phenomenon of interest.
Reflective journaling is a strategy recommended to ensure transparency, so that both ethical and
methodological decisions can be questioned during an audit trail (Munhall, 1994).

In my

reflective journal, I made it explicit that my assumptions, biases, and experiential content
described in my inquiry. I strove to bracket the knowledge acquired from my past experiences as
a palliative and end of life care practitioner, as well as the literature identifying conjectures about
my phenomenon of interest. Other strategies to enhance my openness and objectivity included
open discussions with other members of the research team. Although van Manen asserts that
complete phenomenological reduction is impossible, and that full or final descriptions are
unattainable, we need to pursue human science research with “extra vigour” (p. 18). I realize
that it is impossible to forget all of my preconceived notions. By continuing, however, to
explicate these assumptions, beliefs, and interests, it enhanced my ability to remain unbiased as
much as humanly possible as I listened and probed into participants’ stories.
Design
A hermeneutic phenomenological inquiry was developed to explore the experience of
living with an LVAD as DT from the inside perspectives of patients’ and caregivers’.
Setting
Concurrent institutional review board approval was obtained prior to data collection.
(Appendices C & D). Concurrent IRB approval was required since I accessed my patient
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population at the U of M. I also obtained approval for my previously completed study as
required by the IRB/HIC regulation (Appendices E & F).
Data collection took place at the U of M’s CMCS. The CMCS is an internationally
renowned group of physicians and multi-disciplinary professionals providing medical treatments
and therapies for patients experiencing cardiac disorders resulting in advanced heart failure or
cardiogenic shock. As a regional and national referral center offering state-of-the-art options for
mechanical circulatory support (such as LVADs), the CMCS is one out of three implant centers
in the State of Michigan, implanting over 430 LVADs (i.e., BTT = 377, and DT = 53) since
2005. Susan Wright, former supervisor for the CMCS, has a long history of providing support to
nursing research. Ms. Wright provided me with a letter of support (Appendix G), and facilitated
access to the CMCS outpatient clinic, including providing the office space necessary for
conducting private interviews with the participants. The office space included a private,
spacious, conference room with a large table and six chairs located in the CMCS outpatient
clinic.

The conference room also contained a telephone, a computer, and a printer.

A

photocopier and a facsimile machine for the CMCS were located just down the hall from the
conference room and were easily accessible for my use.
Sample
Once HIC/IRB approval was obtained, a purposive sample of patients with destination
therapy patients and their caregivers who could collectively give voice to their lived experiences
were recruited for this study. van Manen (1990) described that by borrowing other people’s
experiences we can arrive at a better understating of the deeper meanings of the collective human
experiences. Purposive samples are not only recommended to obtain rich data for data
exploration (Denzin & Lincoln, 2005), but to also bring forth participants who can purposefully
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describe an understanding of the phenomenon in relation to the research question (Creswell,
2007), in contrast to overall generalizability through quantitative studies.
Participants met eligibility for the inquiry as patients and caregivers living with DT.
Participants as patients met the following inclusion criteria: 1) had LVAD as a DT for at least
three months, 2) men and women 18 years old and over, 3) able to read, write, and speak
English, 4) have no evidence of cognitive decline, 5) come from all races and ethnicities, and 6)
voluntarily consent to participate in a tape recorded interview. Inclusion criteria are the same for
participants as caregivers of DT patients, except that they must have cared for these patients for
at least 3 months post-hospital discharge. The three-month period was assumed to be sufficient
in adjustment and reflection of living with this device (Casida, Marcuccilli, & Peters, 2011).
Exclusion criteria for both patients and caregivers includes: 1) unable to read, write, or speak
English, 2) less than 18 years of age, 3) exhibiting evidence of cognitive decline, and 4) have an
LVAD as a BTT, or cared/caring for a patient with a BTT.

Exclusion criteria specific to

participants as caregivers of DT patients includes: 1) cared/caring for a patient with DT for less
than three months post-hospital discharge, and 2) cared/caring for an explanted LVAD patient
who received a heart transplant. Additionally, certain groups of special vulnerable populations
were excluded from the study. For example, neonates and young adults were excluded since
having an LVAD is relatively rare in the 0-18 age group. Pregnant women were excluded in the
patient population since LVADs are contraindicated in pregnancy. The population of pregnant
women occurs naturally in the general caregiver population therefore are neither excluded nor
included in the proposed study. Institutionalized individuals and prisoners are excluded since the
proposed study is targeted at the free-living communities of patients and caregivers.
To date, the number of patients receiving LVAD is growing. The CMCS has implanted
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almost 500 LVADs to date – BTT (n = 377) and DT (n = 53). Despite the limited number of
patients available at the CMCS, I initially projected that the number of patients and caregivers
required to illuminate the meaning of DT as lived will be a minimum of five (5) patient/caregiver
dyads, but no more than twenty (20) participants total ( ten(patients and ten caregivers).
Although there are no statistical formulas for determining sample size for qualitative research
(Sandelowski, 1995), the final sample size was determined by information obtained from
participants. Phenomenological studies typically achieve data redundancy, or data saturation (if
no more new information from participants) with 10 or less participants (Dukes, 1984; Lincoln &
Guba, 1985). Although these numbers are estimates, data redundancy, was determined as data
collection and analysis were ongoing.
Data Collection Procedures
Since I accessed my population from U of M, both institutional review boards advised
that potential participants must be recruited by an employee of U of M with no direct clinical
relationships. The research coordinators for the CMCS are employees at the university medical
center who have no direct clinical relationship with research participants. They are primarily
responsible for recruiting potential participants. I trained the research coordinator in the study

protocol (Appendix H).

This protocol contains the inclusion and exclusion criteria for

participant recruitment. To ensure equitable recruitment of both genders, races, ethnicities, and
minorities, and a representative sample of the national indices reported by the national registry
for mechanical circulatory support (Kirklin et al., 2012), I developed an outreach protocol guided
by the National Institute of Health Guidelines on Inclusion of Women and Minorities as Subjects
in Clinical Research (Appendix I). According to the 2012 INTERMACS national registry,
White (n=2074; [69%]), males (n = 2338; [78%]) comprise the majority of the LVAD
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population, followed by females (n = 653; 22%) and Blacks (n = 672; 22.4 %) (Kirklin et al.,
2011). In my qualitative study exploring the sexual and intimate aspects of living with an
LVAD, my sample reflected this national average, 7 males (77.8%) and 2 females (22%).
However, data on ethnicity was not reported by INTERMACS and current datasets do not reflect
racial/gender compositions (e.g., Hispanic/Latino population). Out of the participants eligible
for participation in the study, no Hispanic/Latino participants were eligible for inclusion in the
study. All the participants as patients who met the inclusion criteria were White males (n = 7)
(Table A4).
With regards to the caregiver population, The National Family Caregivers Association
[NCA] (2009) reported that nearly 66% of caregivers in the United States are approximately
49-years old, married, employed, and caring for a widowed mother living on her own. In the
limited LVAD caregiving literature, caregivers were predominantly White women, family
caregivers (e.g., wife, mother, and daughter) of patients who are also predominantly living with a
patient with BTT, with slightly younger ages reported than the national averages. Ages ranged
from 38 to 62 years (Mean = 47.5; SD ± 14) (Baker et al., 2009; Casida, 2005; Dew et al., 2000;
Dew et al., 2004; Kaan et al., 2010). Notably, only one study indicated that most spousal
caregivers worked full-time outside the home (n = 2) (Casida, 2005). Contrary to these findings,
my qualitative study exploring the lifestyle adjustments of caregivers of patients with LVADs,
my sample reflected an older caregiving population with mean age of 57 years and a standard
deviation of 15. This older caregiving population could be because most patients with LVADs
comprise the 40-59 age group (n = 1410; [48.7%]), followed by the 60-79 year-old age group (n
= 1037; [33=4.6%]) (Kirklin et al., 2012), and the indications for LVADs has been reported to
older adults in recent years. The caregiver sociodemographic profile was comprised
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predominantly of retired, White females, ages ranging from 50-74 years old, M = 65, SD = 8.3
(Appendix A, Table A5). It must be noted that the 40-59 age group are mostly patients bridged
to transplant (Kirklin et al., 2011), whereas participants in my inquiry reflect the older adult
population who are only eligible for a DT.
Recruitment.
Potential participants were recruited by the research coordinator via telephone. Twentyfour participants were identified as eligible according to the recruitment protocol provided
(Appendix J). Recruitment letters were mailed out to these participants. Only two patients
called the research coordinator to express interest in participating in the study. Before the day of
a routine clinic visit, the research coordinator asked eligible participants if they were interested
in volunteering for the study. Potential participants were informed that they were required to
participate in one face-to-face interview, lasting for no more than one hour, and one follow-up
telephone call, lasting for no more than 30 minutes after the interview. The recruiter approached
13 participant dyads prior to their routine clinic visits.

Nine patients and nine caregivers

volunteered for the study. Four participant dyads were approached but declined to participate in
the study. Once potential participants expressed an interest in the study and volunteered, dates
and times in which both participants and researcher could meet at the CMCS were arranged. The
recruiter secured availability of a private conference room prior to the interview. On the day of
the interview, she met with participants in the CCS waiting room, and escorted them to the
private conference room. We exchanged introductions, and the process of informed consent
began.
Human Subjects Consideration
Every effort was made to protect both the participants’ health and personal information
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from inappropriate disclosure. In order to ensure privacy, participants as patients and their
caregivers were interviewed separately to promote privacy and confidentiality, and a “do not
disturb” sign was placed outside the door before the start of the interview. One caregiver
requested to be present during the patient interview because of occasional forgetfulness. The
caregiver spoke only when the patient needed assistance. While participants waited for each
other’s interviews, they were offered the opportunity to wait in the CCS waiting room/lounge
area equipped with comfortable chairs and sofas, free refreshments, and reading materials. I
went over the consent form with each participant in the private conference room, allowed ample
time for questions, and answered any questions or concerns they had. I ascertained knowledge
about the purpose, risks and benefits of the study, as well as their role in the study prior to
obtaining informed consent. Participants were informed that participation was strictly voluntary,
they could elect not to answer any questions, and could end the interview at anytime without fear
of repercussions (e.g., plan of care would remain the same regardless of participation in the
study). They were informed that all information would be held in the strictest confidence with
no identifiable markers on any data, and that no information would be shared with their
respective partners. In order to ensure confidentiality, I continually reinforced their privacy and
confidentiality with each step of the data collection procedures. Participants were informed that
if results of the study are published, information would be presented in such a way that it will not
be traced to the respective participant.

Since follow-up interviews were performed via

telephone, participants were encouraged to find a quiet, private place in the home.
The research did not expose the participant to any known risks. Despite the possibility of
any unforeseeable risks associated with any research, the risks associated with the proposed
research were minimal, such as physical harm manifested by fatigue. Since there are human
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subject considerations specific to patients with LVADs, I ensured the participants’ comfort by
suggesting several comfort strategies prior to commencing the interview, such as: 1) encouraged
use of bathroom facilities, 2) offered a cold or warm beverage (free in the CMCS waiting
room/lounge, 3) made sure the batteries to the LVAD are fully charged, 4) keep cell phone
turned on so participants and caregivers can check on each other if needed, and 5) informed them
that they can stop the interview at any time for breaks, or if they want to end the interview. If
participants exhibited any signs of fatigue, such as shortness of breath while talking, the
interview would be stopped.

No participants exhibited any signs of fatigue in which the

interview had to be stopped.

The other minimal risk to participants might have included

psychological harm, such as anxiety. Since participants have this LVAD as a final therapy for
end-stage heart failure, reflecting upon these inside perspectives may be considered sensitive and
possibly upset the participant). If any participants were to experience any of the minimal risks,
consultation services with either a member of the CMCS staff or the psychosocial team was
available upon request. Some participants began to cry when they reflected upon experiences
that elicited emotional feelings. I offered to stop the interview, but participants wanted to
continue with the interview, stating they were fine to proceed with the interview. No patients
required or requested any follow-up consultation with either a member of the CMCS staff or the
psychosocial team.
Despite steps taken to minimize risks to participants, there may be additional, unforeseen
risks. Participants were instructed to notify me, the CMCS Supervisor, and their physicians of
any problems that may have occurred during the research. There were no known reported risks
related to this study. Additionally, participants were informed that participation in more studies
may increase the risks, and/or affect the results of the studies. Participants, therefore, were
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advised not to enroll in more than one study without approval from their doctor. Participants in
this inquiry denied participation in other studies.
In the event that an adverse event occurs, such as a serious illness, death, or even
incarceration of a participant, the outreach program was designed to develop a continuing rapport
with the research coordinators. This is especially important since patients with DT have received
this device as the final recourse for the palliation of the progressive symptoms of heart failure.
Although the average life-span for patients with such a life-sustaining device can reach six or
more years, it is very difficult to predict any illnesses, including the development of comorbidities, device failure, or even death while patients are living with such a life-sustaining
device. Therefore, the research coordinator was instructed to call me as soon as they were aware
of any adverse events, so it could be reported to the HIC/IRB in accordance with the Federal
Common Rule for reporting adverse events of participants in research). There were no known
adverse events reported during the course of the research. After participants were given time to
answer questions, informed consent was obtained on nine (9) patients and nine (9) caregivers.
Study Measures
Cognitive ability was assessed with the Mini-Cog, a reliable and valid tool developed
by Borson and colleagues (2000) (Appendix K). This instrument can be used in a variety
of health care settings, is suitable for older adults with varying literacy levels, even culturallydiverse populations. It can be administered under 3 minutes and used to distinguish between
patients with and without dementia (Borson et al., 2000). Sensitivity and specificity ranges from
76-99%, and 89-93% with 95% confidence, respectively (Borson et al., 2000). All participants
(n = 18) recalled all three words and received a Score = 3 (e.g., non-demented). All participants
(n = 18) passed the clock drawing test (CDT), because the numbers on the clock were in the
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proper sequence, and the hands were drawn as requested, on 3:00. Participants, therefore,
received a normal, non-demented score. The instrument was delivered in less than 5 minutes
across all participants.
Data collection
As previously described, data collection begins with bracketing procedures.

These

procedures included maintaining a reflective journal to openly unveil personal perceptions,
assumptions, and biases about living with an LVAD, and engaging in discussions with other
members of the dissertation committee members. This information was utilized throughout the
duration of my study.

I used open-ended, in-depth, face-to-face interviews and direct

observation for my hermeneutic phenomenological inquiry. As recommended by LeCompte and
Schensul (1999), I strove to keep my participants focused on a particular topic while not
interrupting the natural flow of the interview.
Interviews commenced with participants as patients and caregivers individually, except
as noted for one dyad. First, I obtained sociodemographic data from each participant (Appendix
L & M). Next, participants were informed that the interview will now start and the audio-tape,
placed on the table between me and the participant, was turned on. The order of participants
(i.e., patient or caregiver) was of no importance and the dyads decided amongst themselves who
went first. For the patient interview, the interview commenced by me asking the following
opening question: “Tell me about your experience of living with an LVAD as DT?” (Appendix
N) As the patients described their experiences, I used probing questions such as “tell me more
about that experience...” When the patient described an experience, I asked for more information,
such as, “What was the experience like for you?” The context of these elicitation phrases
remained open, yet stimulated the participant to think deeply and reflectively on their
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experiences, and to clarify and/or expand these experiences as lived.

van Manen (1990)

described that probing questions are the gateway for discovery of the meaning of the
phenomenon as participants’ experience, since meanings are accompanied by reflecting and
refocusing on the phenomenon. Likewise, it was important for me to bracket my beliefs,
assumptions, and presuppositions at this critical juncture of exploring the experience as lived.
The openness of these elicitation phrases assisted me in the exploration of the experience as lived
and helped keep my personal beliefs and biases at bay.
The following research question was developed to explore the meaning of living with
such a life-sustaining device: “Tell me about the meaning of having an LVAD as a DT?”
Similar elicitation phrases, such as, “tell me more about those feelings....” “How does that make
you feel?” were asked to probe deeply into the meaning of the experience as lived. I also asked
participants for stories, including key events, about their experiences that illustrate life with and
the meaning of living with a DT. LeCompte and Schensul (1999) described stories as, “storys
and storytelling permit interviewees to speak from experience about situations that illustrate
points important for the researchers study” (p. 138). Probing questions to guide the story
includes, “Tell me about the day you learned about the LVAD....what you remember first?”
Continued probing questions, such as, “What happened after that...” as well as additional probes,
for example, were used to encourage the participant to remember what led him/her to finally
decide to receive the LVAD, and the emotions and/or feelings experienced during that time, and
so on and so forth. Participant interviews ranged from 33 to 81 minutes with a mean time of 53,
and standard deviation of 17.1. Length of 1st interview transcripts ranged from 11 to 18 pages,
with a mean length of 10.7 and standard deviation of 2.3.
For the participant as caregiver, I followed the same procedures as described above. The
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opening question for these participants was: “Tell me about your experience of caring for
someone with an LVAD as a DT,” followed by “What does it mean to you to care for someone
with an LVAD as a DT?” “Tell me more about those feelings...” and “how does that make you
feel?” I asked participants as caregivers for stories, including key events, about their experiences
that illustrate life with and the meaning of caring for a patient with a DT (Appendix O).
Caregiver interviews ranged from 27-69 minutes (M = 51.3; SD= 15.1). Length in pages of 1st
interview transcripts ranged from 8-15 (M = 11.1; SD = 2.5).
While engaged in participant interviews, I acknowledged and enacted my role as a
participant observer.

van Manen discussed the importance of the researcher becoming a

participant observer by recounting living phrases of participants. During participant interviews, I
made note of the usage particular words, phrases, and the association of non-verbal body
language, such as tears, silence, upper and lower limb gestures, and facial expressions. Unlike
field notes which include an overall description of the setting, the researcher constructs the
experiential anecdote “trimmed of all extraneous, possibly interesting but irrelevant aspects of
the stories.....to highlight specific points that require further reflection and it is this point that
needs honing” (p. 69).
Interview notes were written immediately after each interview, including initial thoughts
about areas needing further exploration in subsequent interviews. After each interview was
finished, the tape-recorded interviews were transcribed by trained transcriptionists and verified
by me for accuracy. The transcribed files and demographic summaries were downloaded in the
NVivo 9 qualitative software program, which are available for audit. If participant transcriptions
were not available prior to starting subsequent interviews, I listened to the recorded voices of
participant interviews and reviewed interview notes several times prior to engaging in further
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interviews. This is critical step in performing my study. Data collection progresses along with
data analysis. This means that I am continually engaging in a dialogue with participants’
descriptions. This is necessary because in order to interpret the meaning of living with DT, I
must always look at the data, question the data, and probe deeply into the meanings of the
experiences of my participants. If subsequent participants described similar experiences and
meanings, I can probe more deeply into these thoughts, words, and phrases, and hopefully
construct what the essence of living with and caring for someone with such a life-sustaining
device. Van Manen (1990) describes this process as immersion. Immersion requires engaging
with the meaning of the texts to gain insight into preliminary or emerging themes (van Manen,
1990).
While data collection was ongoing, I continued the process of immersion by listening to
tape-recorded voices, read, and re-read the transcribed texts in order to uncover statements,
emerging themes and meanings ascribed to experiences. As I reviewed the completed interviews
and commenced subsequent interviews, any unclear, incomplete, or areas needing further
clarification during the first interviews were identified and labeled as areas for further probing. I
engaged in a cyclical process of data collection, data analysis, and member checking (e.g., data
checked with participants).

For example, after about 4 patient and 4 caregiver primary

interviews were collected and analyzed, areas for probing were ascertained. Deeper probing
questions were formulated on initial analysis of these interviews, and then added in a cyclical
way to the ongoing interviews. This constitutes ‘ongoing member-check,’ in which the second
half of primary interviews. For example, interviews with participants 5 through 9 and follow-up
interviews for participants 1 through 9 were done that encompassed the entire set of preliminary
data.
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The 2nd interview consisted of one follow-up telephone call to explore the initial
interview questions, including the second set of questions generated from preliminary data
analysis. One participant was called twice and never responded. There were (n = 5) caregivers
for the 2nd follow-up interview. Second interview times for caregivers ranged from 23 to 60
minutes with a mean of 38.1 and standard deviation of 14.2. Number of pages for second
interview ranged from 5 to 21 pages, with a mean of 12.5 and standard deviation of 6.9. Second
interview times for (n = 7) patients ranged from 10 to 129 minutes, with a mean of 50.6 and
standard deviation of 41.3. Pages for second interview ranged from 3 to 26 pages, with a mean
of 11.5 and standard deviation of 7.3. Enrollment ceased once there was a determination that
there was no more new information from participants. According to Lincoln and Guba (1985),
“Sampling is stopped when there is no new information coming from newly sampled units;
redundancy is the primary criterion” (p. 202). A total of 18 participants (n = 9 patients and n = 9
caregivers) were interviewed. Data saturation was determined after participant interviews with
(N = 7) patients and (N = 7) caregivers became redundant. Two patients and two caregivers were
excluded from the study because of the possibility of receiving a heart transplant. Participant
sociodemographic profiles were constructed (Tables A4 & A5).
Participant appreciation.
As a token of appreciation for participating in my research, participants received $25 cash
for travel expenses ($25 total in travel expenses for each patient/caregiver dyad), and $25 cash
for each participant ($50 total for each patient/caregiver dyad) (e.g., funds did not exceed $75
total for each patient/caregiver dyad).
Data Analysis – Data Interpretation
According to van manen (1990), data analysis in a phenomenological inquiry aims to
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construct descriptions from the participants’ texts in order to elicit the essence of the lived
experience. As a result, phenomenological descriptions are rich descriptions eliciting in readers
the phenomenological nod, that is, an experience we may have experienced or even recognized
(van Manen, 1990). This is accomplished through thematic analysis, which is done across all
participants’ text to elucidate similarities and differences, and phenomenological writing, in
which a phenomenological story explicating the essence of living with DT through themes and
sub-themes was constructed.
Thematic analysis.
van Manen (1990) described three approaches for reviewing the data from macro- and
micro- perspectives. From a macro-perspective, or wholistic (sententious) approach, the texts
were reviewed as a whole. From a micro-perspective, the selective (highlighting) and detailed
(line-by-line) approach, focuses on the parts. All three approaches involve reading, rereading,
reflection, and writing.
Wholistic approach. This goal of the wholistic or sententious approach is to find the
overall meaning of the participants’ voices. First, I separated and grouped the participant texts
into patients and caregivers to preserve the inside perspective of each experience. Then, I read,
reread, and reflected on each text individually. As I read over the texts, I asked questions of the
whole text, such as: “How does this text reveal the meaning of living with DT?” “What are the
phrases that capture the meaning of the text as a whole?” (van Manen, 1990).
Selective approach. In the selective or highlighting approach, I read each sentence or
phrase very carefully. While reading and rereading the texts, I reflected on the words and asked:
“What phrases stand out in the text? Which phrases, sentences or parts of sentences may
represent a theme of my phenomenon? (van Manen, 1990). Then, I highlighted particular
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statements, words, or phrases that represented my phenomenon. I reflected on each word and/or
phrase, as I attempted to understand participants’ experiences and meaning into the phenomenon
of LVAD as DT. The goal of this preliminary approach is to identify words, phrases, and rich
descriptions that illustrate the essence of living with DT.
Detailed approach. Also described as the line-by-line approach, I read each phrase very
carefully. While reflecting and rereading the texts, I will ask: “What does each phrase, sentence
or parts of sentences appear to uncover about the meaning of my phenomenon?”(van Manen,
1990). After highlighting meaningful words and phrases, I compared parts to the whole of
transcribed transcripts to search for shared meanings and differences (van Manen, 1990). Words,
phrases, and clustered topics were coded as nodes and organized into separate patient and
caregiver folders in the NVivo 9 qualitative software.
In van Manen’s (1990) method, both analysis and reflection is done to obtain an
understanding of the phenomenon by comparing and contrasting participants’ texts collectively.
In this phase of analysis and reflection, the research questions were applied to emerging themes
to highlight those which illuminate/uncover the experience of living with DT. Moving back and
forth from the lived experience sources to the whole of the inquiry allowed me to develop an
understanding of the phenomenon and generate new interpretive questions as the process of
thematic analysis and refection continues. Constant comparison of my personal journal entries,
transcribed texts, interview notes, and demographic profiles were ongoing as interviews
continued, and collectively utilized to capture the essence of the participants’ experiences. By
writing, rewriting, and reflecting across all texts, the culmination of these three approaches
produced clustered topics which were organized into emerging overarching themes and subthemes illustrating the experience and meanings of living with DT. The second part of data
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analysis/interpretation includes phenomenological writing as a process of creating a story
describing the essence of participants’ experience as lived.
Capturing the phenomenon through writing.
It is through the process of writing that the meaning of the lived experience emerges (van
Manen (1990). The process of writing and reflecting is an important process to uncover the
essence of phenomenology, as described by van Manen.

As a result, thematic phrases

constructed through analytical reflection provide initial meanings ascribed to the phenomenon
and a foundation for ongoing reflection, writing and re-writing.
As part of phenomenological writing, I continued to explore the lived experience sources
to interpret the essence of my phenomenon. As the phenomenological story started taking form,
I used personal reflections from phenomenological literature, and experiential descriptions to
spark creativity in interpreting, developing and presenting the essence of the DT phenomenon.
The experiential descriptions included entries in my personal reflective journal, which are
available for audit.

In addition, I used various forms of artwork, such as poems written by

phenomenologists, and videos of patients and their caregivers living with LVADs, to stimulate
phenomenological writing. van Manen (1990) described that paintings, sculptures, music, and
cinematography has its own language which gives shape and form to the lived experience. I
utilized many aspects of the arts and humanities, including music and meditation, to help me
create the final phenomenological story. The following section is a compilation of the artwork
articulated with to stimulate phenomenological writing.
Finding meaning through art.
van Manen discussed incorporating many types and sources of meaning to aid in the
interpretation of the lived experience (van Manen, 2002).

These sources included poetry,
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artwork, everyday life experiences, language, social science, historical, cultural, literary, and
phenomenological literature sources.

Sources of adding meaning to assist me in the

interpretation of the lived experience is artwork, photography capturing everyday life
experiences, and music. As I forged on in the construction of the experience and meaning of
living with an LVAD as DT, there came many times where I had to stop and reaffirm my own
life, my own being, and those who are an integral part of my world. I found this step necessary
to recollect my thoughts and pursue my dedication to make the world of DT come to life.
Family. The majority of participants described how important family is and the integral
role good family support plays in all aspects of life. From being there before the LVAD implant,
recovery, and rehabilitation, the importance of having good family support was vital for a happy,
productive live. I, too, can identify with the importance of having a good family support. It was
rummaging through a collage of pictures of those who inspired me the most that helped me
understand what the meaning of life really is. The next two pictures are those of my family –
pictures which to me, bring out the meaning of what it’s like to have the love, support, and
feeling of being cared for by family.
Pictured here is my husband, my pillar of strength, who has played a vital role in the
pursuit of my graduate studies (Figure B5). He is a gentle soul, one who loves all creatures great
and small. Of those creatures walking on twos, fours, or eights, covered with fur, feathers, scales
or leather, he is particularly sensitive to those who are victims of a sometimes cruel world. His
advocacy for these victims shows in all his actions and words, even visible through silence and
tears. I see him here in a mini-reproduction of a Brazilian rainforest in my own home - exotic
birds, green foliage, and flowers indigenous to his native land. His focused, pensive expression
mirrors his ongoing love and perseverance to make this world a better place for everyone. In
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doing so, he made, and continues to make, my life comfortable, filled with love, and a neverending commitment to making all my dreams come true.
Another source of happiness and inspiration is my senior citizen Wheaton terrier (Figure
B6). The expression in this picture represents many years of loyalty and unconditional love as
my protector and companion in times of loneliness and despair. There was never a day gone by
that this crazy but lovable dog has touched my heart and soul in ways beyond expression. His
fun-spirited, zest for life in younger years has now culminated to an attitude of ‘acceptance’ and
a ‘job well-done.’ He continues to wait in joyful hope for his ‘mommy’ to hang out with him,
even if for a few moments.
Return to a new normalcy: Van Gogh self portraits. While writing and rewriting
themes and considering possible interpretations of the lived experience of DT, I turned to the
works of famous artists in hopes of constructing the meaning of living with such a life-sustaining
device. Once again, I knew it was important for me to understand my role as researcher, and to
continue to hold at bay my own personal beliefs. While reviewing the famous paintings and
artwork of many painters and sculptors, I was drawn to the works of van Gogh, specifically his
self-portraits (Figures B7 & B8).
Van Gogh painted over 30 self-portraits in the late 1800s. I found it interesting that the
majority of his self-portraits always portrayed the same expression – a glaring, intense look in his
eyes, tightly drawn lips, and a right or left profile. The bold use of colors and outlining, and the
thick, purposeful brush-strokes exudes an expressive and emotional feeling when observing his
paintings. Circumstances surrounding van Gogh’s tumultuous life are splattered across an array
of canvases, but, the expressions, the expressions of who he is, remains the same. What was the
impetus for creating these self-portraits?

Were these self-portraits a way to express his
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emotional and dramatic world by trying to regain a sense of normalcy? Believing that the latter
is true, we cannot control external forces that influence our thoughts and actions, but we all try to
regain some type of normalcy in the process. This is achieved in realizing that we have the
ability to keep and/or return to normalcy.
As I reflected upon the van Goghs’ self-portraits, I can’t help but think about how
external influences have shaped my thoughts and actions, particularly my journey through
nursing doctoral training. I strove to maintain my normalcy as I progressed through my studies,
but my normalcy was replaced with a new normalcy – the ability to think and perform in ways
never dreamed possible. This was very evident while I interacted with participants’ during
interviews. These participants openly talked about their experiences with me, a stranger, who
asked to enter their private world of living with DT. As I examined how and why these
participants recounted their personal experiences with me, I realized that I became a participant
observer.

van Manen discussed the importance of the researcher becoming a participant

observer by recounting living phrases of participants. But it was not only gathering “living
phrases” that captured participants’ experiences, but my ability as researcher to elicit experiences
as lived through open dialogue, encouraging deep, reflective thoughts, without influencing
thoughts during conversations. Examples included my research skills to promote an open,
comfortable environment for my participants, such as using open-ended questions, positioning
and utilizing my body language to make participants feel comfortable. The feelings of comfort
felt in the room, the amazing, heart-felt stories, the fears and detailed descriptions of very
personal experiences, led me to conclude that I was capable of putting aside my own thoughts,
biases, and assumptions in order for participants to reveal their lived experiences.
The ability to keep in abeyance any confounding thoughts was certainly beneficial for my
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research, but took an emotional and physical toll on my overall well-being. I felt such a deep
remorse for these patients and caregivers. I knew that many of these patients will eventually die,
and that the caregivers will be left alone and distraught with the memories of what could and/or
should have been.

Participant description of their life experiences (e.g., external forces),

influenced my thoughts and actions in such a profound way that I became more pensive and
secluded. I had to search for ways to regain normalcy in my life again (Figure B9). Their stories
just seemed to paralyze me emotionally and physically. A lot of their stories reminded me of
how much I loved my father and how I cared for him day and night as he approached his final
destiny. The images of his pain, suffering, and all those horrible emotions I felt certainly made
me realize that many caregivers can experience post-traumatic stress disorder (PTSD). This
condition is certainly one of my biggest concerns for these caregivers and caregivers in general.
Will they experience PTSD once the patients have passed on?
I have learned that, no matter how destitute you are, there is always hope. There is
always that light at the end of the tunnel. Eventually, we all will find ‘the light of hope’ and
eventually the peace that follows in our hearts when all seems lost. Similar feelings of hope
echoed throughout participant descriptions. From the first time they learned that a mechanical
heart could keep them alive, to hope for new technology when their device stops working, hope
for life seemed a constant and strong feeling expressed across participants’ experiences.
Just like van Gogh painted an array of self-portraits illustrating the forces of change
surrounding him, a desire to return to normalcy was also expressed by participants across the
board. Participants spoke how they strove to achieve a sense of normalcy by adjusting to living
with the device. From caregivers helping patients adjust, to patients themselves accepting and
adjusting in their own ways, the journey to normalcy, for a desire to live life like before, was
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clearly evident in this sample of participants. Although many participants achieved a sense of
normalcy, for many of them, it was a new normal – a normal with nuisances and inconveniences
– but they were all good nuisances and inconveniences – because it gave them more time to live.
Like van Gogh’s self-portraits, external influences continued to affect his life, his world, but, his
search for normalcy through creations on canvas created a world in which, for the moment, was a
distraction from the nuisances of his tumultuous life. We too, change with these external forces,
but continue to search for normalcy in what we have come to know as a new normalcy.
Portraying worry through art. As I continued my search for artwork to help me create
the meaning of living with a DT, I focus on the major feeling expressed by caregivers across the
board: persistent worry and stress. There were several paintings by Picasso (1881 – 1973)
which instilled in me a deeper understanding of the feelings of worry and stress among
caregivers. The first painting is called Woman with a chignon (Figure B10). It is a single
painting/portrait of a woman sitting down, with her hands folded underneath her chin almost as if
to hold her head up. Her eyes look worn and tired, her mouth and lips closed as she just seems to
stare off into space. Her slouched body language exudes a feeling of exhaustion as she seems to
listen to what someone has to say, but is in a far away land. What is she thinking? My
participants as caregivers portrayed this same expression on their faces – the look of exhaustion,
worry, stress – but only when they talked about their experiences of worry and stress, or
recounted what worried them the most. For example, patients were not careful, they wanted to
regain their independence and do what they normally did before, etc. When they started talking
about the ‘good part’ of having an LVAD, like being given more time and feeling better, their
eyes seemed to lighten as if a spark of sunshine came into the room. But once they continued to
recall feelings of worry and stress, their expressions mirrored the woman in the painting.
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Other artwork by Picasso included to illustrate the meaning of persistent worry and stress
where also found that illustrated the experience of being worried. Here, we see the painting,
Lola, Picasso’s Sister (Figure B11). Lola is pictured sitting down with her hands set down in her
lap looking outside. There are lights and what appear to be people in the distance, but Lola is by
herself and appears to be in deep thought. Although her facial features appeared dull, once can
see a very deep, almost lost look in her eyes. Her body language, however, seems to tell us
something else – she is leaning forward, looking outside, as if to see what’s going on outside, or
waiting for the return of someone. This also mirrors what the caregivers have described – there
was never a moment that passed that they didn’t think about their loved ones. Whether the
patient was out by themselves, with friends, or if the caregivers left for some period of time, the
patients were always on their mind. Here, Picasso’s painting, once again, has helped me to
illustrate persistent worry and stress that echoed throughout caregivers’ voices.
Fear of morbidity and mortality. This next painting by Picasso, Woman with a Crow
(Figure B12) illustrates a woman caressing a black crow. In European mythology, the black
crow symbolizes imminent or impending death. Picasso’s drawing brings to life the constant
fear many of the caregivers had —the fear that something bad is going to happen, or worse yet,
the patient was going to die. Thoughts of the patients getting sick again, having to face an
elongated hospitalization, protracted illness, even death, has come across the minds of many
caregivers. How are the patients going to die, what are the signs, how long does he has to live?
This was one of the most difficult parts of my interviews—hearing the stories of their fears,
concerns, and ongoing stress related to knowledge of potential deterioration and the unknown
about the end of life.
Given another chance at life. When participants as patients reflected upon life before the
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LVAD compared to life with their new device, they unanimously described feelings of
impending doom. Phrases used to describe this feeling included, “I was on deaths door,” “I
thought I was going to die,” and “I didn’t think I would see the day I would come out of the
hospital.” Symptoms described by these patients included profound shortness of breath, marked
physical limitations, and having to ‘sit down’ or ‘use a wheelchair.’ One participant even spoke
of making end of life decisions, even saying good-bye to his wife, reminiscing about the good
life they had together. I combed through galleries of paintings, sculptures and artwork to help me
find something that illustrated what these patients were feeling, and how I can construct the
meaning of what it was like to have another chance at life. I turned to the paintings of van Gogh
and found The Raising of Lazarus (Figure B13). At first, I wasn’t sure about it, but as I re-read
patients lived experience sources, feelings of being scared, worried about leaving loved ones, and
having the LVAD for the family illustrated their close brush with death. When they heard about
the lvad, it brought immediate hope for life, where hope was lost. Although patients didn’t
actually die, they were close to dying. The lvad brought to them not only the gift of life, but an
overall improved quality of life as they regained the strength and confidence once again, to enjoy
life.
Other artwork I found was lived experience sources from personal websites.

For

example, I found several LVAD blog sites, where participants told there stories about living with
an LVAD. The most impressive blog was titled, “From the bottom of my LVAD”
(http://fromthebottomofmylvad.blogspot.com/), mirrors responses made by my participants’
feelings for being given another chance at life. One response was, “I am blessed for a better life
because of my lvad.”
Thank you Lord. One of the most inspiring themes that came up from participants was
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thanking the good Lord for being given more time. Phrases expressed by participants included,
“Praise the Lord, that’s all I have to say,” “Thank the Lord,” and “Thank the Lord to give the
doctors the knowledge.” In a religious hymn by Lyte (1793-1847) titled, Praise My Soul the
King of Heaven (Figure B14), the words sung by this chorus seemed to fill my heart and soul
with the true meaning of being thankful to the Lord. The words appeared to mimic the feelings
many participants felt before they had the LVAD – “well our feeble frame he knows, in His
hands he gently bears us,” to after having the LVAD, “ransomed, healed, restored, forgiven.” It
was the tears of joy that were expressed by these participants, the endless groping for words, the
stillness and silence of the room that made me feel this, this, was the true meaning of being
thankful for having an LVAD.
One of the participants wrote a poem for his 50th wedding anniversary, Thank you, Lord,
For This Great Day (Figure B15). In this poem was the phrase, “I guess this is all I have to say,
except Thank you, Lord, for this great day.” Once again, we come across the junction of
language and silence, where, according to Bollnow (1982), we have arrived at the truth of a
phenomenon. It is the searching for words, or lack of finding words, to describe a feeling, a
meaning so deep, that there are no words to describe a feeling, a meaning, or a phenomenon.
The phenomenon of silence and interpretation of meaning.
Consulting the phenomenological literature can also assist in describing and interpreting
the meaning of the lived experience. The phenomenon of silence particularly fascinates me.
Understanding the power of meaning behind non-verbal body language is necessary to fully
grasp the meaning behind a phenomenon. This is true when trying to describe and interpret nonverbal language, such as silence, during participant observation. van Manen (1990) described
that in the absence of speech or language, we find that silence is more powerful than words
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themselves. van Manen (1990) described three types of silence. The silence we experience
when we think of the unthinkable, such as death (i.e., epistemological silence), or the silence that
follows when we are moved by an enlightening or stimulating conversation, such as what may
happen in my interviews (i.e., ontological silence).

In the ontological silence, I can best

explicate this silence during one of my interviews in our recently published study exploring the
experience of caregiving for patients with LVADs (Marcuccilli & Casida, 2011). For example,
when the mother of a 21-year-old daughter with an LVAD tried to describe for me the meaning
of what it was like to care for someone with an LVAD, she appeared at a loss for words. As she
reflected upon this experience, phrases shortened and words were few. Finally, she said, “I don’t
see it as caregiving...she is my daughter...and I am her mother.....that’s just the way it is....” As
our stances locked, she nodded. “....yep...that’s it.....that’s it...” Also during my interviews, I
watched and listened for what van Manen (1990) calls literal silence. This silence occurs as the
pauses and periods of silence “while the conversation halting gropes forward” (p. 113).
Expressions of the types of silence were revealed in this section, and described in more detail in
Chapter 5, Discussion.
Prior to finalizing main themes, I reflected on preliminary themes for at least two weeks
prior to composing overarching themes. Reflection upon preliminary themes involves a process
of inductive thinking (i.e., intuiting), which facilitates reduction revealing essential themes
(Munhall, 1994). During this time, I presented my themes to two members of my dissertation
committee. Themes are considered essential when they reveal the essence of living with DT and
fundamental to the collected descriptions of living this experience (van Manen, 1990). Final
themes were validated by the qualitative methodologist in my committee and consensually
validated by all members of the dissertation committee. A phenomenological story illustrating
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the experience and meaning of living with DT was developed with overarching (i.e., main
themes) and sub-themes (Chapter 4, Results).
Structure of the phenomenological story.
van Manen (1990) suggested several strategies for developing and organizing
phenomenological writing, these include:

1) thematically (e.g., according to themes); 2)

analytically (e.g., description/analysis of a particular experience); 3) exemplificatively (e.g., use
descriptions and examples of other similar phenomenon), 4) exegetically (e.g., through the
thinking of another phenomenological author), and 5) existentially (e.g., weave descriptions with
the existentials of temporality, spatiality, corporeality, and sociality (van Manen, 1990).
Although van Manen asserted that the phenomenologist can utilize one, a combination, or
another structure, I organized the structure of story thematically. How I came to this decision
was the result of my ongoing reflection and interaction with the lived experience sources. As I
continued to write and reflect on participants’ experiences, it was very clear that they were not
only recounting their experiences, but also the story of their life.

From the beginning of

diagnosis with heart failure and deterioration, to living their new life with the LVAD, these were
stories – stories of a world only known to them.
As I continued to reflect on the lifeworld of these participants, the philosophy of
existentialism as described by Sѳren Kierkegaard (2000) came to mind. Kierkegaard (2000)
argued that we as individuals are the ones that give meaning to our lives. We decide what our
lives mean and how we want to live our lives – period. Considering my role as interpreter of the
lived experience, I decided to structure my phenomenological story as an existential biography—
which means that these participants have voiced about how they live their lives with a DT, and
what their life means to them. Although not a complete biography with all the details of their
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life history, the existential biography is a snapshot of their lives before and after being implanted
with a DT.
The existential biography that is presented in Chapter 4, Results, which represents the
culmination of van Manen’s research methods and activities which assisted in my interpretation
of the experiences of living patients and caregivers living with DT. With the help and guidance
of the hierarchical taxonomy and rich descriptions, I was able to construct this existential
biography that draws readers close to what life was like for these participants. While reading
through my interpretations, it was clear that we were given an initial glimpse into the world of
living with DT. Albeit a glimpse into a world in which we have only begun to understand.
Data Management
In order to maintain the privacy and ensure confidentiality of participants and all data
collection materials, all tape-recorded and transcribed interviews, and demographic data were
assigned a unique numerical code and placed in a locked storage cabinet which was only
accessed by me. I used a numbering system for organization of data into cases. For example, for
participant one, I entered “participant 001”on the demographic profile. I prefaced the taperecorded interviews as follows: “This is participant 001.” The interview note was labeled
“participant 001,” and so on and so forth for other participants. This was necessary in order to
keep all data organized and keep me on track of evolving questions.

The transcriptionist

removed all identifying names during transcriptions and replaced them with ‘name.’ I listened to
tape-recorded interviews and reviewed transcripts for accuracy and completeness of information.
In addition, data was stored on my computer which is password-protected, encrypted computer,
which was locked in a file cabinet in my home office when not in use. I exclusively maintained
the NVivo 9 database which is also located on my personal computer. The name and number of
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the participants were entered on a master list which is kept separate from the data. This master
list was located and locked in a separate filed cabinet in my home office and kept long enough to
perform the second follow-up telephone call. At the end of the inquiry, the data was kept for
future reference and the master list was destroyed.
Trustworthiness
It is necessary to demonstrate methodological rigor in qualitative studies in order to
ensure credibility (Sandelowski, 1995). To ensure rigor, Morse and Field (2002) recommended
building strategies into the phenomenological inquiry so that trustworthiness is evaluated on an
ongoing basis.

Strategies designed to enhance rigor included adherence to the overall

methodological approach of van Manen, and methods and procedures of the study. Additionally,
methodological rigor was enhanced by adhering to the four criteria for trustworthiness: 1)
credibility, 2) transferability, 3) dependability, and 4) confirmability (Lincoln and Guba, 1985).
Credibility.
Credibility confirms reliable findings (Lincoln & Guba, 1985). Triangulation of the data,
prolonged engagement, peer debriefing, and member check were strategies utilized to ensure
credibility. To address credibility, triangulation of the data included constant comparison of my
reflective journal entries, demographic profiles, taped and transcribed interviews, field notes, to
uncover the essence of living with DT. Second, prolonged engagement was demonstrated by a
thorough documentation of participant interviews, length of immersion with data, discussions
with dissertation committee members. Member check consisted of one telephone call performed
by me during second interviews to further elicit my understanding of the meaning of living with
and caring for someone with a DT and to confirm emerging themes.

While other researchers

(Morse, 1994; Sandelowski, 1993) report differing opinions with credibility of member checks,
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participants may change their minds about the experience, and/or may disagree with researcher’s
interpretation, Lincoln and Guba (1985) discussed that member checking is key to determining
credibility. Third, peer debriefing included an independent review of the overarching themes and
sub-themes by two members of my dissertation committee.
Transferability.
Transferability is the extent to which the findings of the study can be applied to other
studies (Lincoln & Guba, 1985). Determining transferability is the responsibility of the person
making a transfer (Lincoln & Guba, 1985).

Transferability was facilitated by utilizing a

purposive sample, providing details regarding the research context, and presenting thick
descriptions of procedures, findings, and underlying assumptions.
Confirmability.
Confirmability measures how well the results are supported by the data collected (Lincoln &
Guba, 1985). An audit trail was maintained by me and examined by the dissertation advisor to
determine confirmability. Audit trails are utilized to enhance validity of the study design and
outcomes (Sandelowski & Barroso, 2007), and allow other researcher to follow the decision trail
utilized by the researcher (Guba & Lincoln, 1990; Koch, 1995). The independent audit consisted
of a thorough examination of all documents obtained in the study and the procedures.
Dependability.
Dependability assesses the quality of the methodological procedures (Lincoln & Guba,
1985).

To address dependability, an inquiry audit was performed by a member of the

dissertation committee with qualitative expertise. Validation of research findings was confirmed
through a thorough examination of the research process, methods, procedures, findings, and
implications.
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Summary
This chapter described van Manen’s (1990) philosophy and methodology which guided my
phenomenological inquiry.

The six methodological research themes were described and

incorporated into the procedures of my study. The procedures are described. The chapter
concluded with strategies to ensure trustworthiness.
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CHAPTER IV
RESULTS
Chapter 4 presents the findings of a hermeneutic-phenomenological inquiry which aimed
to uncover the experience and meaning of patients’ and caregivers’ living with an LVAD as DT.
This inquiry aimed further to understand the inside perspective of living with such a lifesustaining device. This chapter is prefaced with a description of the sociodemographic and
clinical characteristics of participants.

Participant experiences are presented as an existential

biography and divided into three parts: 1) Patients with LVADs as DT, 2) Caregivers of patients
with LVADs as DT, and 3) Dyadic meanings.

Themes are organized around the research

questions posed for this inquiry. The chapter ends with a preface to chapter 5, Discussion.
Sociodemographic and Clinical Characteristics
Participant demographics were aggregated using descriptive statistics (e.g., mean, range,
standard deviation). Data were separated into participants’ as patients and participants’ as
caregivers (Table A4 & A5).
Participants as patients.
Patients were all retired White males, ages ranged from 71-76 years old, with a mean age
of 73 and standard deviation of 1.8, attained 13 or more years of education, and length of time
with DT ranged from 8 to 24 months, with a mean implant time of 12.3 and standard deviation of
6.0 (Table A4).
Participants as caregivers.
Caregivers were predominantly retired, White females (n = 1 man, n = 6 females), ages
ranged from 50 to 74 years old with a mean age of 65 and standard deviation of 8.3. (Appendix
A, Table A5). Each of the caregivers in this inquiry were actually a caregiver of the patients in
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this inquiry.
Part I: Patients with an LVAD as DT
Findings in Part I represent patients’ experiences and meanings of living with an LVAD
as a DT. Six (6) main themes, eight (8) sub-themes, and eleven (11) sub-sub themes where
constructed from the data and formed the foundation for an existential biography depicting the
essence of living with a DT: 1) Life begins to change with heart failure; 2) Learning to live with
an LVAD: An evolving process; 3) Adjustments and acceptance come with time; 4) Living
outweighs restrictions; 5) Hope for life through new technology, and 5) Thank the Lord. The
first three (3) themes illustrate patients’ inside perspective of living with a DT, and have
addressed the research question, “What is the experience of living with an LVAD as DT from
patients’ perspectives?” The later themes addressed the research question, “What is the meaning
of living with an LVAD as a DT from patients’ perspectives?”
In the beginning.
As patients’ sat before me in the private conference room, we engaged in cordial
exchanges throughout conversations, even shared beverages and snacks, while waiting for doctor
appointments, routine blood work, or diagnostic testing. As their stories unfolded, most patients
described a normal, full, active life before the onset of advanced heart failure. Responses such as
“I lived a complete, full life,” “I was a super active guy,” and “I was a guy that lived to fish and
hunt, see, and I liked to go camping and stuff like this,” were reported amongst the majority all
participants. Patients worked, played, and lived full lives on their own terms. It was the onset of
heart failure, however, that began the downward spiral of health and the beginning of what
seemed like the end to a familiar life.
Theme 1: Life begins to change with heart failure.
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This theme describes the world of patients with heart failure as they began treatments, the
progressive symptoms of shortness of breath and weakness, learning about the LVAD, and
described their determinism to live. Patients’ lives began to change when they were diagnosed
with heart failure. They were bound to a strict regimen of medications, diet, and exercise. Some
patients talked about being diagnosed with congestive heart failure after having a heart attack.
Others described treatments used and being managed with medications, intercardiac devices, and
even intravenous infusions to reduce the pressure on the left side of the heart. It was the
progressive symptoms of heart failure, however, that patients reported across the board. Five (5)
sub-themes were constructed to illustrate the changes experienced by participants: 1) Weakness,
shortness of breath; 2) Profound limitations; 3) On death’s door; 4) Hope for life through
LLVAD; and 5) Determined to live.
Weakness, shortness of breath.

As patients went on with their lives after being

diagnosed with heart failure, they described experiencing weakness, shortness of breath, with
any physical activities. Phrases used to describe this experience included, “I would get out of
breath pretty easy when I tried to do anything, and “I couldn’t walk from my house to the car and
I had to set to down to take a break.” One participant richly and succinctly described this
experience with even the smallest amount of exertion:
A couple years before the LVAD I was weak, couldn’t do much. Lightest, slightest
exercise I was short-winded. I had trouble walking from the living room to the bathroom
and the living room to the bedroom. Getting bad. And I mean it really winded me. And,
um, if I went down in the basement, I even had to stop half way down. And then when I
came back up I had to stop two times on the stairs, okay (Patient A, p. 10).
While patients struggled with these symptoms, the progressive nature of heart failure
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reared a ferocious wrath on their bodies and lives as they struggled to live their lives.
Profound limitations. This subtheme illustrates the experience of living with profound
limitations as heart failure progressed. As patients began experiencing the end stages of heart
disease (e.g.,) decreased end-organ perfusion, marked shortness of breath, and marked physical
limitations now overshadowed the activities of a once active and fulfilling life. Some phrases
used to describe this experience included, “ I came in, you know, with shortness of breath and
they had to wheel me in, I could hardly walk,” and “I couldn’t, you know, I was losing my liver,
my kidneys and this, and I couldn’t function, see. And they said this was it.”
The majority of patients eventually succumbed to a life of inactivity as this disease
progressed and seemed to ravage their very existence. One participant vividly described his
experience of being unable to do anything while he was in the end stage of heart failure:
I couldn’t do anything. And, you know, I’m sure that would bother people that like to do
certain things. But I had gotten to the point where I was so short of breath that I
couldn’t, you know, when I did something I was so short of breath that I stopped doing
things (Patient A, second interview, p. 5).
Some patients recounted that this progressive deterioration began approximately “4-5
months” to “a year or so before they received an LLVAD.” It was during this time that patients
unanimously began to fear for their lives.
On death’s door. Patients vividly recalled thoughts and images of death while living in
end-stage heart failure. Words such as scared, afraid, worried, and concern dominated phrases
describing their feelings. One patient talked to me about these emotions while engaging in a
face-to-face conversation. He stopped speaking for a moment, then, with a wide-eyed look and
stilled facial expression; he trembled while recalling these feelings during our conversations: “I
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was scared. I was one scared individual. Before the LVAD came into the picture, I was afraid I
was going to die. I had a feeling that I was not going to last long, and that’s not a good feeling.
I’ll tell you that, it’s not a very good feeling.”
Amidst ongoing thoughts of death and dying, patients knew they needed help. It was
during their search for relief, search for answers to relieve their progressive symptoms, that some
patients described a confirmation of their dreaded fears as they met with cardiovascular
specialists: that they didn’t have long to live. Some patients’ recalled that these specialists only
gave them less than a year to live: “I could stay, they couldn’t guarantee me six months later,
see. I might stay, and I might not.” It was during this phase that patients’ heard about the only
treatment option that was left for them – the LVAD.
Hope through the LVAD. Whether it was through a transferring physician or at
the implant hospital, it seemed that just when all seemed lost, the LVAD was their ticket to
life. Patients collectively described when they first learned about the LVAD. One particular
patient poignantly illuminated these feelings through his own words:
Well, anyway, I was, went in and I wasn’t sure I was going to see the day out of the
hospital when I went in January. And that’s when the great physician (name of city)
said to me, he thought there might be a little more tread on his tire. And that
was his exact expression. We got a little more tread on this tire, we’re going to get
you [to come] down to Ann Arbor and see if you would be a candidate for an LVAD.
(Audit Trail, Patient E, 1st interview transcript, p. 5)
Conversations with specialists filled their minds with hope for the future. It was during
these conversations that patients were informed of some rather unexpected news: they will never
be a candidate for a heart transplant because of advanced age. Some of them felt that they were
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victims of age discrimination at first. But as they continued to reflect upon their experiences, it
seemed as if they accepted the fact that they were never going to receive a donor heart:
You know, it really bothered me at first. Because, you know, when he said I was too old
for a heart transplant I felt that, you know, that was discrimination somewhat. Age
discrimination. And, uh, but you know, then I decided rules are rules and I have to abide
by them (Audit Trail, Patient A, 1st interview transcript, p. 11).
Feelings of being ineligible for a heart transplant, however, didn’t seem to dowse hope for these
patients.
Determined to live. In this sub-theme, patients spoke of their will to live. Given a poor
physical constitution and close brush with death, these patients’ were determined to live.
Whether it was for personal reasons or for their family, they described a determination to live, as
recounted by one patient:
But we were always talking, the family was always talking, uh, well let’s, we’ll go here.
Or we’ll go there. Or we’ll go to Cleveland or something, so I always had, no one bought
into well that’s it. Nobody bought into that philosophy. Everyone around me just,
including myself, well there’s other people in other hospitals so let’s look that over
before we resign ourselves to, uh, there’s nothing can be done. So that’s, that’s what got
me through those two rejections (Audit Trail, Patient H, 1st interview transcript, p. 8).
Patients’ now entered a new phase in their life – one that included having an LVAD
implanted in their body. Whether they were already an inpatient at U of M or were transferred,
patients’ had to be admitted pre-operatively for a battery of tests to determine eligibility for
implant. For the sample in this inquiry, pre-testing ranged from 7-28 days (7, 7, 7, 28; M = 12.2,
SD = 12.5). Some patients described being carefully ‘checked out’ before they were cleared for
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surgery: “They check you out pretty good to make sure you’re a good candidate. And, uh,
apparently I was because on February 9th I got my LVAD.”
This preoperative phase marks the close of the 1st theme of this existential biography and
a preface to a world only known to these patients’: the initial encounters of living with an LVAD
as a DT.
Theme 2: Learning to live with an LVAD as DT: An evolving process.
This theme illustrates the timeframe in which patients first received their LVADs, and the
immediate adjustments required to live with this device. Two distinct phases delineated this
evolving process: 1) The postoperative period, and 2) A time for discovery and adjustment.
Post-operative experience. The post-operative experience varied among patients. It
seemed that the severity of the symptoms prior to admission dictated post-operative recovery and
rehabilitation for these patients. The post-operative period, therefore, was experienced very
differently for the majority of them. Severity of illness was also exemplified by the duration of
hospital stay, which ranged from 14 – 120 days (14, 28, 28, 120, M = 47.5, SD = 48.8). During
this time-frame, patients individually described experiencing ICU psychoses, to having difficulty
adhering to the “strictures of being ‘micro-managed” in the hospital. Feelings associated with
this post-operative experience were also individualized and included frustration, depression,
anger and tired. For example, some patients described feeling ‘tired’ of anything and everything
that had to do with being in the hospital, as richly recounted by one patient:
I wanted, I was tired of the strictures of the micromanagement. And all the trappings
that go with it. You know, coming in your room every 20 minutes to do a blood pressure
check, medications, the medication regimen I was on. Drive line changes, dressing
changes, and this whole thing was just not what I really wanted to do. I just wanted to
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go home. Well, obviously I didn’t (Audit Trail, Patient E, 1st interview transcript, p. 8).
It seemed that during the recovery phase, about half of the patients described an almost
immediate sensation of improvement. One patient described this experience for us: “Well, I
guess what stood out, I mean I could tell, I just went two days after I put it in [the LVAD] how
much better I felt. I think that probably stood out more than anything.”
Patients eventually progressed through the immediate postoperative phase and were
discharged home. It wasn’t until they arrived at home, however, that they realized how their
lives were going to change.

The latter phase of this evolving process reveals a time of

adjustment and recovery — a time where patients unanimously described how they incorporated
the LVAD system into their lives.
A time of initial adjustment and discovery. This subtheme reveals some of the initial
struggles, realizations, and emotions surrounding the initial period of adjustments when patients
first came home. Eleven (11) sub-sub themes elucidated these patients’ experiences as they first
came home and as their new lives with the LVAD evolved: 1) Limitations with the LVAD; 2)
Carrying equipment can be uncomfortable; 3) Implement precautions; 4) Having a foreign
body; 5) Carrying around extra equipment; 5) Clothing challenge; 6) Being tethered; 7) Can’t
take showers or baths; 8) Have to have a caregiver; 9) Daily dressing changes; 10) Caregiver
does all driving; 11) Adjusting to IADLs with the LVAD, and 12) Limited sexual activity, were
constructed to illustrate this overarching theme.
Limitations with the LVAD. Patients unanimously described that living with an LVAD
imposed some limitations to a familiar life before the LVAD.

From being limited to

participating in sports, such as golf and hunting, to even activities around the house, patients
described being restricted from these activities.

Words used to describe these limitations
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included, “inconveniences,” “restrictions,” and “confinements.” One patient richly described
having to give up one of his favorite outdoor activities:
That’s my, my problem is because I, I went to do the sports and stuff and I can’t do
it, see. And, you know, I can’t go too far. I’ve got to stick around where, you can’t
just go up north for something like that, see, because you got, this has got to be working
all the time, see. So, you know, I used to go up salmon fishing and go up and put the
waders on and go out in the lake and I can’t do that no more, see. And I can’t do no ice
fishing anymore because that’s, I can’t get in water. It’s, it’s part of the restriction.
That’s about what it is (Audit Trail, Patient F, 1st interview transcript, p. 1).
Patients continued to talk about the imposing restrictions as interviews continued. These
limitations, or ‘inconvenience’ as described by patients are discussed in order of greatest to least
imposition of living with an LVAD.
Carrying equipment can be uncomfortable. This theme reflects the experience
of carrying around the LVAD system on their body. According to the majority of patients, the
biggest limitation to living with the LVAD was having to carry the LVAD equipment around
(e.g., batteries and controller). This meant having to wear the LVAD system attached to them
for the rest of their lives. Words and phrases used to describe the experience of carrying around
the batteries and controller were “uncomfortable,” “tiresome,” “feel the extra weight,” “pulling
on your neck.” For most patients, this was described as an uncomfortable feeling. One patient
further elucidated the experience of feeling tiresome with the equipment even though he had
it for almost a year now: “And its, you got to carry this 24/12 and it gets tiresome after awhile.
I’ve had it for, since December [almost 1 year] and it really gets tiresome of carrying that.”
Another patient described that even though the weight of the equipment wasn’t significant, it was
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still uncomfortable:
It’s just a difference of where, I only got two ways to wear the batteries, so, uh, but it
don’t sound like much but they're 3 pounds a piece, you know, and it just, uh, carrying 6
pounds of extra weight, you know, body weight, it’s like, 6 pounds can be
[uncomfortable] a little bit, you know what I mean, as far as carrying the weight (Audit
Trail, Patient B, 2nd interview transcript, p. 3).
One patient provided a living visual of what it was like to carry an LVAD around:
I’ve had it around my neck [now for] eleven months, and it’s part of me now, you
know what I mean? I would like to take it off my neck sometimes, but I can’t do it.
I’d like to set it down there and go over to the bathroom and take a shower, but you just
can’t do it, you’ve got to take it with you everywhere you go. It’s always got to be there.
You know how you carry a purse… When you go in the house, you [set yours] down, I
can’t do that (Audit Trail, Patient F, 1st interview transcript, p. 5).
An important aspect described by some patients was having to always remember that the
LVAD is permanently attached to you – that it is now part of your life. Patients described that it
was not only vital to remember that that you have this equipment attached to you, but to always
secure it before you make any moves. Here, I can remember the initial conversations with one
participant, and how he looked at me – eyes wide open, slightly leaning forward towards me and
pointing his right index finger in the air, as he described for me in a very serious tone, how
important it was to “grab your lifeline bag before you walk away”:
Uh, the carrying you have to always be aware that, uh, you don’t get up and walk
away with it, pull it off of a chair or off of a table. Uh, so you always have to be, no
matter what’s going on, how busy it is, or, or in the heat of an argument, you don’t
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get up and forget that you have that lifeline bag that you’ve got to have control of.
You know, you always have to, you always have to make sure you grab it before you
walk away (Audit Trail, Patient H, 1st interview transcript, p. 1).
Being aware of your surroundings and implementing necessary precautions was also an
important aspect of learning how to adjust with the LVAD.
Implement precautions. Implementing precautions while living with the LVAD was a
major highlight of the discovery and adjustment phase. As patients started adjusting to living
with their new device, they found that they were not only aware of having the device attached to
them, but were also more protective of it. For example, patients who were trialing the Heartware
LVAD described being careful and making sure the shoulder strap secured the controller. Other
precautions included just being aware of the LVAD itself, your surroundings, and how to protect
the LVAD. A constant vigilance of these precautions was described as having a whole new
responsibility for the LVAD:
Um, other than that, uh, it, it gives you a new respons – it’s like having a new baby.
You’ve got a, you’ve got a whole new responsibility that you didn’t have before.
You’re, I mean you could climb ladders and go cut Christmas trees and, uh, these things
are, uh, you just have to, you have to learn to, that you could endanger yourself if, if you
were reckless with the, with the charging bag and with the lifeline. That’s mostly it.
(Audit Trail, patient H, 1st interview transcript, p. 2).
Having a foreign body. When patients described the actual feeling of having the LVAD
inside their bodies, most of them didn’t feel it. Responses such as “I don’t notice it,” “the LVAD
doesn’t bother me at all,” and “actually, you don’t even feel it,” were general statements made by
patients. Generally, patients recalled feeling uncomfortable with the LVAD at first. There some
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nuisance described which occur to date, such as the external components “pinching,” or feeling
“uncomfortable with the wires in here, where they go it,” or even the “constant itching” under
the binder or from the tape. One participant succinctly summarized the overall consensus that
the LVAD is a part of you:
Well, you know, you know you acclimated to it to some degree. Um, but there’s always
pinch points and itching underneath, especially the binder, you know, just full grade
itching. Um, uh, the, uh, the cord gets stand out a little, reach in there the cords, the
battery cords and the drive line cord are, are kinking, you know. And, um, but, um, it’s,
it’s surprising how you get acclimated to it. To the weight, the positioning of it, you get
to the point where, I don’t know, it’s not in your conscience that you’re wearing that, you
know, it’s just part of you. (Audit Trail, patient E, 2nd interview transcript, p. 4)
Carrying around extra equipment. Patients also described the burden of having to
carry around an extra bag of batteries, controller, even the main power base unit if they had
to travel away from home.

They usually transported the extra equipment in a variety of

luggage-type equipment, similar to carry-on luggage.

Patients described this experience

however, as “confining,” and even “inconvenient,” and richly described by one patient:
“Well, you know, it’s not just this equipment that’s an inconvenience. We, when we
want to go someplace I have to take a battery charger and I have to take my night time
hookup. You know the batteries, when we go someplace.” Other patients even objected
to toting along extra equipment: “[the equipment], which weighs a ton, and I have to
manage that in this big travel case. I don’t like that. I don’t think it’s necessary, I really
don’t.” (Audit Trail, patient I, 1st interview transcript, p. 10)
As patients began to live their lives with the LVAD, they began to experiment with
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different types of clothes or gear designed to protect the outer components of the LVAD. This
was not only limiting, but challenging in itself.
Clothing challenges. Patients unanimously described a trial and error period of finding
comfortable outwear, or gear, designed to protect the external components of the LVAD. At the
forefront of getting dressed was using an abdominal binder to protect the driveline and keep the
dressing intact. The actual process of getting dressed, however, seemed to pose more difficulties.
As patients began to dress themselves, they described dressing as “a little more difficult,”
“challenging,” or even being aware of and more cautious of the LVAD while getting dressed, for
example: “I try to be very careful as soon as I get my shirt on, then I put the strap around my
neck so that it won’t fall out, and it’s just being cautious, that’s all.” One particular patient even
vividly illustrated the process of getting dressed every morning:
Linda: Describe that for me, how you get dressed.
P: This thing gets in the way when I want to pull my pants up past it.
Linda: The controller?
P: Yeah, the controller.
Linda: The controller gets in the way.
P1: Yeah, and then what I do is, is in some cases it’s easier for me to get the, unfasten
the belt and kind of scootch into the pants.
Linda: What is that experience like for you?
P: It was a pain, you know, in the butt. So to speak. At first. But then, you know,
it’s something that I got used to (Audit Trail, patient A, 1st interview transcript, p. 2).
Eventually, patients described “getting used to” or getting “acclimated to getting
dressed,” and even talked about finding the best clothing strategy for them: “So we’re pretty well
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settled on, um, on the arrangement, the clothing arrangement that works for me.” The other
aspect of clothing challenges included finding comfortable outwear to protect the external
components of the LVAD.
To protect the external components of the LVAD, about half of the patients described
using the shoulder strap and securing the controller [housed in a fanny-type pouch] with their
belt-loops and belt for extra protection. One particular patient described his procedure for
protecting and securing the external components of the LVAD:
And the only other thing that I do is, like sometimes when I bend over to get up, the
controller would swing out a little bit in front of me, and I didn’t like that, so what I did
was I just kind of rigged the belt and I put it through the handle, and I have the belt
around my waist, and so that’s just another precaution thing that I’ve done (Audit Trail,
NVivo nodes: patient D, 2nd interview transcript, p.3).
When patients were discharged from the hospital, they were provided with a vest, called
the GoGear, to house the external components of the LVAD. Many of the patients were not
satisfied with the design of this vest and continued trialing other options to house the LVAD
system. As the trial and error process continued, the majority of patients described finding
alternate ways to house the LVAD when they were more active, such as working outside or
engaging in social activities. They described other strategies used to secure these components,
such as “suspender harness,” or “shirts designed for police officers,” or even vests made by their
caregivers. Overall, patients seemed to prefer a fishing vest to keep the batteries and wires in
place. It seemed that this fishing vest held the components better than other strategies as they
engaged in outdoor activities, as described by one patient:
Now, the GoGear, actually it probably would have been better if it would have been the
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smaller size, but they did have a connection between the two halves, but only one, okay.
Whereas the fishing vest is a zipper, so it zips up. So it holds everything in one
place. And I don’t know why I didn’t think of it sooner. I would have, I think I
probably would have enjoyed golfing more than I did with the other equipment (Audit
Trail, patient A, 1st interview transcript, p. 6).
Being tethered. The fourth most described limitation was being tethered to the power
base unit. Patients collectively described being tethered at night. Before going to went to bed,
they described unhooking from their batteries and connecting to the power based unit at night so
they could sleep more comfortably without the batteries. Yet for most patients, being tethered
made them feel limited to a certain degree. Words used to describe the experience of being
tethered included “confined”, “limited,” and “you’re really in the scope, to the scope of the
cords, you know.” The major concern voiced by patients while being tethered was being limited
by the 20-30 foot power cable cord, as recounted by one patient:
You have to take out the batteries and disconnect them and then hook up to the
wall power for the night so that you can sleep more comfortably. And, of course,
once you do that you’re tethered and you’re limited by the scope of that cord. It’s about
25 feet. In my particular home it allows me to get in and out of bed and go to the
bathroom and get into my closet. But, midnight snacks are out. You cannot get to the
kitchen – at least in my home. Maybe that’s a good point, I don’t know. But you do feel
confined. It’s a confining feeling, a confined feeling, when you’re on the wall power
because your mobility limited (Audit Trail, patient E, 1st interview transcript, p. 3) .
To reduce the confined feeling and enhance mobility, half of the patients talked about
switching to the battery packs as soon as they could: “when I’m on battery, I’m quite mobile
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when we’re out wherever we want to go, really.” Given restrictions and limitations illustrated
thus far, most patients recounted that not being able to take a shower was a major limitation to
living with an LVAD.
Can’t take showers or bath. Patients cannot take a shower for at least 6 months after
LVAD implantation to promote healing and prevent infections. After this 6 month period,
patients can opt to shower with a shower bag or kit. This kit holds the external components of
the LVAD. This shower kit is only available for those patients who have the 2nd generation
LVADs, not those who trialing the newer 3rd generation LVADs. For those who have used the
shower kit, phrases to describe the showering experience were straightforward and included,
“Well, it’s a lot easier to shower without this equipment.” One patient described for us the
experience of showering with a shower kit:
I did it two different ways. I have a shower kit and you can either do it with batteries or
you can do it with the tether. And I’ve tested both ways and I like showering with the
batteries in the shower kit rather than hooked up to the tether because the tether gets in
the way in the shower. Actually, it’s not, like I say it would be easier to do without the
equipment, but it’s not that difficult once you get used to it. I’ve got a routine, you
know, my routine changed in the shower (Audit Trail, patient A, 1st interview
transcript, p. 2).
Although patients described taking longer time to take a shower, it seemed like it became
part of their routine as they adjusted to the LVAD. This routine, however, poses another
limitation in many ways – that is, having to have a designated caregiver.
Have to have a caregiver. Before patients are implanted with an LVAD, they must have
a designated caregiver and one or more back-up caregivers. Caregivers are spouses, sons,
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daughters, or even friends who have accepted the responsibility of caring for the LVAD patient.
These designated individuals are instrumental in promoting the health and well-being of LVAD
patients as they assist with the patients’ recovery and beyond. Roles and responsibilities of
LVAD caregivers include assisting patients with their activities of daily living, LVAD system
maintenance, even staying with the patient. Two of the biggest caregiving responsibilities
recounted by patients in this study is the caregivers taking over the driving and performing daily
dressing changes.
Daily dressing changes. To date, daily sterile dressing changes are recommended for all
LVAD patients. In many cases, patients are unable to perform dressing changes independently
because of the position and insertion site of the driveline (e.g., either right, left or mid-abdominal
area, usually above the umbilicus). This experience was described by a patient: “My wife, my
caretaker, she takes care of the lifeline dressings and, um, I don’t, uh, I don’t do that. I can’t do
it the way it’s located. I could do it with a mirror but I’m not sure I could work backwards.” In
addition, those who perform the dressing changes must don sterile gowns, gloves, mask, and
prepare a sterile field with equipment. Patients may have difficultly maintaining a sterile field
during dressing changes.
Maintaining the integrity of the patient’s driveline, however, was collectively described
as an integral role of the caregiver. Phrases used to describe the caregiver performing dressing
changes included, “And she handles the bandages,” “so she does the sterile dressing changes,”
and “my wife, she, uh, she changes dressings everyday with it.” One patient succinctly provided
a visual on how the dressing change was not only performed, but that it only took a few minutes
out of the day: “It’s easiest for me to lay down in the bed and [caregiver] will bring out all of the
pads, the soaps, and different things, and we’ll get it all straightened up, and in a matter of less
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than 10 minutes, why, we’re…I’m back in business.” (Audit Trail, patient I, 2nd interview
transcript, p. 9). Most patients’ didn’t elaborate on the actual process of the dressing changes, but
did talk about another limitation that appeared more difficult to accept: not being able to drive.
Caregiver does all the driving. Patients with LVADs are not allowed to drive. Reasons
include equipment malfunction, controller failure with required change out, or batteries losing
charge and eventual equipment shutdown. In the process, patients may experience a temporary
loss of consciousness as blood may not circulate properly through cerebral arteries. Given these
possibilities, designated caregivers must drive patients everywhere.

For this reason, probably

more so than others, LVAD patients must always have a designated driver. Many patients,
however, did not like the fact that they were unable to drive. Words and phrases used to describe
their feelings included, “terrible,” “you’re an imposition on your spouse, caregiver,”
“frustrating,” and “it’s a great loss of your independence. One particular patient painted a vivid
description of his feelings about not being able to drive:
Oh, I don’t…like it. I don’t like it a bit because I have drove for 50 years or more, and
I’d get in the car and go. But I can’t do it. And I have a hard time, you know, there’s
some stuff I’d like to do by myself, but I can’t do it because I can’t drive, see? You
know, sometimes I’d just get in the car and go fishing, and I can’t do that now because I
can’t drive. She drove with me, but I used to do…once in a while go out by myself, see.
And I just can’t go, you know, to the sporting good store or something like that because I
can’t drive. (Audit Trail, patient F, 2nd interview transcript, p. 2)
Just like the patients recalled how they integrated the LVAD into their basic activities of
daily living (ADLs), the next sub-theme reveals the required instrumental activities of daily
living (IADLs) necessary to promote health, well-being, and safety while living with this device.
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Adjusting to IADLs with the LVAD.

This theme delineates the ongoing adjustment

phase in which patients talked about the care and maintenance of the LVAD, or LVAD-specific
IADLs. Some of the LVAD-specific IADLs patients talked about were maintaining a daily log
of LVAD system readings and performing daily vital signs. Patients are required to document
daily readings found on the display of the controller [flow and pressure readings], vital signs
(e.g., temperature, blood pressure, pulse), and daily weights. One patient richly described for us
this experience shared by others in this inquiry:
First thing up is, what I do, is to start my regimen of taking numbers off of the
control unit, that is the…for my daily log, um, which includes four numbers from
the controller, what the call the TI flow and the tower, and then the RPM, and
[then] take a blood pressure, and while I’m doing the blood pressure, I’ve got a
thermometer in my mouth, and I get my temperature, and then, when I get
through those, I check my machine [for the readings and] will get done with all
that. I get myself weighed, just pull out a scale and jump on the scale and get my
weight, and that completes the log (Audit Trail, patient I, 2nd interview transcript, p.
1).
The other LVAD-specific IADL includes changing batteries. Due to improved battery
technology, the longevity of the batteries for LVADs has increased from 2-3 hours to over 17
hours in most cases. Patients, however, must remain vigilant about the status of their battery
charge at all times and making sure spare ones are fully charged. Although patient phrases
related to changing the batteries were fairly limited to “change the batteries,” one particular
patient poignantly described the experience of what it was like caring for the batteries: “Caring
for it is just a matter of always being ready with your batteries and knowing how long the

122

batteries last, and when an orange warning light comes up how much more you’ve got before the
red change light comes on.” (Audit Trail, patient H, 1st interview transcript, p. 1). Another
LVAD-specific IADL described by patients was emergency preparedness.

Individualized

strategies for emergency preparedness were described amongst most patients. They talked about
various strategies, such as keeping emergency numbers with them, having instructions on how to
change the controller, even carefully watching caregivers’ performing dressing changes so they
could inform others on how to do it if necessary. Phrases describing emergency preparedness
included: “And I keep them close by in case I do have any alerts or something so I can look up.
And also, the numbers to call the LVAD unit and so if I have any problems,” and “...you need a
flashlight. Make sure you have a flashlight handy. At your bedside to help you through the
darkness of an occasional power failure.” (Audit Trail, patient E, 1st interview transcript, p. 4)
Limited sexual activity. Participants’ in this inquiry mutually described having very good
relationships with one another.

For example, patients described relationships with their

caregivers as “very good, very good – we are very compatible,” “It’s a pretty good relationship,”
“I would say it’s excellent. Yeah, we’re very happy. Very content. We’re still in love.”
Caregivers’ responses mirrored patients’ as they talked about their relationships with responses
such as, “It’s great,” “we have a real good relationship. Yeah, I, he doesn’t argue much,” and “I
think we have a good relationship. I always thought that we were very, very close, and he was
always my best friend.”
With our minds full of vivid and rich descriptions of the experience of living with an
LVAD, theme 2 comes to a close as patients continue to live with DT. The next theme of this
experiential biography illustrates more reflective responses which further shape our
understanding of living with this device.
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Theme 3: Adjustments and acceptance come with time.
Theme three (3) represents the culmination of the collective experiences of patients who
reflected upon their initial experiences and fast-forwarded their lives as they see it now. Patients
recalled that they eventually got used to the LVAD attached to their bodies, including carrying or
toting around the extra equipment. Phrases describing this experience included, “But, you know,
actually, it’s not as difficult now as it was a year ago,” “you get used to it,” highlighted these
experiences. It seemed like patients just got used to not only carrying around the device, but it
also became a part of their lives. One patient provided a thick description which for him, was
overwhelming at first, but eventually accepted the device as part of life:
Well, when you first go home like, it’s just like any other recovery time. Except that,
I’m going to say burden, but it’s not now, but at first the burden of, of this, of this
bag attached to you forever, it’s kind of a little overwhelming for a while. But, just
like anything, you actually grow out of it, you don’t, well, that’s just the way it is.
Just think of people that, uh, have amputees, that’s the way it is. You have to live
with whatever they deal you.” (Audit Trail, patient H, 1st interview transcript, p. 5)
As patients reflected upon how they accepted this life-sustaining device as necessary to
live, most of the patients’ talked about the length of time it took to actually feel comfortable
with the LVAD. The general timeframe for the sample of patients in this study ranged from 7
days (e.g., 1 week) to 365 days (e.g., 1 year) (7, 60, 152, 182, 365, M = 189.7, SD = 127.8)
[Length of time was calculated in days].

It was within these timeframes that patients

unanimously described a period of enhanced awareness of physical capabilities and ongoing
strength as time went on. For many patients, this period also revealed a return to a normal life
known to them. These reflective thoughts were elucidated through the following sub-theme,
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Improved quality of life.
Improved quality of life. Patients collectively verbalized that their overall quality of life
improved after LVAD implantation. Phrases used to highlight this theme included, “I am going
to enjoy, I have a better quality of life,” “You’re able to do things. Um, I don’t know how to
describe it really,” and “my quality of life is, is improved substantially. And, uh, I am back.” To
help us understand what life was like before and then after receiving the LVAD, patients’ voices
collectively painted a vivid picture of their lives what life was like before the LVAD.
Improvements in physiological dimension of quality of life included overall well-being and
functionality were described by the majority of patients.

For example, one patient richly

described for us how his overall well-being and functionality improved after the LVAD:
But now I just gradually started getting, you know, my strength back more and walking
and I have been feeling pretty good. So, uh, in that case I’m much better than I was
before I had it put in, because, um, I mean now I can go to the grocery store pretty much
do all the shopping I want to do and even go more besides if I want. If I have to stop at
another store to get, or something like that, I can do that too. (Audit Trail, patient B, 1st
interview transcript, p. 2)
Another patient described a similar experience of improved functionality after the
LVAD:
And I’m getting to do more than I was before I got it, see? I was just [barely able] to go
and get up in the car. And I get outside now and walk around awhile and stuff like that,
see? I go to my son’s place and walk out in the woods or something, and come back.
And I couldn’t do this before, and that’s part of the good points to it. (Audit Trail,
patient F, 2nd interview transcript, p. 3)
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Improvements in the psychosocial dimension of quality of life were also described by
patients.

Whether shopping, socializing, or enjoying fishing in a pontoon boat with their

families, patients were once again able to get out and enjoy their lives. One patient illustrated
how their social life improved after living with the LVAD:
P1: Well, like I say, I mean especially now that I’m feeling better again, it allows me to
go out and do the, you know, do some more things. You know, eat out somewhere, you
know I wasn’t doing that before I had it put in because I didn’t want to go, and I couldn’t,
it cut down a lot on my socializing because I just, sometimes I’d get too tired to go out,
you know, to get together with anybody and I didn’t want to ruin anybody else’s plans by
having to cut, cut everything short because I got too tired or whatever, you know.
(Audit Trail, patient B, 1st interview transcript, p. 2).
This experiential biography proceeds while leaving us with memories about how
patients’ lives improved and how they appeared to reclaim their lives back. Themes presented
thus far illustrate patients’ emic perspective of living with a DT, and have addressed the research
question, “What is the experience of living with an LVAD as DT from patients’ perspectives?”
The final three (3) themes represent the meaning of living with such a life-sustaining device and
answered the research question: “What is the meaning of living with an LVAD as a DT?” 1)
Living outweighs restrictions, 2) Hope for life through new technology; and 3) Thank the Lord.
Theme 4: Living outweighs restrictions.
For the majority of patients, limitations imposed by the LVAD were minimal once they
realized what the LVAD meant to them - they were living. For many patients, talking about this
experience seemed to make them feel alive. The overall consensus was that, yes, the restrictions
were limiting, inconvenient, and restrictive, but, it also has enabled them to live. Phrases chosen
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to describe the meaning of living despite limitations included: “Yeah, it’s just a miracle. When
I, how did it save my life for the better. Not that it doesn’t have its little hang-ups and little
inconveniences, but it’s so worth it. That’s all I can say about it, it’s so worth it,” and “I never
thought much about it, having [it], it’s just that it helped me, and I wouldn’t be here if wasn’t for
the device.”
One particular patient further clarified the meaning of this theme by describing the
restrictions of having an LVAD as a negative, and being able to live as a positive:
Uh, it’s got, uh, a positive and a negative, see. I’m glad I got it because I’m still alive.
And without it I, you know, I would like to be able to do what I used to do and I can’t,
see. And it’s got the positive and a negative. I can’t do what I want to do but I’m glad I
got it because I want, I need it to live, see. (Audit Trail, patient F, 1st interview
transcript, p. 1).
It was the words of the following two patients that seemed to capture the meaning of
having a DT. Here, the first patient describes for us how he “traded” the LVAD for life:
I did a trade off. Uh, you know, uh, to the hospital, I was in four hospitals for 75 days.
And, uh, 2 of the hospitals just told me they could not do anything, and, uh, until the last,
when (name of hospital) told me there’s nothing they could do because the risks were too
high, my cardiologist down there, he says, well, I know who can help you. And he
says U of M has an excellent program. So, so I got a bag [LVAD] and I didn’t have
to go home and go on hospice. (Audit Trail, patient H, 1st interview transcript, p. 2).
Despite DT being described as ‘cumbersome’ to some degree, this particular patient
stressed that LVAD-specific IADLs were not only necessary to live, but also didn’t “bother him
anymore”:
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Linda: Cumbersome. You mean by?
P: The whole thing. You know, moving equipment around and taking all the data
down every day. Having the dressing changed and all that stuff. The whole package
I’ve talked about is cumbersome. Makes me do things that I hadn’t done before. But,
it’s all for the good, for the better. And it’s something I decided, if I wanted to stay alive
I had to live with this. It doesn’t bother me much anymore. (Audit Trail, patient A, 1st
interview transcript, p. 3).
Amidst reflections of life with a DT, there appeared a ray of hope that echoed throughout
participant stories: hope for life through new technology.
Theme 5: Hope for life through new technology.
This theme illustrates hope of living as new technology becomes available. For many
patients, they had already experienced lost hope before the LVAD. This device brought hope
where there once was none. It is this sustaining hope that continued to fill the hearts and minds
of these patients as they go on with their lives with a DT. For example, phrases used to illustrate
this theme included: “I’m hopeful that I can live long enough with what I have to have another,
to another, to another technological breakthrough that might offer me other options. Maybe I
won’t, but I’m not giving up,” and “I’m sure it can fail, I imagine, sometime and with technology
they got, they’ll have something they can replace it with. So, I don’t have any, uh, qualms
there.”

Patients appeared excited and looked forward to being future recipients of new

technology, as vividly described by two patients:
P1: But, uh, seven to ten years, or whatever the life expectancy of this particular device, I
would think by the time I’m ready to change the technology will be so advanced that this
will probably be in a pocket and that you just put it in your pocket. So, actually looking
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forward to those kind of advances. (Audit Trail, patient H, 1st interview transcript, p. 5)
P2: I got to talk to somebody today about stem cell. That went out over the news last
night, about stem cell research on hearts. So, I’m assuming that I will be one of
first candidates…I’m kidding.

the

Um, but boy, I sure as hell would like to try. (Audit

Trail, patient I, 1st interview transcript, p. 1).
As hope for continued life through new technology echoed throughout patients’ voices,
the final theme represents a spiritual gratefulness and gratitude for receiving the LVAD.
Theme 6: Thank the Lord.
While patients reflected on their lives with an LVAD as a DT, “thanking the good Lord”
was an overall sentiment expressed. Phrases such as “praise the Lord I have to say now,” “it’s a
Godsend,” and “I thank the Lord every morning,” were almost joyously exclaimed as patients
recounted how grateful they were to have this device. One patient shared a poem that he wrote
for his 50th wedding anniversary, titled “Thank you Lord, for This Great Day:
Thank you Lord, for This Great Day.
Thank you for all the good things and times along the way.
Thank you Lord for every friend,
May those friendships never end.
Thank you Lord for daughters and sons,
Thank you for all their little ones,
Thank you Lord for sisters and brothers,
Thank you for fathers and mothers.
A mother who said her boys didn’t fight,
But what were they doing out of her sight!
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Thank you Lord for the HeartMate Pump,
It got me up and off my rump!
Thank you Lord for this great life.
Thank you for a wonderful wife.
A wife who seldom got mad.
Threw a slipper once,
Thank you Lord, her aim was bad!
I think this is all I have to say,
Except thank you, Lord, for this great day! (Figure B15).
As with this patient and others who have expressed their gratitude for the opportunity to
have this live-sustaining device, a brief period of silence prefaced by tears of joy, smiles, and
soft bouts of laughter seemed to still the space that was once researcher and participant – a space
now filled with understanding of how much living with a DT means to these participants.
Patients were thanked for their amazing stories and willingness to relive all experiences as
interviews came to a close.
Summary
Part one of this existential biography illustrated the essence of living with DT from the
voices of those who are living with this life-sustaining device. This summary is complimented
with a pictorial summarization illustrating the health and wellness trajectory for patients before
and after receiving DT (Figure B16).

I now turn to the world of those have watched,

experienced, felt, and hoped for those they loved living with DT.
Part II: Caregivers of Patients with LVADs as DT
Part II of this existential biography presents caregivers’ experiences and meanings of
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caring for someone with a DT. Five (5) main themes and nine (9) sub-themes, where constructed
from the data and formed the foundation for an existential biography depicting the essence of
living with a DT: 1) Advanced heart failure is a life changing event; 2) Self-doubt about LVAD
caregiving improved overtime; 3) Lifestyle adjustments come with time; 4) Persistent worry and
stress; and 5) Caregiving is not a burden – it’s part of life. The first four (4) themes illustrate
caregivers’ perspective of caring for someone with DT, and addressed the research question,
“What is the experience of caring for someone with a DT?” Theme 5 addressed the research
question, “What is the meaning of caring for someone with a DT?”
The setting of caregivers’ interviews mirrored patients’ – a quiet, comfortable conference
room at the CCs with exchanges of introductions and pleasantries before commencing
interviews. I encouraged caregivers to keep their cell phones turned on in case the patients
needed them or were called in for their appointments. As caregivers stories unfolded, there
appeared to be a more serious tone expressed throughout conversations – a tone I eventually
understood as they cared for their loved ones with DT.
Theme 1: Advanced heart failure is a life changing event.
Similar to patients’ experiences, caregivers spoke about leading active, full lives with
their loved ones before the onset of advanced heart failure. From taking “wonderful vacations
and trips,” to enjoying personal time, they talked about leading happy, active lives with their
loved ones. One particular caregiver richly described a full active life before DT came into play:
Um, what was it like before? I think we lived, um, in that great spot. I think we’d
probably been happier than, you know, most of the time you’re the kind of people, you
get up, you’re busy and especially my husband. He got up every day and was busy. Um,
went to work, wrote plays, or did his errands, or, spent time with me. And we just lived
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quite full active lives. (Audit Trail, caregiver E, 1st interview transcript, p. 2)
It was the onset of heart failure, however, that began the chain of events which changed
life for many caregivers. Most of them described periods of difficulty [which spanned nearly a
decade] as they managed the “ups and downs” of advanced heart failure. This experience was
recalled by a caregiver:
C: “Um, well probably for the past ten years, it hasn’t been, you know, like it should be
‘cause he wasn’t feeling that good,” and...‘cause this started, like I told you, ten years
ago. When we… when we were in the head-on collision, and along came the [LVAD].
But it’s just been steady hospital for the past ten years. From one thing to another. [The
accident,] the heart attack, when he had his back surgery. It destroyed his heart. (Audit
Trail, caregiver F, 2nd interview transcript, p. 2)
Caregivers gave voice to the immediate period before LVAD implantation and how
quickly patients deteriorated as heart failure progressed. Words and phrases used to describe the
physical status of their loved ones included “getting weaker,” “getting quite weak,” and “getting
really, really weak.” It was during this time that caregivers individually spoke about seeking
help for patients, or even taking on all the responsibilities of IADLs because patients were too
sick. Some of them even described a reversal of roles as their loved ones continued their
downward spiral. For example, some caregivers started doing all the work around the house and
took over driving since patients were too weak to do any activities:
Um, but I, but I was doing a lot of the work because he was so sick that he couldn’t
do it. We built a house when he was sick, and, um, our kids and I – he’d, and he’s
always done that type of work and he couldn’t and that was what was so hard, was that,
you know, I ended up stepping in and doing that. So, you know, I was used to doing
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things. I had done that. I mean, I went out and shoveled the snow, I did a lot of the stuff.
(Audit Trail, caregiver A, 1st interview transcript, p. 7)
Caregivers feared for their loved one’s lives as they continued to search for help. Many of
them knew that life was limited for their loved ones and that they needed help. One particular
caregiver bravely recounted the precise moment she felt her husband was going to die. Her
voice became very low, while hiding back tears. Sniffles preceded almost every word as she
looked off into the distance, almost as if she was reliving this experience:
“...what it’s like to say goodbye because you know your husband’s dying.

Its

interest, I thought it was interesting because there’s not a whole lot you can say
to each other. There’s only a few things, you know, you just say to each other,
it’s been a wonderful life and, um, I don’t want you to go and, um, um, I don’t
know, it’s not real, definitely not out of the books or magazines, you know. Uh,
love story, you know, even though we love each other very much and we have a
great relationship, but, you know, sit in a room at the doctor’s office and you don’t
know if that’s the last time he’s going to be hospitalized. You just hold hands
and say it’s been wonderful (Audit Trail, caregiver E, 1st interview transcript, p. 3).
It appeared that at this moment, caregivers experienced a feeling of helplessness for their
loved ones. Just when all seemed lost, they heard about the LVAD. This theme was further
elucidated by the sub-theme, Hope for life renewed, as caregivers described a flickering ray of
hope for life.
Hope for life renewed. Once caregivers learned about the opportunity for a chance to
live, they expressed feelings of hope and determinism for another chance at life.

They

unanimously recounted the experience of learning about the LVAD and how it provided hope
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and the opportunity for life, as described by this participant: “I think it, uh, you always hope that
things will, especially with the U of M and all the new things have come out medically. I felt
that when they explained this LVAD, that this would be an answer to sustaining his life a little
longer.” Amidst feelings for hope for life, caregivers seemed relieved that there was finally help
for their loved ones. For example, one caregiver richly describe for us the feeling of hope
revived as they learned about the LVAD:
So we’re in the hospital room and there’s, you know, you don’t know what’s going to
happen. And this one particular doctor came in and, um, started, he was like a, we call
him our Angel because he had the best, um, bedside manner. Dr. ----, came in, did the
reports, talked about professions, you know, what do you do for a living and so now
you’ve got two equal men talking to each other. And, um, in the conversation the
doctor said I think we can go down that road. And I said, ‘is there more road to go
down?’ We didn’t know. And, um, he gave us a few more [details about] things and
then he said, I think there’s more tread on those tires. And, um, and I believe that he’s
the doctor who said “what about an LVAD.” So, it’s like this doctor was so, um, such a
[God-send] and, when he said there’s more road to go down, (husband) shed a tear in the
room and I slept. Because of what that one doctor said. And so we knew there was
hope and within about 48 hours he was down here. (Audit Trail, caregiver E, 1st
interview transcript, p. 5)
We leave the first theme of caregivers’ existential biography with a better understanding
of the initial struggles and feelings of hope for life as caregivers embark upon a new, but
uncertain journey. Whether their loved ones were transferred or admitted to the hospital for preoperative testing and eventually surgery, the next themes represent a plethora of mixed emotions
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of fear, doubt, and worry, as they come to realize what caregiving for a patient with DT entailed.
Theme 2: Self-doubt about LVAD caregiving improved overtime.
While patients were hospitalized, health care professionals, including nurses, spoke to
caregivers about their new roles and responsibilities as DT caregivers. Initial thoughts and
feelings brought them back to the memories of watching their loved ones struggle to live. While
recalling these experiences, the majority of them “burst into tears”. Words and phrases used to
describe these feelings included “scary,” “overwhelming,” and “anxiety-producing.” Feelings of
hope transformed into feelings of self-doubt and fear as the realization of making a life-long
commitment as designated caregiver became an overwhelming experience: Phrases used to
describe self-doubt included, “Could I do it?,” “I can’t handle this,” and “...am I going to be able
to do this.” Caregivers poignantly described their experiences when they first learned about their
new responsibilities, for example:
Um, you know, we’re going to have to learn how, how to maintain it and everything.
And, um, it was a bit overwhelming. But it was something we knew we had to do and so
it really, there were moments that I was really concerned, could I do it? That was kind of
scary. In the beginning, scary I’d say it was. (Audit Trail, caregiver D, 1st interview
transcript, p. 4).
Caregivers began to learn about caring for the patient and the LVAD system as patients
entered the postoperative phase. It was during this time that caregivers spoke about ongoing
stresses as they learned to care for their loved ones. One sub theme shed light on how caregivers
strove to overcome self-doubt and armed themselves with the knowledge to care for their loved
ones.
Learning to care all over again. The majority of caregivers spoke about their LVAD
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training experience in the hospital. Care including learning about the LVAD system, such as
device maintenance, trouble-shooting and emergency procedures. One of the biggest challenges
described by caregivers was learning how to do the sterile dressing changes. Fear, nervousness,
even self-doubt were felt by caregivers as they learned how to perform dressing changes. It
appeared that they were more ‘nervous’ in front of health care personnel, as recalled by one
caregiver: “I think I was more nervous when we were in the hospital, and we would change the
dressing everyday in the hospital with the nurse, you know, watching me.” Similarly, other
caregivers reported feeling uncomfortable in front of the nursing staff as recounted by another
participant: “And, you know, of course they wanted me to do it for training, you know. I just
didn’t, you know, and maybe it was because people were watching me. Or maybe it’s because
I’m supposed to perform.” One particular caregiver richly described feeling overwhelmed and
how the nursing staff promoted and instilled confidence to learn:
Linda: Tell me about the experience of doing the dressing change. What’s that like
for you?
C: At first it was overwhelming. I didn’t think I could do it. I really didn’t. I mean, it
was, that was, you know, it was scary for me. And probably part of, I never wanted to be
a nurse. I, you know, that was not my calling, so I didn’t even think I could
do it to be perfectly honest. When they first told me I was like “I can’t do that” you
know. And then they explained to me, like, yes you can. It’s like getting a new
baby. You know, you learn how to take care of them step by step and then it’s just part
of the routine. And that’s really the way it was. (Audit Trail, caregiver A, 1st interview
transcript, p. 9)
Similarly, another caregiver vividly recalled these initials fears which eventually subdued
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with time:
And then, ‘oh, you’re here, okay good, well, you know, we’re going to have you trained
here and we’ll do that tomorrow.’ And of course, that is anxiety producing because
you’re being trained on something that’s brand new and in the medic – when you’re not
a medical person it’s not only very new, it’s terrifying, life and death at that point. Now
it’s quite simple and you wonder what you were up tight about. But, and then, being
trained to do the drive line dressing. I remember clearly having this desire to run.
Thinking in my mind, um, how if you didn’t like your husband, this would be one heck of
a time to go. And again, because it’s given to you very intensely, you know, all sterile
and you’re being trained very specifically. And you’re just thinking, am I going to be
able to do this. Um, and of course, it’s a very simple thing to do now, but at the moment
it’s quite frightening. (Audit Trail, caregiver E, 1st interview transcript, p. 6)
As patients recovered and LVAD training in the hospital was complete, it was time to go
home. Discharge home signals the close of the 2nd theme and precedes the transition home for
caregivers and patients. It was during this transition and beyond that caregivers met face to face
with their new roles, responsibilities, and lifestyle modifications required to care for someone
with a DT.
Theme 3: Lifestyle adjustments come with time.
This theme marked the transition and initial phase of adjustment for caregivers as they
managed their new roles and responsibilities. It was during this phase that they described a
plethora of responsibilities and lifestyle modifications necessary to care for a patient with DT.
This theme was further explained by seven (7) sub-themes: 1) A reversal of roles, 3) Personal
interests on hold; 3) Keeping it normal; 4) Doing all the driving; 5) Dressing changes; 6)
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Increasing independence after LVAD, and 7) Move forward.
A reversal of roles. The majority of patients required a lot of assistance when they first
came home and throughout recovery and rehabilitation. Roles and responsibilities of caregivers
included performing ADLs such as bathing and dressing. Since patients are unable to take a
shower or bath, most caregivers described having to bathe the patient when they first came home
and to date. Some of them said they had to dress the patient in the beginning, as described by
two caregivers: “It took us two hours to get him dressed in the morning, and I was, you know,
helping him and, you know, he was confused at times putting his clothing on. And, you know,
do I got suspenders first, or am I going to put it underneath or over,” and “Pretty much it was
helping him with dressing and that, in the beginning, at the very beginning. Caregivers also
individually described performing many of the IADLs, such as household chores, cooking,
cleaning, running errands, paying bills while their loved ones recuperated. Words and phrases
used to describe that caregivers performed many if not all of the duties included at the very
“everything,” “I did everything,” and “I would do everything at home, everything that (name)
used to do.” One caregiver richly described the experience of role reversal as her husband
recuperated:
Linda: What are some of the other things that you had to take on?
C: Well, at first, when he first came home from the hospital, um, everything.
Everything, you know. You pack the bags and you load the bags in the car. And
you, you do everything at first. And you drive. Our life was I pack my bags, he threw
them in the car and he drove. And that, so, you know, that maybe typical male/female
relationship, um, changes a little bit. (Audit Trail, caregiver E, 1st interview transcript,
p. 8)

138

Other activities included performing LVAD-specific IADLs, such as daily monitoring
and maintenance, performing vital signs, changing batteries, even describing emergency
procedures they had in place.
Seeing these patients in a state of dependency sparked many feelings and concerns
amongst caregivers, especially younger caregivers.

In some cases, it was necessary to make

some personal lifestyle modifications in order to care for the LVAD patient.
Self- interests on hold. Generally, most caregivers spoke about giving up some hobbies
or personal activities while caring for the LVAD patient. It appeared, however, that some of the
younger caregivers feared that their life was going to completely change. Younger caregivers’
(e.g., 50, 61, 62) thoughts of losing their freedom were replaced with thoughts of being stuck in
the house caring for their loved ones. One caregiver specifically described being scared that she
would never be able to get out of the house. As she talked to me about this experience, she
started to tremble – she looked at me with tears in her eyes, face flushed red, and sat very, very
still. She looked at me with her eyes wide open, barely blinking:
I mean, I still was scared about him coming home, and what it was going to mean.
Was I ever going to be able to get out of the house, you know, just to leave…like, I
would like to work out everyday, and I thought, “Am I not ever going to be able to
do that again?” You know, is my whole life going to change totally? So, scary. (Audit
Trail, caregiver I, 1st interview transcript, p. 1).
Another caregiver described a similar experience of not having as much free time
anymore:
I’m not resentful, um, it can get tiring, um, play, I wish I had more opportunities to go
laugh and play. I can remember the times where, um, you know, after the intensity of it
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all, and just going someplace for three hours and maybe, and realizing, oh my God, I just
had fun. You know, I just laughed because you get so wrapped up with it all. (Audit
Trail, caregiver E, 1st interview transcript, p. 9)
Amidst adjusting to these lifestyle modifications, another role articulated by caregivers
was striving to maintain a normal life as possible for patients.
Keeping it normal. In this theme, caregivers unanimously described how they tried to
maintain normalcy for patients living with an LVAD. Strategies to promote and maintain
normalcy included things like talking with patients, helping them with projects, maintaining the
home environment, and enhancing personal interests. It seemed that caregivers were always
‘doing’ and ‘trying’ to help the patient live a normal life.

One participant, for example,

described how she and her family modified the patient’s environment so he could continue to
fish and hunt:
So, he likes to fish and he likes to hunt. We had a boat that we, he was not safe in
because he, if he was to fall into the water it would kill him. So, as a family, um, we
talked it over, we got a pontoon and when he goes out we go with him. We watch him
carefully. It has rails. He wants to hunt. My son has now built him a blind with a heater
and a couple windows in it. And it’s like a treehouse with steps up it. So basically, with
his type of personality, uh, he never, we, we get obstacles but we try to find a way of
going around those obstacles. Uh, and not altering his life completely to a nothing.
(Audit Trail, caregiver F, 1st interview transcript, p. 1)
Caregivers continued to talk about promoting normalcy even against the recommended
protocol for living with an LVAD—particularly, driving. Even though patients are allowed to
drive with an LVAD, one caregiver similarly stressed how it important it was to promote
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normalcy by maintaining regular activities for the patient:
You know, some of the precautions they have on the meds, don’t drive, he doesn’t drive
but if I think he’s okay to, I let him. Because that’s one thing he’s used to doing every
day. Can’t take everything away. If he feels like driving and he’s not a hindrance to
anybody or if he, he’ll let me know if he can’t do it anymore, you know, if he can’t drive,
or if he’s tired. (Audit Trail, caregiver H, 1st interview transcript, p. 2).
Despite going against some of the recommended restrictions, caregivers strove to adhere
to the required protocols – including driving. As caregivers continued to describe their
experiences, having to do all the driving was another challenge which surfaced amongst
conversations. Theme 3 is further elucidated by this change in roles and responsibilities.
Doing all the driving. As caregivers spoke about having to take over the driving, four
(4) caregivers didn’t mind doing all the driving. Several phrases from caregivers illustrated that
taking over driving was not a problem for them, for example: “I don’t mind traffic. Traffic is
like the weather, you can’t do a dang thing about it so there’s no sense in whining or
complaining about it. It’s not going to change just for you. At least I get out and see things,”
and “Me doing the driving? I love driving.” The rest of the caregivers, however, felt that having
to drive was one of the biggest lifestyle modifications imposed by the LVAD. This experience
was richly described by one caregiver:
Well, I think one of the big things, and probably one of the more difficult things for both
him and me, is the driving. You know, he had to give up driving and I had to take it over.
And that, that has been, that was probably the difficult thing because he still wants to
drive, and I say, you know, well he drives but he just doesn’t have the wheel in his hand.
(Audit Trail, caregiver A, 1st interview transcript, p. 4).
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Given the restrictions imposed by living with a DT, caregivers strove to maintain as
much of a normal life as possible for these patients. It was still necessary to incorporate LVADspecific IADLS care into their daily routines. This included performing daily sterile dressing
changes.
Daily dressing changes. Caregivers unanimously stated that they performed the sterile
dressing changes. Whether it was done after breakfast or before they went to bed, they described
changing the dressing every day. For most caregivers, it seemed that they were comfortable
performing dressing changes once they got home. Caregiver phrases to describe this experience
included, “...the dressing part of it and, you know, that wasn’t, that wasn’t really bad,” “The first
week when we were home, it went very well, I would say,” and I’m very comfortable with it. I
was very comfortable when I come home.” Two caregivers specifically described for us what it
was like when they first came home: (C1) “So then by the time I got home, I had quite a bit of
experience doing it everyday. I had done it a couple weeks in the hospital and three weeks in the
rehab, so I had, like, five weeks under my belt by then,” and (C2) “Well, he was in there a
month, so I changed it quite often in that month, in the room.”
Feeling comfortable with dressing changes, however, was initially very anxietyprovoking for many caregivers. Words like “overwhelming,” “scary,” and “terrifying” echoed
throughout initial experiences. Despite these feelings, caregivers eventually acclimated to the
daily dressing changes. Phrases used to describe this adjustment included “dressing changes are
part of life,” and “...it’s just part of the routine.”

Two phrases extracted from caregiver

transcripts illustrate how they assimilated dressing changes into their daily lives: (C1) “But it
seems so routine that we just, um, he wakes up in the morning and we immediately, before he
even gets out of bed, we do, um, the sterile dressing,” and (C2) “But, um, now it’s, you know,
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it’s just like brushing my teeth, you know? We get ready for bed, I brush my teeth, I go in and I
take care of his dressing. And that’s it. It’s just part of my life. It’s just the way it is. It’s not a
big deal.” (Audit Trail, caregiver A, 1st interview transcript, p. 3).
It appeared that as caregivers adjusted to daily dressing changes, it took less time to set
up and perform them. At first, times for dressing changes ranged from 25-45 minutes (25, 30,
35, 45; M = 33.8, SD = 8.5). As caregivers became more comfortable and confident with
dressing changes, it took less time. Time reported by caregivers ranged from 5-17 minutes (5,
13,15,15,17, M =13, SD = 4.7). One caregiver richly and succinctly articulated the process of
setting up the sterile field, including the initial and current time to perform the dressing changes:
Um, it took me, I would say a half hour at first, because I didn’t… I’d have to stop and
think, okay, I need to put the gown on, I need to put the cap on, I have to get two masks,
one for him, one for me. And now, I have it all set up in our bedroom, where I have a
little drawer where I have the gown, the next drawer I get the towel, the next drawer I get
the face mask, and up on the top, I have all the gauzes lined up, and the gloves. Sterile
gloves and the exam gloves. I got [bandages] that they’re right near the bed, along with
the solutions, the saline and the wash solutions. So…and the tape. I use both surgical
tape and the paper tape, because he is allergic to the surgical tape. I don’t feel I need the
surgical tape, but he likes it covering the other tape, makes it feel a little more secure
somehow. So now, I’m down to about 15 minutes. So I went from like a half hour to 15
minutes (Audit Trail, caregiver F, 2nd interview transcript, p. 3).
Caregivers also described feeling more comfortable with their new roles and
responsibilities as time went on. Although times varied widely, comfort level ranged from 7 to
180 days (7, 67, 7, 30, 180, M = 58, SD = 72.4) after discharge from the hospital. It was during
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this time that they noted that as patients started feeing better, they began to take over some of
their own care. The next two sub-themes illustrate the final adjustment phase of both patients’
and caregivers’.
Increasing independence after LVAD. Most caregivers described patients’ reclaiming
some of their own roles and responsibilities, including ADLs and LVAD-specific IADLs.
Patients prepared their own meals, performed LVAD-specific IADLs, and even helped out care
givers. The following two phrases selected from participant voices illustrated how roles reversed
after patients started feeling better: “I mean, actually he took over some of the stuff that I had
been doing because he was feeling better,” and “But it’s been a few months now so he’s really
taken over, you know, doing whatever he can do, he does.” One caregiver specifically described
for us how her husband helped her after having the LVAD and became more independent as time
went on:
Well, he’s, um, basically trying to help me all the time. But, um, he’s trying to do
more and more for himself so I don’t have that much to do. The main thing I do is
change his dressing, his driveline every day, every morning. And, uh, wash his back
when he gets, you know, uh, that’s the only thing he can’t do is his back and right after
we do the driveline we do the bathing, you know, and he’s to the point where he can do
all of that for himself. So, mostly all I do is set him up and get him ready for the
driveline. If it wasn’t where it is, he’d probably do it himself. (Audit Trail, caregiver
H, 1st interview transcript, p. 1)
As these patients became independent and started doing more things, it appeared that
caregivers understood that it was necessary to keep going describe restrictions. The next subtheme illustrates retrospective reflections of moving forward despite restrictions imposed by DT.
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Move forward. While reflecting upon their experiences, it seemed as if caregivers just
adjusted their lives to DT and continued to enjoy their lives despite restrictions.

Several

caregivers poignantly elaborated on their feelings as illustrated in the two exemplars below:
And, so, you know, I mean, every time there’s a little bit, um, more progress where
we can do more and more, uh, we’re happy about it. Like, if there’s a will, there’s a
way. For him, he’s very much like, well, let’s try to do this. Let’s try to go if we
can. So we do whatever we can do, um. He doesn’t like to just sit around. (Audit Trail,
caregiver F, 1st interview transcript, p. 5).
The other caregiver specifically and vividly illustrated that no matter what happens in life, you
just adjust and ‘must move on’:
That’s part of life, it’s still moving on. So we have restrictions, it’s okay. We still
can find a way to enjoy ourselves. Neither one of us give up. That’s the way we have
run our lives and we encourage our grandkids, if you get hurt and that is one of the
reasons that I think he’s still on this earth, he is showing these people that you just
can’t give up. No matter what. If you sit and cry and whine about what’s going on,
you’ll never move forward in your life at all. Never. You [wont]. This happened to me.
And irregardless of what goes on in your life, you need to move forward and look
forward, not back. (Audit Trail, caregiver F, 1st interview transcript, p. 10).
We close theme 3 with a growing understanding of how caregivers modified their
lifestyle and adopted roles and responsibilities to promote and maintain health and well-being
among patients with DT. Despite these roles, concerns about patient health, safety, and personal
well-being were at the forefront of caregiving roles and responsibilities and continued to endure
to this day.
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Theme 4: Persistent worry and stress.
Theme 4 represents the culmination of worry and stress experienced by caregivers from
the outset of advanced heart failure to living with a DT. Being a caregiver for DT marked the
beginning of a life filled with persistent worry and stress across all caregivers. Words which
predominantly echoed throughout caregivers’ stories included “worry,” and “stress.”
Caregivers’ descriptions of worry and stress ranged from coming home early from social
gatherings, to worrying about patient getting sick again. Phrases used to specifically illustrate
this phenomenon are described by several caregivers as they go on with their lives:
Even when I go away, whether it’s my friends or go away, I cut it short to get back to
check on him because it’s always underlying what if he can’t get to the phone,” and “But,
you know, I keep an eye just to make sure that he’s not getting too tired or something like
that. And I’ll tell him once in a while, time to quit.”
Other caregivers recounted an ongoing concern of not getting “too comfortable” with
patients’ progress for fear of relapse. This was richly described by on caregiver, as she almost
spoke very slowly and deliberately about this experience while wiping her eyes with a tissue:
I hover, I watch out for him, I take care of him, I think about him every minute.
And it’s only been 9 months and I can go away from him and realize that I haven’t
thought him for the last hour. I’m worried about him unconsciously. And, uh, you
worry about them. You think about him. You’re, your life, you base, your life is
based around him. And I go back to that thing, you know, there will be times when
I’m gone away from him and he’s off doing his thing and I’m doing mine and I
realize I haven’t worried about him for the last three hours. But then, you start to
worry that the shoe is going to drop. Just that little anxiety, like, I don’t want to get
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too comfortable here because, you know. I think that’s that destination thing. Um.
Linda: When you say you don’t want to get too comfortable?
C: Well, because he’s still a sick man and you just want to be in reality. Um, it can get
bad again. (Audit Trail, caregiver E, 1st interview transcript, p. 1)
Similarly, another caregiver richly described her experience of persistent worry:
You’re always, I believe you’re always on edge, because this is something that is, you
know. He is a medical patient. He is a cardiac cripple, really. Actually, a cardiac cripple
because I, anything could happen at any time, and I think that, that part I didn’t mention,
you’re always on edge. (Audit Trail, caregiver F, 2nd interview transcript, p. 11).
Worry continued to surface in caregivers’ descriptions as they expressed feeling stressed
over patients not being careful, even feeling invincible after they received the LVAD. This was
described as very stressful experience. It seemed like caregivers had to always remain vigilant to
patients’ whereabouts and activities at all times. This experience was vividly recounted by one
caregiver as she wiped away her tears during our conversation:
And there’s still some things he’s very, very uncautious about some things. So I
have to remind him he’s wearing this because he forgets he has it sometimes, you
know. And, um, I look out for him...and sometimes he’s not careful and I’m the one
that watches, that’s where I get, be careful (husband), you know. Don’t lean by the
stove. Things that he doesn’t – he was reaching up over the stove and the burner was on,
and I said, ‘oh, you can’t do that, you know’. You just have to figure out things, when
you get to the sink make sure you’re faucets are all that spray thing, um, it stuck and was
spraying everywhere. Well it could have got the LVAD. Things like that, you’ve just
got to be very careful what you’re doing. It’s stress. (Audit Trail, caregiver F, 1st
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interview transcript, p.3)
One caregiver captured the collective feeling of worry and stress coupled with fear for patient’s
health:
C: Well, um, I don’t want it, I don’t want to see him – I mean I guess I don’t know for
sure how much his heart can take. Even though he has the pump, he’s not Superman.
And he is, you know, he’s 75 years old and he still sometimes thinks he’s a lot younger
and he can do a lot more, and he can’t. And I don’t want him to overdo and then have
to pay for it. That’s why I worry.
Linda: What do you mean by having to pay for it?
C: Well, then maybe he’ll do harm to his heart, or maybe, you know, then he has
(unclear), then he is very tired, you know. And then the rest and, you know. But, I
think, sometimes I think he forgets he has the LVAD and he just tries to live life like
he did before.

And probably I worry more about that than he does. (Audit Trail,

caregiver A, 1st interview transcript, p. 1).
It appeared, however, that one of the most stressful feelings for caregivers was making
sure that the LVAD system was always working. Caregivers knew that this device was saving
their loved one’s life so they were always checking battery status and the LVAD system itself.
One caregiver described this experience for us: “Um, and I’m always keep looking over at them
to see if there’s any orange lights showing up in the (unclear). If it is, I go like this [caregiver
nudging patients’ arm].And then he’ll get up and change it or I’ll go and get him a new battery or
something.” (Audit Trail, caregiver H, 1st interview transcript, p. 5).
From looking over the patients’ shoulder to personally making sure batteries were
charged, a pervasive fear for the patients’ life seemed to overcome every thought and action for
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some caregivers. One caregiver vividly described her experience for us:
[Patient hooks up to power base unit at night] And sometimes he hasn’t hooked it quite
right. And, uh, called the alarm and he don’t hear it. So he can never be left alone, um,
at all. Um, and that’s my biggest stressful thing. Him sitting in a chair and falling
asleep and I’m not paying attention. Um, you know, and doing things in the yard
and that turns yellow. I’m always afraid that the battery has been yellow for a
while and he hasn’t heard it. So I pretty well stay pretty close to him at all times. I
think the stressful part is if I was to get sick or something. You know, not being
[there] (Audit Trail, caregiver F, 1st interview transcript, p. 4).
It was readily apparent through caregivers’ voices that persistent stress and worry
prevailed in the heart and minds of these caregivers. One particular caregiver summed up the
pervasive worry and stress experienced by caregivers – a feeling that seemed to capture the
collective experiences, whether articulated, thought, or even felt:
So there’s always worries and stress. But life is always worry and stress, so. Taking care
of an LVAD patient is like life – a lot of worry and stress. It’s like the weather, it’s not
going to change. It’s like traffic—it’s not going to change. They’re not going to make
special rules just for you. (Audit Trail, caregiver B, 1st interview transcript, p. 6).
This section of caregivers’ existential biography marks the end of the experiences of
caregiving for patients with DT. We turn to the final theme which illuminates the meaning, or
essence of the experience of caring for a patient with a DT. This theme addressed the research
question, “What is the meaning of caring for a patient with DT?”
Theme 5: Caregiving is not a burden – it’s part of life.
In this final theme, caregivers unanimously described that caregiving is not a burden but

149

part of life.

Reflections on caregiving for patients with DT included what the caregiving

experience meant for these participants. Descriptions illustrating this theme ranged from ‘I’m
just a son taking care of his father....but I’m just helping him. This isn’t anything about me, [its]
about them,” to “You know, you have a spouse, you take care of them, you do their laundry or
whatever. You know, you just do those things and that’s all part of being married. Same like he
does things for me, you know.” Although caregivers did describe that the overall caregiving
experience can be overwhelming, they considered caregiving as part of life. Phrases used to
describe this experience included, “I wouldn’t have it any other way,” “I certainly would do it all
over again because we do have each other, and we do, you know, there are things that we do
together still, and I love him. So, it’s worth it for sure,” and “I think, basically they’re just so
grateful to see their husbands feeling better and being able to do things that, you know, it’s worth
whatever extra effort you have to do just to see them thriving.” Several caregivers provided
emotionally-provoking experiences, but one caregiver succinctly captured the essence of
caregiving as a way of life:
I don’t see it as a big burden or anything like that. It’s just the way life is and you,
you take what, you know, what is handed to you and you just deal with it, you know.
And I don’t anticipate any, I don’t know, I don’t anticipate any big hurdles, but if there
are, we’ll face them, tackle them. You know, that’s the way I look at it.
(Audit Trail, caregiver A, 2nd interview transcript, p. 3)
Ending conversations with caregivers seemed to be a purging event as they collectively
thanked me for listening to their stories. As with this caregiver and others in this inquiry, I
thanked them for taking me along the road of emotions, trials and tribulations as they adjusted
their lives to caring for someone with a DT.
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Summary
Part two of this existential biography has illustrated the essence of living with DT from
the voices of those caring for someone living with this life-sustaining device. This section is
complemented with a figure illustrating that while adjustments took time, caregiving is not a
burden despite pervasive worry and stress (Figure B17). I now turn to the shared meanings of
participants’ in this inquiry as the finale to the inside perspective of living with an LVAD as a
DT.
Dyadic Reflections
The final part of this existential biography sheds light on the dyadic perspective of
patients and caregivers, specifically, dyadic congruency (e.g., consistency in perspectives).
Consistency in perspective was found in five (5) themes illustrating the essence of living with a
DT: 1) Good family support; 2) Good interpersonal relationships; 3) Destiny is you die; 4)
Uncertain future; and 5) Given more time.
Theme 1: Good family support.
The importance of having a supportive family was an integral component of recovery and
rehabilitation. From learning about LVAD care, dressing changes and emergency procedures, to
just being there, participants spoke about the importance of good family support and what it
meant to them. Caregivers’ experiences included family providing support from dog sitting to
staying with the patient if they had to go out and run some errands, for example:
And my daughter and son-in-law, I mean, if we said would you, I mean they’d drop
everything and do it. And our daughter has, a couple of times when we found out that
we needed to go down to Ann Arbor and back in the same day, I mean she’s taken off
work and done it. She just, we don’t even ask her, she says I’m going with you, you
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know. So they’re there for us, they’re very supportive. (Audit Trail, caregiver E, 1st
interview transcript, p. 5)
Similarly, patients collectively described the importance of good family support. Phrases
used to illustrate patients’ beliefs included:

“Family.

That’s what’s left.

[important], and what they do and what I do, we all just do it together.

The family is
And, we’re all

family....my granddaughters, and my daughters, and my great-grandkids, they’re looking out for
me all the time.”
One patient described for us how his other son learned to care for the driveline and help
out as much as he can:
My other son, a while back he learned how to change my drive line too. He took
vacation time and he learned how to do that so there’s times that he does it. Sometimes
he’ll stop after work and a lot of times he does it on the weekends. So that helps give
(name of son) a break too.

And there’s been times he’s brought me up here for

appointments. (Audit Trail, patient B, 1st interview transcript, p. 7).
Theme 2: Good interpersonal relationships.
Participants’ in this inquiry mutually described having very good relationships with
one another. For example, patients described relationships with their caregivers as “very
good, very good – we are very compatible,” “It’s a pretty good relationship,” “I would say it’s
excellent. Yeah, we’re very happy. Very content. We’re still in love.” Caregivers’ responses
mirrored patients’ as they talked about their relationships with responses such as, “It’s great,”
“we have a real good relationship. Yeah, I, he doesn’t argue much,” and “I think we have a good
relationship. I always thought that we were very, very close, and he was always my best friend.”
Family support and good interpersonal relationships are not only important for assisting
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participants with ADLs and LVAD-specific IADLs, but for also ongoing support given the last
therapeutic option available for patients.
Theme 3: Destiny is you die.
The reason why patients had a DT was known to the majority of participants: this was
the last therapy available to them. Patient responses mirrored caregivers as they spoke about the
phrase DT, and what it meant to them. When patients were asked if they every heard the phrase
DT, three (3) out of seven (7) patients heard the phrase. Of those that never heard the phrase,
responses included, “Oh, I don’t like that phrase,” “I’m not sure what that means,”
“destination....that sounds......ooooo....I don’t like that.” Patients who heard the phrase described
that it meant, “till the end,” “destiny is you die,” and “I’m going to have it until the end.” One
patient richly described his understanding of the phrase DT by talking about death and accepting
DT: “Uh, in my mind, I accept it as, well, that’s no more than your destiny. That’s, uh, you’ll be
on it until they change it or until you contract some other kind of, of problem, or until the end of
your life.”
When caregivers were asked if they ever heard the phrase DT, four (4) of them never
heard the phrase, while the other three (3) did. When I asked them about what the phrase meant
to them, about half didn’t like the phrase and wished it meant something more positive. In the
wake of these end of life reflections, it appeared that many patients had already reflected upon
their own mortality. In the beginning of this existential biography, patients already talked about
a close encounter with death. Some even described making funeral arrangements, or donating
their body to science. Phrases illustrating acceptance of death included, “But if, you know,
something else happens, it happens. That’s destiny too,” and “I don’t have any problems, I’m in
a destination mode. I was in, I’m already in a destination, everybody’s in a destination mode.
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We’re all going to die someday, right?” These end of life decisions, including the following rich
descriptions, suggested that patients have not only thought about death, but have accepted it:
Well, I kind of look at it that, uh, I’m 71 years old. I’ve lived a good life. And if I died
tomorrow, God doesn’t owe me anything. I’ve had a good life and so it wouldn’t, I
can’t say it wouldn’t bother me if I died, but it, uh, it’s not, it doesn’t scare me, you
know. I’m content with where I am. (Audit Trail, patient D, 1st interview transcript, p.
10).
Caregivers’ also knew that DT was the last option available for patients. Phrases used to
describe this understanding included: “Because there’s nothing more beyond the LVAD. He
doesn’t get a new heart after,” and “It means that he’s not going to get a transplant, and till
destinate, till the end of his life.” What was not known, however, is the how much more time
they had with this mechanical device.

Although participants’ acknowledged that death is

inevitable, they also described their feelings towards not knowing what the future holds. It was
the uncertainty of the future, specifically related to how or the way patients were going to die
that seemed to concern both patients and their caregivers.
Theme 4: Uncertain future.
Patients and caregivers shared the same feelings about an uncertain future. It seemed that
most patients, although accepted death, didn’t want to think about how they were going to die.
The following phrases vividly recount patients’ feelings of not wanting to know, or even not
thinking about how they are going to die: “I don’t think about what would happen if the pump
would stop,” and “how much longer have I got? I really don’t know. I’m just going to take it one
year at a time, not day, not day by day… I go by years. They go by too fast, though,” and “if
there’s a time will come when I can’t have it replaced again or something like that, I

don’t
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know. I don’t really think about that, so, um, until just now when I bring it up.”
One particular patient described what seemed to be the collective thoughts about the end
of life:
If things start to shut down, is it going to be shutting down similar to what…will I be
feeling something similar to what happens when the hemoglobin slows down? Or starts
acting up? What’s coming up for me? I don’t know what to look for. Will I see it…will
I notice anything? I guess I would. But I don’t know…is it heart, is it blood, is it
machine? What is it? So, I don’t know if anybody can tell me that. I really don’t. I don’t
think anybody can really forecast that to any degree of accuracy. It probably just depends
on how well I continue to do the things I’m supposed to be doing. (Audit Trail, patient
I, 1st interview transcript, p. 5).
Similarly, caregivers described an uncertain future for their loved ones. Some talked
about not knowing “how long this would last, we don’t know anything.” Others described the
uncertainty surrounding devices still in clinical trials:
...we don’t know how much, you know. He thinks probably 5 years, but I’m not sure.
Um, I support this new device, I don’t know what the long term is. I don’t know if
anyone does. That’s why I think it’s important he’s in a study to let other people know
and that he’s got longer to live. (Audit Trail, caregiver H, 1st interview transcript, p. 8).
Some caregivers reported a lack of information about how an LVAD patient dies. One
particular caregiver captured the general uncertainties surrounding death with an LVAD. She
also richly described her feelings about the lack of information provided about how an LVAD
patient dies:
And now, you know, ‘go live, go live your life, go be happy, go live your life’ [patient
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talking like health care providers at implant hospital]. And then that’s the information
you have. Then, I’ve had my mind, um, well like how does a person with an LVAD die?
How’s he going to die? Um, is it, I’ll leave it at that. I don’t have information on how
he’s going to die. Um, or what are the signs of things getting worse. (Audit Trail,
caregiver E, 1st interview transcript, p. 11).
As both patients and caregivers reflected about an uncertain future, they were also
grateful for another chance at life. The following sub-theme further elucidates the dyadic
meaning of having another opportunity to live.
Theme 5: Given more time.
As participants recounted snap shots of life before the LVAD, both patients and
caregivers alike described their gratefulness and gratitude for being given more time to live.
Patients collectively agreed that if it wasn’t for the LVAD, they wouldn’t be alive right now.
Patients in this inquiry viewed having a DT as chance to live. Patient phrases used to describe
this theme included, “I’m still here,” “I might not have been there if I wouldn’t had it put in,”
and “And I talk it over with people now and they say, I mean, what is that [LVAD done for me]
…is that I’m still around. I probably would have been gone by now if it wasn’t for this.” One
patient vividly expressed for that that being given more time is “a positive”: “You know, just the
fact that, that this thing could keep me going for another five, six or more years. That’s a
positive. Because if those doctors had been right, I’d have been dead anyways. I could have
been dead now.” Another patient pointed out that having DT is “an opportunity to live longer”:
At 73, um, with the attitude I have and the lifestyle I have, it works for me, so, uh, I have
no, have no, uh, no thoughts of I did it wrong. I don’t have any of that. I, uh, I see it as
a, it’s an opportunity. Opportunity to live longer. If, uh, I’ve already, already outlived
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what those first two hospitals gave me. So, I’m, uh, money in the bank so far. (patient
008, 1st interview transcript, p. 8).
This same patient poignantly stressed that just because you receive an LVAD doesn’t mean that
your life is over – it’s just begun, “If someone says that they can’t live with it, they’re sadly
mistaken. And, uh, they, uh, they need somebody to, uh, to talk to, that’s for sure, because it’s
not a life stopper, it’s a life giver, so, uh, that’s, you know, that’s, that’s the way I feel about it.”
(Audit Trail, patient H, 2nd interview transcript, p. 8).
Similarly, caregivers described patients being given another opportunity to live. Phrases
used to explicated this experience included, “gift of life,” “new lease on life,” and“I’m going to
have him longer.” Several caregivers provided rich descriptions about what it meant to have
their loved ones live longer, for example: “It means everything. I mean, he wouldn’t, I know he
wouldn’t be here today. We would not have the life we have today without it. It means
everything to me. So, I’m very, very grateful.” Likewise, another caregiver vividly described
being given the chance to enjoy life once again through the miracle of birth:
And we have one with the great-grandbaby, and you can see the joy in his face with her
on his lap. This is after he had his…well, she was born on the 25th and he had it [LVAD]
on the 29th, but you know, this is part of the joy of extending your life with his LVAD.
That is one of the assets of having this and being alive, is being able to share that, you
know? It is, it’s just a miracle. It’s coming up on a year, and we’re so very, very
fortunate to have him. (Audit Trail, caregiver F, 2nd interview transcript, p. 16).
Participants’ voices are dimmed for now as this existential biography comes to a close. A
close marked by the limited number of pages and an attempt by the researcher to capture the
essence of living with DT. For these participants, DT is not only a device used to provide relief
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from symptoms and extend life a little longer— but a device which has filled the hearts and
minds with hope and life despite limitations and uncertainties.
Summary
Chapter 4 presented the findings of a hermeneutic phenomenologic inquiry aimed at
uncovering and understanding the essence of living with DT from patients’ and caregivers’
perspectives. An existential biography illustrated participants’ lives as patients, caregivers, and
dyads, to illuminate a better understanding of the experience of living with such a life-sustaining
device. Chapter 5, Discussion of Findings, presents an overall interpretation of the findings and
concludes with implications for future studies.
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CHAPTER 5
DISCUSSION OF FINDINGS
Chapter five discusses the findings of a hermeneutic-phenomenological inquiry which
uncovered patients’ and caregivers’ inside perspective of living with an LVAD as DT. I chose
this method of inquiry as a way to shed light on participants’ experience from this life-sustaining
device. Using this approach has uncovered the existential experience and meaning of living with
an LVAD as DT —a perspective mostly heard from those waiting for a donor heart.
Roy’s Adaptation Model ([RAM] Roy 1991; 1999), was used as the guiding framework
through which the discussions of the findings are described. This conceptual model was chosen
to frame the discussion because of the way participants’ lifestyle adjustments mirrored the
adaptive processes described in this model.

Themes are discussed relative to the extant

knowledge and emerging research. Weaving constructed themes and the extant literature through
the major assumptions and concepts of the RAM will illustrate a clearer understanding of the DT
experience. van Manen (1990) concurs, positing that discussion of the findings leads to a better
understanding of the lived experience.
This chapter is divided into three sections. It begins with a discussion of findings framed
within the RAM, is followed by the strengths and limitations, and concludes with implications
for nursing practice and directions for future research.
Roy’s Adaptation Model: Theoretical Assumptions
According to Roy (1991; 1999) persons are viewed as bio-psycho-social beings
continuously interacting with an ever-changing environment. These persons have the capability
to adjust to changes in this dynamic environment in order to promote and maintain survival,
health, well-being and quality of life. Health and illness are inevitable dimensions within

159

dynamic environments. In order to respond positively to health and illness across the life-span,
one must adapt. In order to respond to this dynamic environment, one must adapt. Roy posits
that adaptation occurs when there is a positive response to environmental changes, and that
persons possess both inherent and acquired mechanism to adapt. One’s adaptation, however, is a
direct outcome of internal and external stimulus exposed to environmental influences and the
adaptation level of the individual. Roy describes three components of environmental stimuli: 1)
Focal stimuli 2) Contextual, and 3) Residual. For the purposes of this inquiry, focal and
contextual stimuli are discussed.
Focal stimuli.
Focal stimuli are described as internal and external factors predominantly faced by
individuals. In this inquiry, the focal simuli for participants reflects two different phases in their
lives: 1) Life changes with advanced heart failure, and 2) Initial encounters with the LVAD as a
DT. Lastly, an internal focal stimuli manifested by persistent stress and worry as described from
caregivers’ perspectives.
Life changes with advanced heart failure. The first theme in this inquiry, Life begins to
change with heart failure, characterizes the external stimulus as the progressive symptoms of
advanced heart failure overcame patients’ lives. It was during this time that patients’ in this
inquiry and others (Casida, Marcuccilli, & Peters, 2011) revealed the experience of profound
breathlessness and physical limitations imposed by the end-stages of advanced heart failure
(inevitable illness). Patients in this inquiry, however, provided thick, rich descriptions of this
experience as they reflected upon their initial experiences.

These rich descriptions are an

integral component of ensuring methodological rigor, and can facilitate trustworthiness of the
data through transferability.
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Patients’ sentiments reflected the internal stimuli as they described their experiences with
end-stage heart failure. The sub-themes, On death’s door, Hope for life through the LVAD, and
Determined to live, characterized an internal stimulus as patients’ isolated personal feelings
about their own mortality, yet expressed a determinism and a hope for life as they sought
treatment for their progressive symptoms. It was during this time that caregivers’ of patients
with advanced heart failure began to experience and feel the changes associated with this
progressive syndrome.
In the first theme, Advanced heart failure is a life-changing event, caregivers described
the experience of a life-changing event as the patients progressed towards end-stage heart failure.
Caregivers’ external stimulus at this time was characterized by watching their loved ones
struggle with marked shortness of breath and profound reductions in functionality. This external
stimulus was also manifested by seeking help from any resource possible, to relieve these
grievous symptoms, including taking on many duties once performed by patients.
Internal stimuli expressed as caregivers’ feelings highlighted the experience of a lifechanging event.

For example, caregivers’ feelings indicated fear and helplessness as they

watched their loved ones succumb to the grips of end-stage heart failure.

Feelings of

helplessness and fear of death characterized caregivers’ internal stimuli as there seemed no hope
for life. When all seemed lost, the sub-theme, Hope for life renewed, replaced feelings of
helplessness and fear of death among participants’ —one which brought forth hope for life. This
finding represents a new perspective not found in research exploring living with an LVAD from
patients’ perspectives (Canody & Savage, 1999; Casida, Marcuccilli, & Peters, 2011; Chapman,
Parameshwar, Jenkins, Large, & Tsui, 2007; Samuels, Holmes, & Petrucci, 2004).
Hope for life, however, appears to be a shared sentiment between caregivers in this
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inquiry and those caring for BTT patients (Casida, 2005; Marcuccilli & Casida, 2011). Whether
caregivers’ hoped for continued life with an LVAD as a BTT (Casida, 2005), a DT in this
inquiry, or hoped for life through a donor heart (Marcuccilli & Casida, 2011), LVADs seem to
restore hope and sustain hope where there once was none for these caregivers. For some patients
with advanced heart failure and their caregivers, however, there is no hope for life. This is
clearly evidence among older adults (e.g., ≥ 72 years old) with end-stage heart failure, and/or for
who have one or more comorbid condition (e.g., diabetes, cancer, active infectious processes,
stroke, etc.). These patients will not be eligible for a DT and will continue to experience
uncomfortable symptoms refractory to maximal medical management. As a result, some
caregivers, will continue to experience negative health-related outcomes reported in the
literature, such as depression (Luttik, Blaauwbroek, Dijker, & Jaarsma, 2007a; Luttik, Jaarsma,
Veeger, & van Vledhuisen, 2005; Mahoney, 2001; Molloy, Johnston, & Whitham, 2005; Murray
et al., 2002), caregiver burden (Karmilovich, 1994; Saunders 2008; 2009), worsening overall
health (Luttik et al., 2007a; Luttik et al., 2005; Pressler et al., 2009), and poor health-related
quality of life (Luttik et al., 2007b; Pressler, 2009). These caregivers may never have the
opportunity to experience hope for life for their loved ones and may continue to experience poor
health outcomes once their loved ones are gone. For caregivers’ in this study and beyond, the
LVAD brought forth hope for life and the chance for a better quality of life for everyone
involved. Implantation of the LVAD as a DT marked the second phase of the focal stimuli
shared by participants’ in this inquiry.
Learning to live with an LVAD: An evolving process.

Patients’ and caregivers’

experiences in this phase represented two (2) related external foci: 1) Post-operative recovery,
and 2) Having a foreign body.
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Post-operative recovery.

First of all, patients’ were recovering from an extensive

surgery. Patients’ collectively described being in the hospital for pre-operative work-up, and up
to two months for the post-operative phase. For some patients in this inquiry, being in the
hospital was a very difficult experience. Having to stay in the hospital for several weeks meant
having to comply with the “micro-management” of the hospital environment. This experience
was a constant source of frustration for some patients’ in this inquiry – an experience shared by
other patients hospitalized for LVAD implantation (Dew et al., 1999; Grady et al., 2003).
Having a foreign body. Secondly, patients’ were getting used to having a foreign body
attached to them. In the sub-theme, Having a foreign body, patients’ in this inquiry initially
described feeling uncomfortable with the device attached to them. They mostly described
soreness around the neck and shoulders initially, and nuisances experienced to date, such as
itching under the binder, pinches, and wires curling under the binder. These patients, however,
didn’t elaborate about the first time they saw the LVAD attached to their bodies, as patients in
other studies have (Casida, Marcuccilli & Peters, 2011; Chapman, Parameshwar, Jenkins, Large,
& Tsui, 2007). Internal stimuli manifested as feelings of shock and disbelief echoed throughout
patients’ voices as they tried to grip the reality of seeing a mechanical device attached to their
bodies (Casida et al., 2011; Chapman et al., 2007). Patients in these studies, however, expressed
feelings of self-doubt intermingled with the reality of living with this life-sustaining device
(Casida et al., 2011; Chapman et al., 2007) — a feeling shared by caregivers in this inquiry and
those in other studies (Marcuccilli & Casida, 2011; Baker et al., 2010; Casida, 2005).
Although caregivers in this inquiry and others unanimously reported the unwavering help
and support of nurses and health care professionals (Casida et al., 2011; Kaan, Young, Cockell,
& MacKay, 2010, Baker et al., 2010), the theme in this inquiry, Learning to care all over again,
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captures the realization that they had to learn to care for their loved ones in a different way – a
way laced with self-doubt, even continuous fear. Caregivers were now required to adapt to a
mechanical device – a highly technical piece of equipment that will sustain the life of their loved
ones. For many caregivers, they had no technical or medical/nursing background. For example,
caregivers’ descriptions were laced with feelings of uncertainty, lack of self-confidence, even
expressions of vulnerability due to feelings of inadequacy and perceived lack of knowledge.
Caregivers’ feelings can be explained by an assumption of the theory of stress and coping
(Lazarus & Folkman, 1984). This theory posits that highly stressful conditions may result in an
increased perception of loss of control, vulnerability, even uncertainty.

From the initial

diagnosis of heart failure to caring for someone with an LVAD as a DT, persistent worry and
stress appeared to remain an internal focal stimulus throughout caregivers’ lives and emotions.
In the theme, Persistent worry and stress, caregivers’ in this inquiry have described the
experience of caregiving as pervasive worry coupled with stress. Keeping a watchful eye over
patients’ activities [including the LVAD system] delineated an ongoing burden despite patients’
progression towards better health and well-being. Being ‘hypervigilant’ was also described
among five (N = 5) caregivers of BTT patients (Marcuccilli & Casida, 2011). Strategies used by
caregivers’ to cope with their feelings included constantly checking LVAD battery status and
power unit, looking out for patient safety, returning home early from social outings, even helping
with projects around the house. Coping strategies utilized by
participants in this inquiry can be further explained by the stress and coping theory.
Stress and coping theory. According to this theory, there are two coping strategies: 1)
problem-focused coping (e.g., which involves using focused strategies by learning more about
the problem, learn new skills to help deal with the problem, and/or adapt their lives around the
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situation), and 2) emotion focused coping (e.g., altering thoughts and feelings about a situation,
such as positive thinking or even accepting the situation as is) (Lazarus & Folkman, 1984). In
the current inquiry, caregivers were faced with a life-threatening circumstance and had to learn
how to care all over again. Caregivers’ behaviors can be explained by one of two coping
strategies described by Lazarus and Folkman (1984), namely problem-focused coping. This type
of coping strategies involves using focused strategies by learning more about the problem,
learning new skills to help deal with the problem, and/or adapt their lives around the situation.
Keeping a watchful eye over patients’ can be explained as a coping strategy, namely problemfocused coping, in which caregivers adapted their lives around the lives of their loved ones.
Persistent worry and stress are major factors contributing to overall caregiver burden, and
continues to be reported among caregivers of patients with heart failure (Martensson, Dracup, &
Fridlund, 2001; Murray et al., 2002; Scott, 2000), caregivers of patients with advanced heart
failure (Braun et al., 2007; Clark et l., 2006; Harding, Higginson, & Donaldson, 2003; Herbert,
Arnold &Schulz, 2007), and caregivers of patients with LVADs as a BTT (Baker, Flattery,
Salyer, Haugh, and Maltby, 2009; Casida 2005; Casida, Marcuccilli & Peters, 2011; Dew et al.,
2000; Kaan, Young, Cockell, & Mackay, 2010). Although one caregiver in this inquiry openly,
but quickly described a bout of “feeling blue,” feelings of depression were not openly discussed
among others. Caregivers of patients with DT may also experience negative health-related
outcomes as described among caregivers of long-term life-sustaining devices, such as
mechanical ventilation (Douglass & Daly, 2003; Im, Belle, Schulz, Mendelsohn, & Chelluri,
2004), percutaneous implants for peritoneal dialysis (Belasco, 2002; Belasco et al., 2006), and
caregivers of ICD patients (Dougherty & Thompson, 2009; Jenkins et al., 2007; Sowell, Sears,
Walker, Kuhl, & Conti, 2007). Nevertheless, pervasive worry and stress can increase one’s risks
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for negative health outcomes such as depression (Luttik, Blaauwbroek, Dijker, & Jaarsma,
2007a; Luttik, Jaarsma, Veeger, & van Vledhuisen, 2005; Molloy, Johnston, & Whitham, 2005),
increased caregiver burden (Saunders 2008; 2009), worsening overall health (Luttik et al., 2007a;
Luttik et al., 2005; Pressler et al., 2009), and poor health-related quality of life (Luttik et al.,
2007b; Pressler, 2009). Ongoing assessments and screening for depression amongst the growing
population is of caregivers with long-term, life-sustaining devices is warranted.
Understanding the various external and internal focal stimuli as integral components of
adaptation provided a deeper understanding of living with a DT. The discussion continues with a
view into surrounding factors influencing participants’
Contextual stimuli.
Contextual stimuli are factors that contribute to the effect of the focal stimulus. The
theme, Good family support, was recognized as a shared contextual stimulus from both patients’
and caregivers’ in this inquiry. Participants described the importance of having good family
support, and how it plays a vital role in their overall health and well-being. Other studies also
reported satisfaction with family support from patients’ (Grady et al., 2002; Grady et al., 2004;
Samuels, Holmes, & Petrucci, 2004) and caregivers’ experiences (Casida, 2005; Marcuccilli &
Casida, 2011), but from mostly a BTT perspective.

Conversely, other qualitative studies

reported sacrificing familial relationships as they cared for patients with LVADs (Baker,
Flattery, Salyer, Haugh & Maltby, 2010; Kaan, Young, Cockell, & MacKay, 2010). Perhaps
contextual factors related to a younger age cohort (ages ranging from 44 to 66 years old, with a
mean age of 51 and standard deviation of 14), compared to an older age group in this inquiry
(ages ranging from 50 to 74 years old, mean age of 65 and standard deviation of 15), could
explain the differences and/or value in having good family support. Older adults may have more
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support through children, grandchildren, and long-established relationships through extended
family.
Another contextual stimuli related to the caregivers in this inquiry is reflected by the
theme, Personal interests on hold. Caregivers’ in this inquiry talked about giving up many
things that they enjoyed to do, such as sewing, going to bible study, or even spending weekends
away with friends. This experience was shared amongst caregivers of BTT patients, who spoke
of sacrificing personal relationships, hobbies, even employment while caring for their loved ones
(Marcuccilli & Casida, 2001; Baker, Flattery, Salyer, Haugh & Maltby, 2010; Casida, 2005;
Kaan, Young, Cockell, & Mackay, 2010).

Contextual factors related to gender (e.g.,

predominantly female caregivers), could explain the difference in having more personal interests.
The following section discusses the main concepts used to describe the process of
adjustment among participants in this inquiry, and includes the extant literature to
supplement/support discussions.
Theoretical Constructs and the Process of Adaptation
There are 3 main concepts in the RAM which illustrate the process of adaption: 1)
Coping processes, 2) Adaptive modes; and 3) Adaptation levels.

Each concept has sub-

constructs which will be defined and discussed from patients’ and caregivers’ aspects within the
context of DT.
Coping processes.
Coping processes are defined as inherent or acquired ways of interaction within a
dynamic environment (Roy, 1980; 1990). Person’s behaviors stem from two subsystems
illustrating these coping processes: 1) Cognator subsystem, and 2) Regulator subsystem.
Cognator subsystem. This coping process includes four cognitive-emotion pathways
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innate to all human beings: 1) perceptual and information processing, 2) learning, 2) judgment
and 4) emotion (Roy, 1980; Hanna & Roy, 2001). Patients in this inquiry and others (Casida,
Marcuccilli, & Peters, 2011; Chapman, Parameshwar, Jenkins, Large, & Tsui, 2007) have
demonstrated the intricate interplay between these cognitive emotion pathways as they described
feeling frustrated about the restrictions imposed by the LVAD as they learned to operate,
trouble-shoot, and live with

the LVAD system.

Similarly, caregivers described feeling

overwhelmed, anxious, and even frightened as they learned to care for their loved ones.
Regulator subsystem. These adaptive processes are the inherent pathways in the human
body that automatically respond through chemical, neural, and endocrine mechanisms. Patients
in this inquiry had the added component of a mechanical circulatory support device attached to
the left ventricle of their heart. The adaptive responses required to accept this device were
manifested as patients’ bodies physiologically accepting the device with no evidence of
rejection.

Although some patients’ who had the 2nd generation HeartMate II (Thoratec

Corporation) described some complications with their device (e.g., stroke, infection, device
change-out, and GI bleeding), patients’ bodies physiologically accepted the device without
further complications to date. Their experiences mirrored the ccontinued improvements in
LVAD and clinical management since the REMATCH trial which reported fewer adverse
effects, and device durability in long-term DT patients (Lietz et al., 2007; Long et al., 2005;
Long et al., 2008; Park et al., 2005). Interestingly, three (3) of the patients’ in this inquiry are
enrolled in a clinical trial testing the 3rd generation, magnetically levitated LVAD (e.g.,
HeartWare, Thoratec Corp). To date, two (2) patients experienced adverse events with the 3rd
generation LVAD.

One (1) patient contracted bacterial pneumonia [which warranted

hospitalization], but did not have to have the device replaced. The other patient experienced a
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mild stroke which affected his speech and memory, all of which have improved since
participation in this inquiry. No known published evidence has illustrated longevity, survival
rates, or adverse events related to these latest technological advancements.
Caregivers’ adaptive processes are related to the body’s ability to function under
continuous stress and worry. Although I do not have personal health information, the adaptive
processes seem to be functioning in caregivers’ as evidenced by overall healthy physical
appearances and descriptions indicating the ability to function despite persistent worry and
stress.
Adaptive Modes.
According to Roy, the coping processes described in the previous section interact with
four adaptive modes: 1) Physiologic-physical 2) Self-concept-group identity, 3) Role function,
and 4) Interdependence (Roy, 1980; Hanna & Roy, 2001).
Physiologic-physical. This mode includes maintaining physical integrity. Foundational
human requirements to sustain life include the need for water, air, and nutrition, elimination, a
balance between activity and rest, and protection are hallmarks of this level. In the theme, A time
for discovery and adjustment, patients’ talked about how they incorporated their basic human
needs as they adjusted to DT. At first, there were many restrictions imposed by the LVAD
which required immediate adaptation described by patients in this inquiry and others (Chapman,
Parameshwar, Jenkins, Large, & Tsui, 2007; Casida, Marcuccilli, & Peters, 2011).

These

included having to carrying around extra equipment (i.e., in case batteries ran down or controller
needed to be changed), being unable to take a shower, swim or bathe, having their wound
dressed everyday, protecting the LVAD, not being able to drive, performing LVAD-specific
IADLs, and being tethered to the equipment. Patients’ in this inquiry, however, did not report
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difficulty with performing LVAD-specific IADLs, compare to those in other studies who
reported fear and anxiety coupled with self-doubt as they learned to manage LVAD-specific
IADLS (Chapman, Parameshwar, Jenkins, Large, & Tsui, 2007; Casida, Marcuccilli, & Peters,
2011).
Finding clothes to house and protect the outer components of the LVAD (e.g., batteries
and controller) posed some challenges as the process of adjustment continued (Casida,
Marcuccilli, & Peters, 2011). The trial and error process of trying on different vests and clothing
strategies was described elsewhere (Casida et al., 2011), including a case report revealing the
clothing challenges and body-image disturbances of a woman with an LVAD (Marcuccilli &
Casida, 2012).

Eventually, patients in this inquiry preferred a fishing vest from a local

sportswear stores over the modular vests provided by the implant hospital and LVAD
manufacturers. The fishing vest seemed to distribute the weight of the batteries and controller
more evenly, thereby reducing discomfort in the neck area. Moreover, pockets and a “zip-up”
jacket style gave the sensation of security as patients’ engaged in ADLs. Since men are the
currently the largest group receiving and LVAD, more studies comparing and contrasting
different clothing strategies to protect the external components of the LVAD are warranted.
Additionally, most participants reported that choosing the right type of clothes makes a
difference in engaging in activities. Early integration of proper clothing types, therefore, may
facilitate earlier acceptance and adaptation. This inquiry provides an in-depth view into the
clothing challenges of men but more research is needed to facilitate early, positive adaptation of
living with a long-term LVAD.
Self-concept-group identity.
Roy (1991; 1999) described self-concept as an adaptation mode. For example, patients
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with LVADs are attached to internal and external components which can cause psychological
distress and potentially alter perceptions of self-concept (eg, mental images about the self in
relation to the body). Although LVADs have improved the quality of life of patients with
advanced heart failure (Grady et al., 2001; 2002; 2003; 2004; Casida, Marcuccilli, & Peters,
2011), living with this implanted device may also cause major psychosocial issues for patients.
Thus patients may have difficulty in modifying self-concept which can affect their ability to
carry out the required self-care of the LVAD system, affect ego integrity, and also affect their
willingness to engage in social relationships. The ability to modify self-concept, therefore, is
vital for promoting and maintaining emotional integrity, continued adherence to LVAD regimen,
and the development and continuation of social relationships leading to improved quality of life.
Although one study identified threats to self-concept (Chapman, Parameshwar, Jenkins, Large, &
Tsui, 2007), a more recent study explored how patients with LVADs modify their self-concept
(Marcuccilli & Casida, 2012). To date, scant literature suggested that recipients of LVADs may
encounter difficulty modifying their self-concept, and therefore be able to achieve a level of selfacceptance to continue with prescribed medical regimen (Casida, Peters, & Magnum, 2009).
Conversely, patients’ experiences in this inquiry and those in a more recent study (Marcuccilli &
Casida, 2012) did not appear to have difficulty with modifying self-concept. In fact, patients’
unanimously indicated that the LVAD not only improved their quality of life, but also saved their
life. They accepted themselves as needing the LVAD in order to live and therefore readily
engaged in the prescribed medical regimen. However, in a related study exploring the impact of
LVADs on recipients’ bodies and lives (Chapman et al., 2007), retrospective reflections of living
with an LVAD after participants received a heart transplant were dramatically different. They
described a profound alteration in body-image elucidated by initial shock and bodily scarring.
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Similar to Marcuccilli & Casida’s (2012) study, patients in this study accepted the LVAD as
necessary to live, even stating that it has become a part of their lives. Given the fact that these
patients have never received a donor heart, it is likely that they modified their self-concept in
order to accept the LVAD because they knew that this was the last treatment option for them, or
because they were older (eg, ≥ 65), or knew that there was a shortage of organ donors and they
would not likely receive a transplant.
Another integral component of maintaining self-concept and psychosocial health are sex
and intimacy. Sexual activity and intimacy are normal human behaviors that are important
dimensions of quality of life.

Although this phenomenon is gaining interest, it remains

underreported in the LVAD literature (Casida, Marcuccilli, & Peters, 2011; Grady et al., 2001;
2002; 2003; Samuels, Holmes, & Petrucci, 2004). Sex and intimacy represent normal human
behavior and a vital component of promoting self-concept, psychosocial quality of life, and
fostering satisfying interpersonal relationships.

For example, a phenomenological study

exploring sex and intimate behaviors among (N = 9) patient’s found that as overall strength
improved, sexual functioning improved, along with an increased sense of connectedness and
intimacy. Casida (2005) also reported improved personal relationships among (N = 3) spousal
caregivers of patients waiting for transplant. Few patients in this study described a desire for
sexual activity, but accepted limited physical sexual activity due to aging, and ongoing disease
process. Although Roy (1983; 1991; 1999) didn’t discuss sex and intimacy as basic human
requirements, sex and intimacy represent normal human functioning and an integral component
of quality of life through fostering satisfying interpersonal relationships. Future studies honing
in on improving sexual activity, or increasing intimate behavior among this group can improve
and/or maintain satisfying sexual and intimate behaviors.

172

Role function.
Roles functions are the collective actions performed by individuals and the related
feelings and attitudes attributed to these functions. In the theme, Lifestyle adjustments come with
time, caregivers talked about their integral roles in helping the patient with their bio-psychosocial needs, recover, and adjust to living with an LVAD. For example, caregivers had to
initially perform many of the functions required to maintain physical integrity, including
monitoring the LVAD system, maintaining intake and output and providing nutritious meals for
their loved ones. Other responsibilities included taking on roles once performed by the patients,
doing all the driving, and performing dressing changes — roles described by caregivers of
patients with LVADs in other studies (Baker, Flattery, Salyer, Haugh, & Maltby, 2010; Kaan,
Young, Cockell, MacKay, 2010; Marcuccilli & Casida, 2011). These role functions mirror
problem-focused coping strategies in which caregivers learned new skills (e.g., performing
dressing changes), and adjusted their lives around the situation (e.g., role reversal, driving).
Caregivers in this inquiry described having the added burden of promoting and
maintaining normalcy for patients despite restrictions imposed by the LVAD. In the theme,
keeping it normal, caregivers unanimously described how they tried to maintain normalcy for
patients living with an LVAD. Strategies to promote and maintain normalcy included talking to
patients, assisting them with projects and activities they liked to do, and making the home
environment more comfortable for them. It seemed that caregivers were always focused to
ensure as much a normal life as possible for their loved ones. These problem-focused coping
strategies were also articulated in a qualitative study exploring the caregiving experience of (N =
6) caregivers of patients waiting transplant (Baker, Flattery, Salyer, Haugh, & Maltby, 2010). It
seemed that caregivers of patients with LVADs for any indication adopted problem-focused
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coping strategies as necessary for promoting psychosocial health and well-being for their loved
ones. Problem-focused coping strategies, therefore, are necessary for maintaining and promoting
overall health and well-being among patients with LVADs across the board.
Interdependence.
Roy (1983; 1991; 1999) described the concept of interdependence as feeling secure in
nurturing, interpersonal relationships. These relationships focus on the value of mutual love,
respect and valuing of interpersonal relationships and support systems. Participants’ in this
inquiry mutually described very good relationships with one another.

The majority of

participants across the board talked about having a great relationship with their spouses, a
finding also reported amongst spousal caregivers of patients waiting for transplant (Casida,
2005).
Adaptive levels.
Roy (1983; 1991; 1999) described that successful adaptation occurs as a result of positive
responses to changes in the environment. Adaptive levels reflect the changing point of the
process of adaptation and are characterized by three levels of adaptation: 1) Integrated life
process, 2) Compensatory process, and 3) Compromised process.
Integrated life process. Indicates a level of adaptation where structure and functions
of life are working together to meet one’s needs. In the theme, Adjustments and acceptance
come with time, patients talked about integrating and accepting the inconveniences, nuisances,
and restrictions of the LVAD as necessary to life. They talked about being able to eat again,
performing their own LVAD-specific IADLs, even engaging in more physical activities like
walking and playing golf. As they felt stronger and were able to do more things, their overall
quality of life improved – a shared perspective among patients in other studies (Grady et al.,
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2001; Grady et al., 2002; Grady et al., 2003; Grady et al., 2004; Casida, Marcuccilli, & Peters,
2011). The essence of living with a DT became apparent as patients accepted and adapted their
new lives with the LVAD.
Meaning of living with a DT. In the theme, Living outweighs restrictions, the meaning
of having an LVAD as a DT became clear as patients’ accepted this device as necessary to live.
It was at this point that they began to reflect upon how their lives were before the LVAD — they
not only accepted their restrictions, but embraced them because it enable them to live – a finding
reported amongst patients waiting for transplant (Casida, Marcuccilli, & Peters, 2011).
Accepting the LVAD in all aspects of lives, bodies, and emotions, can also be described as an
emotive-focused coping strategy incorporated by these patients. Although patients’ in Casida
and colleagues (2011) phenomenological study revealed several strategies for coping, such as
humor, remaining active, prayer, and church activities, patients in this inquiry talked about ‘just
accepting’ the device. Perhaps an investigation into the coping strategies used by patients with
DT would identify successful coping strategies for future LVAD recipients.
A novel finding that has not emerged in other studies was reflected in the theme, Hope
for life through new technology. Patients’ bridged to transplant must often wait for almost 1 year
before receiving a transplant (OPTN/SRTR, 2011). Certainly these patients live with the hope
that one day they will receive a heart transplant. Although patients in this inquiry understand
that they will never receive a donor heart, mostly because of their age, they have the hope of the
future. Whether it was stem cell injections, or new LVAD technology, these patients continued
to hope for life through new technology.
Another theme representing the meaning of living with a DT was reflected in the dyadic
theme, Given more time. The meaning of having and being given the chance to live, represented
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the true essence of having a DT. Notably, it was participants’ use of silence while recounting
their experiences that gave voice to the meaning of being given more time. I also noticed that
participants’ bodily movements seemed to change prior to the silence.

For example,

participants’ bodily movements seemed to still. Facial expressions and tonal inflections lowered
and appeared more serious. Tears filled participants’ eyes with subsequent tearing, and soft
crying. This body language prefaced silence – the silence described by Bollnow (1982) through
van Manen (1990) as having reached the limits of language and arriving at the essence of the
phenomenon. For van Manen (1990), it was the powerful expressions of body language that
made silence seem more powerful that words themselves, as participants’ collectively described
the meaning of being given more time. The silence expressed by these participants is also
described by van Manen (1990) as ontological silence, in which participants seemed at a loss for
words when they tried to describe for me what it was like to be given more time to live. Despite
shared feelings of being given more time to live, participants’ were also faced with an uknown
future.
Uncertain future. This theme represents the mutual concerns of participants’ in this
inquiry about the end of life experience with a DT. Participants’ across the board knew that DT
was the last therapeutic option available for them. Although some of them never heard the
phrase DT, they knew that they were eventually going to die –

it was the surrounding

circumstances about dying with an LVAD that remained a mystery to most of them. It is
interesting to note here that most participants who talked about death, seemed to be actually
afraid to mention the word death, dying, or even appeared uncomfortable with discussing the
subject. The silence surrounding conversations about death was clear. This was described by van
Manen (1990) as epistemological silence—the silence experienced when thinking of the

176

unthinkable, such as death. From wondering about future complications to uncertainty about the
end of life, there seemed to be some unanswered questions about prognostication, the way
patients were going to die, and how long they had to live. This made me think about the
literature (Brush et al., 2010; Byram, 2012; Swetz et al., 2011a; Swetz et al., 2011b) and
AHA/ACC guidelines identifying the need for pre-implantation palliative care and end of life
discussions among patients’ with heart failure and their family caregivers. When I inquired
about any end of life conversations with health care providers, only one (1) patient talked about
being approached by a social worked to ascertain any end-of-life care needs, whereas others had
none such discussions with their health care providers. Some patients’ with the 3rd generation
HeartWare LVAD were told by their physicians that they don’t know how long they were going
to live – they could even outlive their spouses. Other participants’, especially caregivers,
wondered about what the end of life would entail for their loved ones. Some participants’ talked
about making funeral arrangements, even donating their body to science. Two (2) patients’
articulated that they would prefer to die instead of having a long, protracted death – end of life
options shared by other patients with advanced heart failure (Levenson et al., 2000; McCarthy et
al., 2008). However, no one talked about having an advance directive in place, or having
palliative or end of life care discussions with healthcare providers. This is consistent with the
literature reporting a lack of communication about palliative and end of life choices among
patients with heart failure and their family caregivers (Aldred et al., 2005; (Levenson, McCarthy,
Lynn, Davis, & Phillips, 2000; McCarthy et al., 2008; Selman et al., 2007). Current ACC/AHA
guidelines concur with the expanding literature recommending timely palliative and end of life
care in order to facilitate quality care among patients with advanced stages of heart failure
(Brush et al., 2011; Goodlin, 2009; Hunt et al., 2005; Hunt et al., 2009; Hupcey et al., 2009;
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Jessup et al., 2009; Rizzieri et al., 2005). Many of these patients, however, are referred only
when they are near death (Goodlin, 2009; Quaglietti et al., 2005; Rizzieri et al., 2005). These
results were exemplified in a recent retrospective analysis which reported that a reduction in
quality of life or decline in health status resulted in end of life discussions with patients’ and
their family caregivers (Brush et al., 2011). We have done a disservice to this population in
meeting the palliative care and end of life care needs. The prospect of impending death is
certainly a very stressful situation for anyone. Identifying and incorporating approaches that
integrate a discussion of palliative care at some point during the latter stages of illness but prior
to the onset of very advanced disease has the potential to identify the end of life choices of the
patient while not stripping hope for life. Initiating discussions about palliative care and end of
life care preferences prior to deteriorating health status can help alleviate some stress by
identifying care preferences and ensuring death with dignity (Brush et al., 2010; Byram, 2012;
Swetz et al., 2011a; Swetz et al., 2011b). This could improve the quality of life of both patients’
and their family caregivers during a very difficult time. More research, however, is needed to
examine the palliative care and end of life preferences among this growing population. Perhaps
a prospective, descriptive study examining palliative and end of life choices among
a larger sample of patients’ and caregivers’ living with DT would illuminate
preferences for palliative and end of life care.
The final theme, Thank the Lord, concomitantly reveals an ongoing faith and
thankfulness to the Lord, as expressed in Casida and colleague’s (2011) study. The theme in this
inquiry captures a glimpse into patients’ religious and spiritual beliefs about Divine intervention
at a time when all seemed lost.

These beliefs illustrate one philosophical assumptions

delineating the RAM in relation to God— the acknowledgement of a symbiotic relationship
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between the world and God.
Compensatory process. In this level, the cognator and regulator coping mechanism
have been activated by a challenge to the person or group. For caregivers’ in this inquiry and
others (Baker, Flattery, Salyer, Haugh, & Maltby, 2010; Casida, 2005; Kaan, Young, Cockell,
MacKay, 2010; Marcuccilli & Casida, 2011) persistent stress and worry were elements of this
challenge as caregivers strove to continue in their roles and responsibilities—a finding which
rings true amongst caregivers of patients with other chronic illnesses reported previously in this
inquiry and elsewhere.

The difference between those studies, this inquiry, and a

phenomenological study by Marcuccilli & Casida (2011) were very clear – caregiving was not a
burden, but a way of life. For these caregivers, it was all about what wives do for their husbands
– what son’s do for their fathers – a responsibility that wasn’t termed a responsibility – but just
the way life is. This coping strategy used by caregivers’ in this inquiry can also be termed
emotion focused coping, since they just seemed to accept and adapt to their new caregiving roles
despite pervasive worry and stress. Perhaps this also could be explained by being in long-term
relationship and a sense of commitment felt by virtue of being a spouse or a son. Either way,
caregivers have incorporated a compensatory process of adjusting to persistent worry and
stress by embracing their caregiving role as part of life.
Compromised process. The final level of the RAM represents inadequate integrations
and compensatory life processes – an indication of an adaptation problem. Participants in this
inquiry have not illustrated compromised processes, as they have accepted their lives and roles
required of living with a DT. It is noteworthy to report that, despite a higher level of acceptance
and adaptation in this inquiry and caregivers’ in other studies (Casida, 2005; Marcuccilli &
Casida, 2011), other qualitative studies report overall burden amongst caregivers of LVAD
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patients awaiting donor hearts (Baker, Flattery, Salyer, Haugh, & Maltby, 2010; Kaan, Young,
Cockell, MacKay, 2010).

Further studies utilizing mixed-methods, larger samples across

multiple settings, and longitudinal designs will be helpful in examining factors related burden
and adaptation among this growing population. Perhaps examining a variety of instruments
related to caregiving outcome, such as the Appraisal of Caregiving Scale (ACS) (Oberst,
Thomas, Grass, & Ward, 1989), the Bakas Caregiving Outcomes Scale (BCOS) (Bakas &
Champion, 1999; Bakas, Champion, Perkins, Farran, & Willilams, 2006), even the MOS 36-item
short form health survey (SF-36) (McHorney, Ware, Lu, & Sherbourne (1994), can assist in the
measurement of caregiving outcomes, even stimulate the development of future instruments,
aimed at measuring caregiver outcomes among this growing population.
Strengths and Limitations
This hermeneutic phenomenologic inquiry provided an in-depth look into the experience
of living with a DT among patients’ and caregivers’ living with DT. Although the sample,
reflected exclusively White men and women recruited from a single university medical setting.
participants are representative of the population of patients with an LVAD as a DT (Kirklin et
al., 2011). Moreover, due to the possible sensitive nature of knowing that DT is the final therapy
for them, participants may have not fully explicated their inside perspectives. By using a
purposive sample, however, participants shared rich, in-depth descriptions regarding their
adaptive processes, meanings about living with DT, and uncertainties about the end of life,
thereby facilitating transferability at researchers’ discretion. There are important limitations
inherent in qualitative studies, such as phenomenology.

Van Manen (1990) asserts that

phenomenology does not purport to objectify the human experience; rather, it aims to increase
the understanding of a certain phenomena and the meanings attributed to them. This is of
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particular value to the practice of nursing, since we seek to understand the human experience.
Understanding the experience of DT from patients and their caregivers may serve to enlighten
nursing practice.
Implications and Relevance to Nursing
Despite the limitations, findings in this inquiry add to the knowledge of the experiences
of DT among patients and caregivers. As the world begins to age, chronic illnesses will increase,
specifically advanced heart failure. The utilization of life-sustaining devices, such as DT, will
become a viable option for improving overall health and quality of life among this population.
Given the growing body of knowledge related to advancement in technology and improvement
in survival rates among LVAD recipients, very little has been implemented to address health
behavior issues, palliative care and end of life care needs, and overall quality of life of older
adults with DT, including their caregivers. Caregivers are instrumental to the health and wellbeing of patients with such life-sustaining technology. Yet, their health behavior needs and
issues have only begun to emerge as well. To date, very little published have explored patients’
and caregivers’ inside perspectives of living with a DT.

Findings from this inquiry have

provided a significant contribution to the knowledge of life-sustaining devices from a palliative
care and end of life care perspective. In doing so, findings have both pragmatic and research
implications. First, it begins to address the paucity in the literature warranting investigations into
the bio-psycho-social-spiritual needs, health behaviors, and quality of life dimensions of
patients’ and caregivers’ living with a DT (Pressler, 2009; Kaan, Baker, Casida, Marcuccilli, &
Peters, 2011; Marcuccilli & Casida, 2011). Second, findings can be used to help nurses and
other health care providers understand the adaptive processes and needs and concerns of this
population. Findings can also be used to inform a holistic approach to providing palliative care
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and end of life care designed to improve well-being, quality of life and ensure death with dignity.
Directions for Future Research
Despite this new knowledge, more research is needed. For example, investigations using
larger sample sizes, a more diverse demographic profile of participants across multiple settings,
and other study designs, such as mixed-methods, longitudinal designs, and eventually
interventional studies, can be developed to enhance generalizability. The Hispanic/Latino
population is already the largest minority group in the nation, and is projected to make up 20% of
the U.S. population by 2050 (Older Americans, 2010).

Including these demographic

compositions (and ethnicities) in the database should stimulate research among diverse groups so
we can better understand behaviors, health outcomes, health care use, and eventually tailor
culturally-sensitive interventions for this expanding population. Other theoretical constructs of
the RAM (e.g., focal, contextual, and residual factors) can be used to examine the bio-psychosocial-spiritual variables predictive of patients’ and caregivers’ perceptions and capability to live
with and adapt to DT. Finally, findings from this inquiry have helped me to recognize the need
to optimize adaptation and health behaviors to improve the quality of life for this population.
The opportunity to explore the lived experience of living with a DT has led to the development
of a program of research dedicated to meet patients’ and caregivers’ palliative and end of life
care needs (Figure B18). As my program of research emerges, investigations related to
perceptions, health behaviors, and quality of life outcomes will culminate in the development of
health behavior interventions aimed at modifying health behaviors to improve quality of life
among my population of interest. One of the first intervention studies I plan to develop is a
health behavior modification intervention aimed at reducing stress and promoting healthy
behaviors among family caregivers of adults with advanced heart failure with palliative and end
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of life care needs. Eventually, I plan to develop and test a nurse-led or community-based
interventions aimed at modifying health behaviors to promote quality of life among older adults
with advanced heart failure using life-sustaining technologies and their family caregivers. With
the advent of health care reform by 2014, future studies can inform public health-based programs
aimed at health behavior modification programs for both patients and their family caregivers. A
very critical component of my program of research is the opportunity to integrate health
behaviors interventions into health care systems and/or community-base settings. Translation
into practice is paramount for population-based health behavior modification and to improve the
quality of life for older adults with advanced heart failure using life-sustaining-technologies, as
well as their family caregivers.
Conclusion
An interpretation of the lived experience from patients’ and caregivers’ perspectives
culminated into an existential biography illustrating the evolving process of adjustment over time
as participants’ accepted and integrated DT into their lives. The themes identified in this
hermeneutic-phenomenological inquiry were consistent with the concepts of adaptation within
the RAM. Overall, positive adjustments were illustrated as patients’ accepted their device as
necessary to live, exhibited an improved overall quality of life, and gratefulness for life.
Caregivers’ also illustrated a positive adaptation during the caregiving process because they, too,
where grateful for more time with their loved ones, and accepted caregiving as part of their lives,
despite persistent worry and stress. Dyadic perspectives reflected the importance of good family
support and nurturing interpersonal relationships amidst uncertainties about dying and death.
Future studies are needed to drive evidence-based practice clinical guidelines and to continue to
advance the science of life-sustaining technologies, caregiving, and palliative and end-of-life
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care.
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APPENDIX A
Table A1
Table A1
Stages of Heart Failure
______________________________________________________________________________
Stage A

Stage B

Stage C

Stage D

______________________________________________________________________________
Patients at high risk

Evidence of structural

Evidence of heart

Refractory end-stage

for developing heart

heart disease.b

failure symptoms and

heart disease

structural heart

requiring frequent

disease (symptomatic)

hospitalizations for

failure.a

treatment.c
_____________________________________________________________________________________________

Note. Adapted from “2009 focused update incorporated into the American College of
Cardiology/American Heart Association 2005 guidelines for the diagnosis and management of
heart failure in adults: A report of the American College of Cardiology Foundation/American
Heart Association Task Force on Practice Guidelines,” by S. A. Hunt et al., 2009, Journal of the
American College of Cardiology, 53, 1343-1382.
a
Patients may have high blood pressure, coronary artery disease, diabetes, history of drug or
alcohol abuse, history of rheumatic fever, or a family history of cardiomyopathy. b Structural
heart disease includes left ventricular enlargement, heart fibrosis, valve disease, previous heart,
dyspnea, fatigue, exercise intolerance. c Patients may require inotropic infusions, an LVAD, an
artificial heart, a heart transplant, or hospice care. Marked symptoms at rest despite optimal
medical management.
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APPENDIX A
Table A2
Table A2
New York Heart Association Functional Classifications
______________________________________________________________________________
Class

Patient Symptoms

______________________________________________________________________________
Class I (Mild)

No limitation of physical activitya

Class II (Mild)

Slight limitation of physical activityb

Class III (Moderate)

Marked limitation of physical activityc

Class IV (Severe)

Unable to carry out any physical activity without discomfort.

______________________________________________________________________________
Note. Adapted from “Heart Failure Society of America, The Stages of Heart Failure – NYHA
Classification,” accessed October 2, 2010 http://www.abouthf.org/questions_stages.htm.
a
Ordinary physical activity does not cause undue fatigue, palpitation, or dyspnea (shortness of
breath).bComfortable at rest, but ordinary physical activity results in fatigue, palpitation, or
dyspnea. cComfortable at rest, but less than ordinary activity causes fatigue, palpitation, or
dyspnea. d Dyspnea at rest or with very little exertion. If any physical activity is undertaken,
discomfort is increased.
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APPENDIX A
Table A3
Table A3
Heart Transplant Eligibility Criteria
______________________________________________________________________________
Inclusion criteria

Exclusion criteria

______________________________________________________________________________
Refractory cardiogenic shock

Systemic illnesses (˂ 2 year

Other contraindications

life expectancy
______________________________________________________________________________
Dependence on IV inotropes

Malignancies

Advanced age (˃ 72 years age)

Peak VO2˂ 10ml/kg/min

AIDS

Any active infection (excluding

Ischemia limiting daily

Active manifestations of

device-related LVAD infections)

activity and not amenable to

lupus, sarcoidosis,

Active peptic ulcer disease

coronary bypass surgery

amyloidosis with multi-organ

Diabetes with neuropathies

(CABG)

involvement.

Peripheral vascular or

Symptomatic/refractory

Irreversible renal or hepatic

cerebrovascular disease

ventricular arrhythmias

dysfunction.

Morbid obesity (body mass index

Significant obstructive

˃ 35 kg/m2

pulmonary disease (FEV1 <1
L/min).

Cachexia (body mass index ˂ 18
kg/m2
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Pulmonary hypertension

Creatinine ˃ 2.5 mg/dL or

(pulmonary artery systolic

Creatinine clearance ˂ 25 mL/min

pressure >60 mm Hg).

Bilirubin ˃ 2.5 mg/dL
Severe pulmonary dysfunction
with FEV1 ˂ 40% normal
Recent pulmonary infarction
within 6 to 8 weeks
Difficult-to-control hypertension
Irreversible neurological or
neuromuscular disorder
Active mental illness or
psychosocial instability
Drug, tobacco, or alcohol abuse
within 6 months
Heparin-induced
thrombocytopenia within 100 days

______________________________________________________________________________
Note. Inclusion criteria: IV (e.g., intravenous); and VO 2 (e.g., oxygen consumption per unit
time). Inclusion criteria adapted from, “ACCF/AHA/ACP/HFSA/ISHLT 2010 clinical
competence statement on management of patients with advanced heart failure and cardiac
transplant: A report of the ACCF/AHA/ACP task force on clinical competence and training,” by
F. Pagani, et al., 2010, Circulation, 122, 644-672. Exclusion criteria adapted from, “Listing
criteria for heart transplantation: International Society for Heart and Lung Transplantation
Guidelines for the care of cardiac transplant candidates,” by M. Mehra, et al., 2006, Journal of
Heart Lung Transplant, 25, 1024–1042.
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APPENDIX A
Table A4
Table A4
Patients’ Sociodemographic and Clinical Data
Education

Marital

Designated

Reason for

Months

(Years)

(Years)

Status

Caregiver

LVAD

with

M = 73

M = 15.4

LVAD

SD 1.8

SD = 1.1

M = 12.3

Participant Age

Sex

Race

SD = 6.0

1

75

Male White 16

Married

Spouse

DT

17.0

2

72

Male White 12

Widowed

Son

DT

10.0

3

71

Male White 16

Married

Spouse

DT

9.0

4

72

Male White 15

Married

Spouse

DT

8.0

5

72

Male White 13

Married

Spouse

DT

10.0

6

73

Male White 16

Married

Spouse

DT

8.0

7

76

Male White 16

Married

Spouse

DT

24.0

Note: DT = DT
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APPENDIX A
Table A5
Table A5
Caregivers’ Sociodemographic and Clinical Data
Education Marital

Relationship

Employment

Time/day

(Years)

(Years)

to Patient

Status

with

M = 65

M = 13.4

SD = 8.3

SD = 1.5

Participant Age

1

72

Sex

Race

Female White 14

Status

patient

Married Spouse

Volunteer

Almost
all day

2

50

Male

White 12

Single

Son

None

Almost
all day

3

69

Female White 12

Married Spouse

Volunteer

All day

4

61

Female White 16

Married Spouse

Retired

18
hours/day

5

69

Female White 12

Married Spouse

Retired

24/7

6

74

Female White 14

Married Spouse

Retired

24/7

7

62

Female White 14

Married Spouse

Retired

24/7

Note: 24/7 = 24 hours a day, 7 days a week.
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APPENDIX B
Figure B1

______________________________________________________________________________
Figure B1. External components of LVAD. Reprinted with permission from Thoratec
Corporation, 2011
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APPENDIX B
Figure B2

1st generation
LVAD

2nd generation
LVAD

3rd generation LVAD
______________________________________________________________________________
Figure B2. Comparison of 1st, 2nd, and 3rd generation LVADs (Reprinted with permission from
Thoratec Corporation, 2011.
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APPENDIX B
Figure B3

Internal component of a 2nd
generation LVAD

Internal
component of a
3rd generation
LVAD

_____________________________________________________________________________
Figure B3. Internal components of 2nd and 3rd generation LVADs. Reprinted with permission
from Thoratec Corporation, 2011.
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APPENDIX B
Figure B4

PARTS:
Lived experience sources
Tape-recorded interviews,
researcher journal, field
notes
RESEARCHER:
Co-creates lived
experience

WHOLE:
Relate parts back to
the whole

______________________________________________________________________________
Figure B4. Structure of the hermeneutic circle
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APPENDIX B
Figure B5

Figure B5. My husband.
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APPENDIX B
Figure B6

__________________________________________________________________________
Figure B6. My boy.

196

APPENDIX B
Figures B7 and B8

________________________________________________________________________________________________

Figure B7. van Gogh Self-Portrait 1889.
Musee d'Orsay, Paris.

Figure B8. van Gogh Self-Portrait 1889.
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APPENDIX B
Figure B9

______________________________________________________________________________
Figure B9. LMR self-portrait. 2011.
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APPENDIX B
Figure B10

______________________________________________________________________________
Figure B10. Pablo Picasso. Woman with a Chignon. 1901. Oil on canvas. Fogg Art Museum,
Harvard University, Cambridge, MA. USA.
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APPENDIX B
Figure B11

____________________________________________________________________________
Figure B11. Pablo Picasso. Lola, Picasso’s Sister. 1899. The Cleveland Museum of Art.
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APPENDIX B
Figure B12

______________________________________________________________________________
Figure B12. Pablo Picasso. Woman with a Crow. 1904. Charcoal, pastel, and water-color on
paper. Toledo Museum of Art, Toledo, OH. USA.
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APPENDIX B
Figure B13

______________________________________________________________________________
Figure B13. Vincent Van Gogh. The Raising of Lazarus. 1890. van Gogh Museum,
Amsterdam.
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APPENDIX B
Figure B14

Praise My Soul the King of Heaven
Praise my soul the King of heaven
to His feet they tribute bring
ransomed, healed, restored, forgiven
who like thee His Praise should sing
Praise Him! Praise Him! Praise Him! Praise Him!
Praise the everlasting King
Praise Him for His grace and favour
to our fathers in distress
Praise Him still the same for ever,
slow to chide and swift to bless.
Praise Him! Praise Him! Praise Him! Praise Him!
Glorious in His faithfulness
Fatherlike he tends and spares us
well our feeble frame he knows
in His hands he gently bears us
Rescues us from all our foes
Praise Him! Praise Him! Praise Him! Praise Him!
Widely as His mercy flows
Angels helps us to adore Him
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Ye behold Him face to face
Sun and moon bow down before Him
Dwellers all in time and space
Praise Him! Praise Him! Praise Him! Praise Him!
Praise with us the god of grace
______________________________________________________________________________
Figure B14. Praise my soul the King of heaven.
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APPENDIX B
Figure B15
Thank you, Lord, for This Great Day
Thank you for all the good things and times along the way
Thank you Lord for every friend
May those friendships never end
Thank you Lord for daughters and sons
Thank you for all their little ones
Thank you Lord for sisters and brothers
Thank you for fathers and mothers
A mother who said her boys didn’t fight
But what were they doing out of her sight
Thank you Lord for the HeartMate Pump
It got me up and off my rump
Thank you Lord for this great life
Thank you for a wonderful wife
A wife who seldom got mad
Threw a slipper once
Thank you Lord, her aim was bad
I think this is all I have to say
Except thank you Lord for this great day.
______________________________________________________________________________
Figure B15. Thank you, Lord, for This Great Day. Author_patient participant.
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APPENDIX B
B16

______________________________________________________________________________
Figure B16. Health and wellness trajectory of patients before and after the LVAD.
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APPENDIX B
Figure B17

_____________________________________________________________________________
Figure B17. Caregivers’ trajectory of adjustments and pervasive worry overtime.
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APPENDIX B
Figure B18
Program of Research
*Palliative and End of Life Care in Older Adults with Chronic Illnesses Who Require LifeSustaining Technology
Patients with chronic
illnesses: advanced heart
failure, stroke, mechanical
circulatory support devices,
and their caregivers

Palliative
Care

Perceptions

Illness
Health behaviors
Stress
Life-sustaining
technology

End of life
Care

Quality of life
Outcomes

Health
Behaviors

Coping
Treatment/Illness
Health promotion

Reducing
Symptom burden

Health Behavior
Interventions

Translation into practice

*Adapted from Indiana University College of Nursing’s Health Behaviors Research Framework

Bio-psycho-sociospiritual
well-being
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Appendix B
Figure 19

_____________________________________________________________________________________________

Figure 19. New self-portrait: LMR.
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APPENDIX C
The University of Michigan Institutional Review Board Approval

Medical School Institutional Review Board (IRBMED) • 2800 Plymouth Rd., Building 200, Room 2086, Ann
Arbor, MI 48109-2800 • phone (734) 763 4768 • fax (734) 763 9603 • irbmed@umich.edu

To: Dr. Francis Pagani
From:

Michael

Geisser

Alan

Sugar

Cc:

Jesus (Jessie)

Casida

Francis

Pagani

Rosalind

Peters

Lydia

McGowan

Susan

Wright

Sarah

Fox

Linda

Marcuccilli

Subject: Amendment [Ame00024322] Approved for [HUM00028567]
SUBMISSION INFORMATION:
Study Title: Self-Concept of Adults Living with Long-Term Implantable LVADs & Lifestyle Adjustments of
Caregivers
Full Study Title (if applicable): Self-Concept and Lifestyle Modification of Adults Living with Long-Term
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Implantable Left Ventricular Assist Devices & Lifestyle Adjustments of Caregivers
Study eResearch ID: HUM00028567
Amendment eResearch ID: Ame00024322
Amendment Title: HUM00028567 (AMDT Part 3)
Date of this Notification from IRB: 8/10/2011
Date of Approval for this Amendment: 8/9/2011
Review: Expedited
Current IRB Approval Period: 2/1/2011 - 1/31/2012
Expiration Date: Approval for this expires at 11:59 p.m. on 1/31/2012
UM Federalwide Assurance (FWA): FWA00004969 expiring on 11/17/2011
OHRP IRB Registration Number(s): IRB00000244
Approved Risk Level(s) as of this Amendment:

Name

Risk Level

HUM00028567 No more than minimal risk
NOTICE OF IRB APPROVAL AND CONDITIONS:
The IRBMED has reviewed and approved the amendment to the study referenced above. The IRB determined that
the proposed research continues to conform with applicable guidelines, State and federal regulations, and the
University of Michigan's Federalwide Assurance (FWA) with the Department of Health and Human Services
(HHS). You must conduct this study in accordance with the description and information provided in the approved
application and associated documents, as amended.
APPROVAL PERIOD AND EXPIRATION: The approval period for this study is listed above. Please note the
expiration date is not changed by the approval of this amendment. If the approval lapses, you may not conduct work
on this study until appropriate approval has been re-established, except as necessary to eliminate apparent immediate
hazards to research subjects. Should the latter occur, you must notify the IRB Office as soon as possible.
IMPORTANT REMINDERS AND ADDITIONAL INFORMATION FOR INVESTIGATORS
APPROVED STUDY DOCUMENTS:
You must use any date-stamped versions of recruitment materials and informed consent documents available in the
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eResearch workspace (referenced above). Date-stamped materials are available in the "Currently Approved
Documents" section on the "Documents" tab.
RENEWAL/TERMINATION:
At least two months prior to the expiration date, you should submit a continuing review application either to renew
or terminate the study. Failure to allow sufficient time for IRB review may result in a lapse of approval that may
also affect any funding associated with the study.
FUTURE AMENDMENTS:
All proposed changes to the study (e.g., personnel, procedures, or documents), must be approved in advance by the
IRB through the amendment process, except as necessary to eliminate apparent immediate hazards to research
subjects. Should the latter occur, you must notify the IRB Office as soon as possible.
AEs/ORIOs:
You must inform the IRB of all unanticipated events, adverse events (AEs), and other reportable information and
occurrences (ORIOs). These include but are not limited to events and/or information that may have physical,
psychological, social, legal, or economic impact on the research subjects or others.
Investigators and research staff are responsible for reporting information concerning the approved research to the
IRB in a timely fashion, understanding and adhering to the reporting guidance
(http://www.med.umich.edu/irbmed/ae_orio/index.htm ), and not implementing any changes to the research without
IRB approval of the change via an amendment submission. When changes are necessary to eliminate apparent
immediate hazards to the subject, implement the change and report via an ORIO and/or amendment submission
within 7 days after the action is taken. This includes all information with the potential to impact the risk or benefit
assessments of the research.
SUBMITTING VIA eRESEARCH:
You can access the online forms for continuing review, amendments, and AEs/ORIOs in the eResearch workspace
for this approved study, referenced above.
MORE INFORMATION:
You can find additional information about UM’s Human Research Protection Program (HRPP) in the Operations
Manual and other documents available at: www.research.umich.edu/hrpp.
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Alan Sugar

Co-chair, IRBMED

Co-chair, IRBMED
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APPENDIX D
Wayne State University Human Investigation Committee Approval
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APPENDIX E
The University of Michigan IRB Amendment: Continuation of Study

Medical School Institutional Review Board (IRBMED) • 2800 Plymouth Rd., Building 200, Room 2086, Ann Arbor, MI 48109-2800 • phone (734) 763 4768 • fax (734) 763 9603 •
irbmed@umich.edu

To: Francis Pagani
From:
Michael

Geisser

Alan

Sugar

Cc:
Jesus (Jessie)

Casida

Francis

Pagani

Rosalind

Peters

Maureen

Daly-Myers

Lydia

McGowan

Sarah

Fox

Linda

Marcuccilli

Subject: Amendment [Ame00027519] Approved for [HUM00028567]
SUBMISSION INFORMATION:
Study Title: Self-Concept of Adults Living with Long-Term Implantable LVADs & Lifestyle Adjustments of
Caregivers
Full Study Title (if applicable): Self-Concept and Lifestyle Modification of Adults Living with Long-Term
Implantable Left Ventricular Assist Devices & Lifestyle Adjustments of Caregivers
Study eResearch ID: HUM00028567
Amendment eResearch ID: Ame00027519
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Amendment Title: HUM00028567_12-28-11 Ame update CVs Casida-Peters
Date of this Notification from IRB: 1/18/2012
Date of Approval for this Amendment: 1/18/2012
Review: Expedited
Current IRB Approval Period: 12/20/2011 - 12/19/2012
Expiration Date: Approval for this expires at 11:59 p.m. on 12/19/2012
UM Federalwide Assurance (FWA): FWA00004969 expiring on 6/13/2014
OHRP IRB Registration Number(s): IRB00001995
Supporting Documents: Updated CVs for Jessie Casida and Rosalind Peters
Approved Risk Level(s) as of this Amendment:
Name

Risk Level

HUM00028567

No more than minimal risk

NOTICE OF IRB APPROVAL AND CONDITIONS:
The IRBMED has reviewed and approved the amendment to the study referenced above. The IRB determined that
the proposed research continues to conform with applicable guidelines, State and federal regulations, and the
University of Michigan's Federalwide Assurance (FWA) with the Department of Health and Human Services
(HHS). You must conduct this study in accordance with the description and information provided in the approved
application and associated documents, as amended.
APPROVAL PERIOD AND EXPIRATION: The approval period for this study is listed above. Please note the
expiration date is not changed by the approval of this amendment. If the approval lapses, you may not conduct work
on this study until appropriate approval has been re-established, except as necessary to eliminate apparent immediate
hazards to research subjects. Should the latter occur, you must notify the IRB Office as soon as possible.
IMPORTANT REMINDERS AND ADDITIONAL INFORMATION FOR INVESTIGATORS
APPROVED STUDY DOCUMENTS:
You must use any date-stamped versions of recruitment materials and informed consent documents available in the
eResearch workspace (referenced above). Date-stamped materials are available in the "Currently Approved
Documents" section on the "Documents" tab.
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RENEWAL/TERMINATION:
At least two months prior to the expiration date, you should submit a continuing review application either to renew
or terminate the study. Failure to allow sufficient time for IRB review may result in a lapse of approval that may
also affect any funding associated with the study.
FUTURE AMENDMENTS:
All proposed changes to the study (e.g., personnel, procedures, or documents), must be approved in advance by the
IRB through the amendment process, except as necessary to eliminate apparent immediate hazards to research
subjects. Should the latter occur, you must notify the IRB Office as soon as possible.
AEs/ORIOs:
You must inform the IRB of all unanticipated events, adverse events (AEs), and other reportable information and
occurrences (ORIOs). These include but are not limited to events and/or information that may have physical,
psychological, social, legal, or economic impact on the research subjects or others.
Investigators and research staff are responsible for reporting information concerning the approved research to the
IRB in a timely fashion, understanding and adhering to the reporting guidance
(http://www.med.umich.edu/irbmed/ae_orio/index.htm ), and not implementing any changes to the research without
IRB approval of the change via an amendment submission. When changes are necessary to eliminate apparent
immediate hazards to the subject, implement the change and report via an ORIO and/or amendment submission
within 7 days after the action is taken. This includes all information with the potential to impact the risk or benefit
assessments of the research.
SUBMITTING VIA eRESEARCH:
You can access the online forms for continuing review, amendments, and AEs/ORIOs in the eResearch workspace
for this approved study, referenced above.
MORE INFORMATION:
You can find additional information about UM’s Human Research Protection Program (HRPP) in the Operations
Manual and other documents available at: www.research.umich.edu/hrpp.
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Alan Sugar

Co-chair, IRBMED

Co-chair, IRBMED
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APPENDIX F
Wayne State University Amendment: Continuation of Study
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APPENDIX G
Letter of Support
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APPENDIX H
Recruitment Protocol for Research Coordinators
Inclusion Criteria for Patients with DT
Able to read, write, and speak English
Men and Women
Must be 18 years of age and older
All races: American Indian/Alaska Native, Black or African American, Asian, Native
Hawaiian/Other Pacific Islander, and White
All ethnicities: Hispanic/Latino, non-Hispanic/Latino
Voluntarily consent to participate in a tape recorded interview
No evidence of cognitive decline
Must have the LVAD as a DT for at least three months
Exclusion Criteria
Unable to read, write, or speak English
Less than 18 years of age
No evidence of cognitive decline
Has the LVAD as a BTT
Had an LVAD then received a donor heart
Inclusion Criteria for Caregivers of Patients with DT
Able to read, write, and speak English
Men and Women
Must be 18 years of age and older
All races: American Indian/Alaska Native, Black or African American, Asian,
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Native Hawaiian/Other Pacific Islander, and White
All ethnicities: Hispanic/Latino, non-Hispanic/Latino
Voluntarily consent to participate in a tape recorded interview
No evidence of cognitive decline
Must have cared for someone with an LVAD as a DT for at least three (3) months.
Exclusion Criteria
Unable to read, write, or speak English
Less than 18 years of age
No evidence of cognitive decline
Cared for someone with an LVAD for less than three (3) months
Cared for someone with an LVAD as a BTT
Cared for someone who received a donor heart after LVAD implantation.
Thank you!

Linda Marcuccilli, PhD Student, RN
Linda Marcuccilli, PhD Student, RN
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APPENDIX I
Outreach Protocol: Inclusion of Women and Minorities
*Proposed Outreach Guidelines
Understand study population.
I will engage in culturally sensitive practices to enhance recruitment and retention of
women and minority populations. I will meet potential participants at the Center for Circulatory
Support outpatient clinic, or a setting of their choice, including community settings, in order to
build trust and enhance the quality of interview. I will spend time with the potential participants
before the interview to build rapport, establish trust, and understand cultural, ethnic, and racial
backgrounds.
Establish an explicit outreach plan.
I will dialogue with LVAD coordinators and make suggestions for establishing set-goals
for recruiting and retaining study participants. Suggestions for LVAD coordinators to enhance
the inclusion of women and minorities, including: Engaging in culturally appropriate
conversations and building trust to enhance recruitment and retainment of women and minorities.
I will communicate with the LVAD coordinators on a weekly basis to keep lines of
communication open.
Achieve agreement on research plans.
I will collaborate with Susan Wright, supervisor/facilitator, LVAD coordinators of the
Center for Circulatory Support, [and community members if any], and members of the
dissertation committee to achieve consensus about the aims and structure of the proposed
research.
Design and conduct evaluations.
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I will collaborate with the supervisor/facilitator, LVAD coordinators, [community
members if any], and members of the dissertation committee to evaluate the recruitment and
retention strategies. Strategies includes: 1) assessing potential participant responses to
recruitment and retention strategies; and 2) assessing compliance through participation in first
and second interviews. Additionally, participants will be asked [at the end of each interview]
about the context of questions in relation to understanding the experience and meaning of living
with DT.
Progress of study.
I will elicit feedback from the supervisor/facilitator and LVAD coordinators about the
progress of the study, and number of accrued participants [including minority and ethnic study
participants] on a weekly basis to evaluate recruitment and retention processes.
Establish and maintain communication.
I will keep supervisor/facilitator, LVAD coordinators, [community members if any], and
members of the dissertation committee informed of research study progress, including emerging
themes. Finally, as a token of appreciation for the participants, collaborating institution, and any
involved community leaders, I will invite participants to a 30-minute presentation of the study
results at the completion of the study.

*Based on the Outreach Notebook for the NIH Guidelines on Inclusion of Women and Minorities as Subjects in
Clinical Research. NIH Publication No. 97-4160, 1997. U. S. Department of Health.
http://Grants.nih.gov/grants/funding/women_min/women_min.htm.
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APPENDIX J
Recruitment Slip

Hello, Mr. /Mrs. ____________________.
We are looking for research participants who either have a LVAD as a DT, or care for a person
with a DT. We would like to talk about your experience of living with and caring for someone
with a LVAD as a DT. Research volunteers will participate in one face-to-face interview, lasting
for no more than one hour, and one follow-up telephone call, lasting for no more than thirty (30)
minutes after the interview. The study is strictly on a voluntary basis, and requires us to pass on
your name and home phone number to the primary research investigator, Linda Marcuccilli, to
contact you.
If you would like to hear more about the research, please let us know so that we can contact the
primary research investigator to discuss your participation in the research study.
Thank you!
The Center for Circulatory Support
The University of Michigan Health Care Systems
Primary Research Investigator
Linda Marcuccilli, PhD Student, RN
Wayne State University College of Nursing
lckmster@hotmail.com
1.313.300.9269
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APPENDIX K
Mini-Cog
The Mini Cog Administration
The test is administered as follows:
1. Instruct the patient to listen carefully to and remember 3 unrelated words and then to repeat
the words.
2. Instruct the patient to draw the face of a clock, either on a blank sheet of paper or on a sheet
with the clock circle already drawn on the page. After the patient puts the numbers on the clock
face, ask him or her to draw the hands of the clock to read a specific time.
3. Ask the patient to repeat the 3 previously stated words.
Scoring
Give 1 point for each recalled word after the clock drawing test (CDT) distracter.
Patients recalling none of the three words are classified as demented (Score = 0).
Patients recalling all three words are classified as non-demented (Score = 3)
Patients with intermediate word recall of 1-2 words are classified based on the CDT (Abnormal
= demented;
Normal = non-demented)
Note: The CDT is considered normal if all numbers are present in the correct sequence and
position, and the hands readably display the requested time.
From Borson, S., Scanlan, J., Brush, M., Vitallano, P., & Dokmak, A. (2000). The Mini-Cog: A
cognitive ‘vital signs’ measure for dementia screening in multi-lingual elderly. International
Journal of Geriatric Psychiatry, 15(11), 1021-1027. Copyright John Wiley & Sons Limited.
Reproduced with permission (See below).
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Mini-Cog Permission for Use
Copyright.com special order (10211320)
Confirmation Number: 10211320
Updates on Items You Ordered:
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 51252744
Current Status: Granted
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APPENDIX L
*Demographic Profile of Adults with LVADs as DT
Participant Code:
Age:

Gender:

Race (circle one):
African American

Asian

White/non-Hispanic

Black/non-Hispanic

Native American

Alaska Native

Pacific Islander

other (please specify):

2 or more races (please specify):
3 or more races (please specify):
Decline to answer:
Ethnic Origin:
Hispanic

Latino

Other (please specify):

Marital Status (circle one):
Married

Single

Divorced

Widow

Domestic Partner
Number of Children:
Highest Educational Level (circle one):
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
HS

TT

AD

UG

20 +

Other (please specify):

G

D

(HS = high school; TT = technical trade; AD = associate degree; Undergrad = bachelor’s degree;
Grad = graduate degree; D = doctoral degree)
Relationship to caregiver: _______________________________________________________
Living Arrangement: (dwelling, number of people living in home):_____________________
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Do you live with your caregiver? _________________________________________________

*Adapted from Casida (2009) Self-Concept and Lifestyle Modification of Adults Living with
Long-Term Implantable Left-Ventricular Assist Devices: A Qualitative Study
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APPENDIX M
*Demographic Profile of Caregivers of Adults with LVADs as DT
Participant Code:
Age:

Gender:

Race (circle one):
African American

Asian

White/non-Hispanic

Black/non-Hispanic

Native American

Alaska Native

Pacific Islander

other (please specify):

2 or more races (please specify):
3 or more races (please specify):
Decline to answer:
Ethnic Origin:
Hispanic

Latino

Other (please specify):

Marital Status (circle one):
Married

Single

Domestic Partner

Decline

Divorced

Widow

Number of Children:
Highest Educational Level (circle one):
0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19
HS

TT

AD

UG

G

20 +

Other (please specify):

D

(HS = high school; TT = technical trade; AD = associate degree; Undergrad = bachelor’s degree;
Grad = graduate degree; D = doctoral degree)
Relationship to LVAD patient: ___________________________________________________
Living Arrangement: (dwelling, number of people living in home):_____________________
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Are you currently working? If so, hours per week: __________________________________
Hours spent with LVAD patient per day: _________________________________________

*Adapted from Casida (2009) Self-Concept and Lifestyle Modification of Adults Living with
Long-Term Implantable Left-Ventricular Assist Devices: A Qualitative Study.
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APPENDIX N
Patient Interview Script
Questions for participants with LVAD DT
Tell me about living with an LVAD.
Tell me about a typical day about life with an LVAD – from the time you get up until the time
you go to bed.
When you look back over the time when you have had this LVAD, what event stands out in your
mind?
What are all the things you must do to care for your LVAD?
How would you describe your life just before you received this LVAD?
What are all the things that changed after you received this LVAD?
Who are designated as your caregivers?
What are all of the responsibilities of a caregiver?
How would you characterize your relationship with your caregiver?
As you know, you meet this research study’s inclusion criteria because your LVAD was the only
therapeutic option available to you. Could you describe what is means to you to have the LVAD
under these circumstances?
I wonder if you know what medical practitioners call your circumstance.
Have you ever heard someone call this circumstance a “DT”
In your opinion, what do you make of this terminology?
Imagine for a moment your caregiver’s perspective on having an LVAD as a final therapy. In
your opinion, how would they describe knowing that there are no other options?
Is there anything else that I didn’t think to ask that, in your opinion, would help me understand
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your experiences caring for someone with an LVAD as a final option?
Thank you for you time and patience. Your answers will help healthcare professionals provide
care for recipients of LVADs.
Probing Questions:
Examples, neither inclusive nor exhaustive:
Are there other things that make it stand out?
Can you describe your feelings surrounding [name of their event]?
Are there other things that you do every day...
How did that make you feel...
Are there other things about living with an LVAD that would help me understand what it is like
to live with it?
I’m not sure I understand what you men when you say [their exact words]. Could you explain
that for me?
Could you describe an example or situation that illustrates what you mean when you say [their
exact words]?
Could you describe a situation that illustrates your relationship with your caregiver?
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APPENDIX O
Caregiver Interview Script
Questions for caregivers for a patient with a DT
Tell me about caring for someone living with an LVAD.
Tell me about a typical day for caregivers caring for someone with an LVAD – from the time
you get up until the time you go to bed.
When you look back over the time when you have been caring for someone living with this
LVAD, what event stands out in your mind?
What are all the things you must do as a caregiver for someone with an LVAD?
Now, I’d like to go back in time and discuss the time when you first learned that the person you
are caring for would receive this LVAD. How would you describe your life just before the
person you are caring for received this LVAD?
Now think over the period from learning about this LVAD and now: What are all the things that
changed after the person you are caring for received this LVAD?
Now, I would like to talk about how you coordinate your care with the LVAD recipient.
What are all of the responsibilities of the LVAD recipient?
How would you characterize your relationship with the LVAD recipient?
As you know, you meet this research study’s inclusion criteria because an LVAD was only
therapeutic option available to the person you care for. Could you describe what is means to you
to care for someone with an LVAD under these circumstances?
How would you describe knowing that there are no other options?
I wonder if you know what medical practitioners call your circumstance.
Have you ever heard someone call this circumstance a “DT?”
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Finally, imagine for a moment the LVAD recipient’s perspective on having an LVAD as a final
therapy. In your opinion, how would they describe the LVAD recipient’s knowing that there are
no other options? What do you think their feelings are about their having no other options?
Is there anything else that I didn’t think to ask that, in your opinion, would help me understand
your experiences caring for someone with an LVAD as a final option?
Thank you for you time and patience. Your answers will help healthcare professionals
understand the needs of caregivers of recipients of LVADs.
Probing Questions:
Examples, neither inclusive nor exhaustive:
Are there other things that make it stand out?
Can you describe your feelings surrounding [name of their event]?
Are there other things that you do every day...
How did that make you feel...?
Are there other things about living with an LVAD that would help me understand what it is like
to live with it?
I’m not sure I understand what you men when you say [their exact words]. Could you explain
that for me?
Could you describe an example or situation that illustrates what you mean when you say [their
exact words]?
Could you describe a situation that illustrates your relationship with your caregiver?
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Left-ventricular assist devices (LVADs) have improved the quality of life for many
patients with advanced heart failure. Past research focused on technology issues and survival
rates, but patients’ and caregivers’ perspectives of living with an LVAD as a destination therapy
(e.g., permanent alternative to transplant) was not explored. Roy’s adaptation model provided a
framework to guide an understanding of how participants adjusted and accepted living with
destination therapy. A hermeneutic-phenomenology as described by van Manen was used to
explore and describe the essence of destination therapy from patients’ and caregivers’
perspectives in order to understand the meaning of this experience. Data saturation was achieved
with 14 participants (7 men as patients, 71-76 years old; 1 man and 6 women as caregivers, 5074 years old), who lived with destination therapy at home. Data was collected using open-ended
interviews, thematic analysis was ongoing, and final themes were consensually validated.
Procedures to ensure trustworthiness are described. Themes were consistent with Roy’s
adaptation model. Participants illustrated a process of adjustment and eventually accepted the
LVAD as part of their lives. Patients adjusted to the LVAD as part of their bodies, accepted the
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device as necessary to live, and exhibited an improved quality of life. Caregivers described
persistent worry and stress and accepted caregiving as part of life. Dyadic perspectives reflected
gratefulness for more time to live despite uncertainties about death and dying. Findings advance
the knowledge of destination therapy management.

These findings may direct a holistic

approach to palliative and end of life care, and can heighten nurses’ awareness about the process
of adaptation as a vital component for the promotion and maintenance of health and well-being
among this growing population.
Key words:

left-ventricular assist devices, destination therapy, caregivers, hermeneutic

phenomenology, Roy Adaptation Model.
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AUTOBIOGRAPHICAL STATEMENT

As I reflect upon the words set forth by van Manen in my preface, I was ‘struck with
wonder,’ even ‘rendered speechless,’ as participants’ recounted their lives and experiences of
living with DT. Being given the opportunity to hear the stories of participants’ experiences of
living with a such a life-sustaining device has clearly affected me emotionally, but I am still
Linda – a woman, a wife, a mom, a spiritual human being, and a nurse scientist. Yes, the stories
of my participant struggles, thoughts, beliefs, and brushes with death, have clearly affected me in
ways that are indescribable. But in the end, I learned to embrace the external forces which come
our ways in unexpected ways – to turn to my family for support, believe in myself, who I am,
and the work I’m going to do to help those afflicted with life-limiting illnesses and their
caregivers. My new self-portrait (Figure B19) reflects an infectious enthusiasm for a life filled
with unknowns and hopes for a productive and successful career in meeting the needs of those
who need it most.

